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ABSTRACT
Only one in ten Entamoeba histolytica infections is invasive but they are responsible for an 
annual death toll of up to 100,000 people. A key question in amoebiasis is, therefore, what 
is responsible for the variable outcome of infection. To investigate whether it is linked to 
the genotype of the infecting strain, we developed 6 pairs of species-specific primers for 
genotyping after investigating 46 potentially polymorphic short tandem repeat loci adjacent 
to tRNA genes that were identified during the E. histolytica genome project. We tested the 
primers using E. histolytica samples from Bangladesh and 11 other countries. Results 
revealed that the genotypes present in 3 different clinical populations - asymptomatic, 
diarrhoeal/dysenteric and liver abscess - were different from each other. A few individual 
genotypes also showed links to the outcome o f infection although their sample coverage 
was low and therefore they had little predictive value. Although the loci used as 
polymorphic markers are unlikely to be directly responsible for the outcome of infection, 
the results do suggest that parasite genetic factors are at least partly responsible.
Our multilocus genotyping method is simple and reliable as it amplifies DNA extracted 
from axenic or xenic culture, stool samples, and liver abscess pus samples. We believe that 
these markers will help in studying the patterns of transmission o f this important disease 
and the epidemiological links between individual infections.
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CHAPTER 1
INTRODUCTION
Entamoeba histolytica is an intestinal protozoan parasite and the causative agent of 
amoebiasis. According to the most cited reference (Walsh, 1986) one-tenth of the world 
population is infected with E. histolytica, resulting in up to 100,000 deaths worldwide each 
year (Anonymous, 1997; Petri et al, 2000). However, this estimate predates the formal 
separation of pathogenic E. histolytica from non-pathogenic E. dispar (Diamond and Clark, 
1993) and is now being reassessed. Current data indicate that E. dispar is perhaps ten times 
more common than E. histolytica world-wide (Gathiram and Jackson, 1985), but local 
prevalence may vary significantly. However it is already clear that not all E. histolytica 
infections lead to disease in the host but that at most one in ten E. histolytica infections 
progresses to development of clinical symptoms (Gathiram and Jackson, 1987). 
Nevertheless, E. histolytica remains a significant source of morbidity and mortality in 
developing countries (Stanley, 2003). For example, the annual incidence o f amoebic 
dysentery in preschool children in Bangladesh is 2.2% compared to 5.3% for Shigella 
dysentery. In that country one in every 30 children dies of diarrhoea or dysentery before 
reaching his or her fifth birthday (Haque et al, 2003). In Hue City, Vietnam the annual 
incidence o f amoebic liver abscess is 21 cases per 100,000 inhabitants (Blessmann et al, 
2002).
1.1. Entamoeba histolytica and Entamoeba dispar
There are many species in the genus Entamoeba and at least six of them infect humans, 
namely Entamoeba histolytica, E. dispar, E. coli, E. moshkovskii, E. hartmanni, and E. 
gingivalis. In addition there are very rare case reports of E. polecki and E. chattoni 
infections in humans (Chacin-Bonilla, 1992; Kuroki et al, 1989; Sargeaunt et al, 1992; 
Verweij et al, 2001) though they are normally associated with pigs and non-human 
primates, respectively. It is only E. histolytica that causes disease in humans. This organism
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is the fourth leading cause of mortality due to a protozoan infection after malaria, Chagas’ 
disease, and leishmaniasis and the third cause o f morbidity among protozoa after malaria 
and trichomoniasis (Anonymous, 1998).
The correct taxonomic classification of Entamoeba species is not very clear. The following 
is one the taxonomic classification of Entamoeba histolytica that has been widely used 
(Levine et al, 1980); however, many of the taxonomic names may not represent 
monophyletic evolutionary groups:
Kingdom
Subkingdom
Phylum
Subphylum
Class
Order
Family
Genus
Species
Protista
Protozoa
Sarcomastigophora
Sarcodina
Lobosea
Amoebida
Endamoebidae
Entamoeba
E. histolytica
1.1.1. History
This brief history of E. histolytica is based on: Martinez-Palomo (1993) and Petri (1996).
In 1875, Fedor Aleksandrovich Losch first identified amoebae in clinical samples from a 
case of fatal dysentery, reproduced the disease in dogs, and suggested the name Amoeba 
coli for this species. In 1890, Osier first positively diagnosed a case of amoebic liver 
abscess. One year later Councilman and Lafleur, at Johns Hopkins Hospital, confirmed the 
pathological role o f amoebae through studies on patients with dysentery and liver abscesses 
and introduced the terms “amoebic dysentery” and “amoebic liver abscess”. The organism 
was formally named Entamoeba histolytica by Schaudinn in 1903. In 1919, Dobell 
reviewed all the published species descriptions and concluded that there was only one
12
species of Entamoeba in humans that produced quadranucleated cysts, and retained 
Schaudinn’s name E. histolytica for it.
As early as 1925, Brumpt suggested the existence of two morphologically identical species, 
one being pathogenic and the other not, and proposed the name Entamoeba dispar for the 
nonpathogenic species. Following much debate E. dispar was finally separated from E. 
histolytica (Diamond and Clark, 1993) and accepted as a distinct species.
1.1.2. The life cycle
Dobell described the life cycle of E. histolytica in 1928. It consists o f four consecutive 
stages, namely, trophozoite, precyst, cyst, and metacyst. Infection is acquired by the 
ingestion of the mature cyst form of the amoeba which is, in contrast to the trophozoite 
form, resistant to the acidic pH of the stomach. Excystation occurs as it enters the large 
bowel, with the emerging amoeba dividing into four and then eight metacystic trophozoites. 
Trophozoites have the ability to colonize and / or invade the large bowel and may encyst. 
Cysts do not develop within tissues (Petri, 1996).
Upon excretion, cyst forms o f the amoeba remain viable for weeks to months depending on 
environmental conditions but excreted trophozoites degenerate rapidly outside the body. 
Infection can result from the ingestion o f a single cyst (Ravdin, 1995), however a higher 
inoculum results in a shorter incubation period of a few days for the onset of disease rather 
than the more usual few weeks. The duration of infection varies from subject to subject and 
cysts have been demonstrated in untreated persons for as long as two years (Martinez- 
Palomo, 1993). A schematic representation of the life cycle o f E. histolytica is shown in 
Figure 1.1.
1.1.3. Morphology
Under normal light microscopy the morphology o f E. histolytica and E. dispar trophozoites 
and cysts is considered to be indistinguishable (Diamond and Clark, 1993). The trophozoite
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form of both species is highly dynamic and pleomorphic (i.e. many-formed) with an 
average diameter of 25 pm (range 10-60 pm). It has a single nucleus o f 3-5 pm in diameter, 
which contains fine peripheral chromatin and a central karyosome (dark-spot-like in 
appearance). The nucleus has no fixed position in the cytoplasm, and also moves freely. 
Motility and pseudopod formation are rapid and unidirectional, although movement rarely 
occurs in a straight line.
The mature cyst is round to oval shaped and contains 4 nuclei (i.e. is quadranucleate). Its 
average diameter is 12 pm (range 10-16 pm). Generally, glycogen and chromatoid bodies 
(aggregated crystals of ribosomes) are seen in the immature precystic stage but disappear as 
the cyst matures. The nucleus is smaller than in the trophozoite and also contains a smaller 
centrally located karyosome.
In general, in axenic culture E. dispar trophozoites are elongated while E. histolytica 
trophozoites are more round shaped. Also the cell surface o f E. histolytica is rough with 
numerous small circular openings in contrast to that of E. dispar which are smoother in 
appearance.
1.1.4. Cultivation
In 1925, Boeck and Drbohlav first successfully cultivated E. histolytica in vitro by using 
Locke’s-egg-serum medium. However the most frequently used xenic culture media (in the 
presence of a mixed bacterial flora) are those of Balamuth (1946), Jones (1946), and 
Robinson (1968). These media are not specific for E. histolytica and E. dispar and support 
the growth of other Entamoeba species. The first axenic cultivation of E. histolytica was 
achieved by Diamond (1961, 1968, 1978). Clark (1995) first established E. dispar in axenic 
culture after much difficulty. Clark and Diamond (2002) have provided a succinct account 
of the history o f intestinal amoeba cultivation.
14
A -  Infective Stag«
A - Diagnostic Stage
*  Noninvastve Colonization 
jTjj = Intestinal Disease 
□  - Exlraintestinal Disease
m -
E*cysla!ioo
O
r * %
—e-MuStipiica.ion
Trophozoites \ ,  fV) V*
a
Cysts iik A
Figure 1.1. Life cycle of Entamoeba histolytica (taken from: www.dpd.cdc.gov/dp- 
dx/HTML/ Amebiasis.htm).
1.1.5. C.linical manifestations
Most A. histolytica infections remain asymptomatic. Invasive intestinal infection or 
amoebic colitis is marked by loose stools containing blood and mucus. Complications of 
amoebic colitis include perforation and secondary bacterial infection of ulcers and are
15
associated with very high mortality rates. Occasionally, chronic ulceration results in 
amoeboma formation (a tumour-like growth due to amoeba).
The most common form of extraintestinal amoebiasis is the amoebic liver abscess, which 
unless properly diagnosed and promptly treated is a potentially lethal disease. In areas of 
endemicity, amoebic liver abscess is suspected in a patient with fever, weight loss, and 
right upper quadrant pain and tenderness (Haque et al, 2000).
There are sporadic case reports of cerebral amoebiasis (Hughes et al, 1975; Sundaram et al, 
2004; Schmutzhard et al, 1986) which has an abrupt onset and rapid progression, resulting 
almost always in death. Infections of kidney (Ramakrishnan et al, 1971), heart (Mehta et al, 
1968), lung (Hara et al, 2004; Lichtenstein et al, 2005; Snyders and Welke, 1989; Teramoto 
et al, 2001), appendices (Casavilca et al, 2000; Ramdial et al, 2002), and skin (Kroft et al, 
2005; Magana et al, 2004) by E. histolytica have also been reported.
Although E. dispar is considered a harmless commensal in human hosts, there are a few 
reports that E. dispar is capable of producing variable focal intestinal lesions in animals 
(Chadee et al, 1985; Espinosa-Cantellano et al, 1997; Vohra et al, 1989). Also there is some 
evidence that pathological changes may occur in some humans (McMillan et al, 1984) due 
to E. dispar infection. All these findings indicate that there may be some strains of E. 
dispar that are capable of producing mild disease in hosts.
1.1.5. Treatment
E. histolytica infections can have various manifestations in humans. Infected persons may 
remain asymptomatic throughout before clearing the amoebae spontaneously. 
Alternatively, infection may cause invasive disease at intestinal or extraintestinal sites. 
From the treatment point of view a decision has been made that E. histolytica infections, 
whether symptomatic or not, must be treated (Anonymous, 1997). On the other hand, E. 
dispar infection (and perhaps E. moshkovskii infection as well) does not require any
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treatment but should be monitored closely for the possibility of becoming co-infected with 
E. histolytica. This depends on being able to distinguish the species, however.
The treatment of amoebiasis has two fundamental goals: one, to eliminate the passage of 
cysts or trophozoites from the bowel lumen, and two, to cure invasive disease at both 
intestinal and extraintestinal sites. Diloxanide furoate (Furamide) is currently considered 
the drug of choice for eradicating intralumenal cyst passage and has an 85% success rate 
over a 10-day course (3 doses of 500 mg per day). Treatment is considered successful if  the 
stool remains free o f cysts or trophozoites for one month. Diloxanide is relatively nontoxic 
with only occasional mild gastrointestinal symptoms (McAuley et al, 1992). Another 
lumenal agent is paromomycin (Humatin). Unlike diloxanide it is not absorbed from the 
gastrointestinal tract and therefore is safe in pregnancy. Its side effects can include 
diarrhoea and abdominal pain (McAuley and Juranek, 1992). However, a recent study has 
compared the efficacy of both drugs and has shown that paromomycin had a much higher 
cure rate than diloxanide furoate (85% versus 51%) in the treatment of asymptomatic E. 
histolytica carriers (Blessmann and Tannich, 2002).
Metronidazole (Flagyl) is the preferred drug for patients with acute and chronic invasive 
intestinal disease. Metronidazole is a 5-nitroimidazole derivative with anti-microbial 
activity against some anaerobic bacteria as well as protozoa such as E. histolytica and 
Giardia intestinalis. Investigations in many controlled studies have shown that 
metronidazole has a cure rate of over 90% (Samuelson et al, 1992; Simjee et al, 1985). 
Depending on the amount of drug (750 mg to 2.4 g) metronidazole can be used for 3 to 10 
days to achieve success (Briggs et al, 1994). Although multi-drug resistance genes and 
drug-efflux mechanisms do exist in E. histolytica, resistance to metronidazole has not yet 
been a clinical problem. Since this drug cannot eliminate the intestinal infection, a lumenal 
agent must also be administered with or following it. Common side effects of 
metronidazole include gastrointestinal (metallic taste, abdominal discomfort) and central 
nervous system (headache, dizziness, and drowsiness) problems (Roe, 1985). Tinidazole, 
another 5-nitroimidazole, is another drug of choice outside of the USA and Canada for 
invasive amoebiasis and has fewer side effects.
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For the treatment of extraintestinal lesions like amoebic liver abscess, the drug of choice is 
again metronidazole: a single dose of 2.5 g for mild to moderate disease is enough followed 
by an agent to eradicate intralumenal infection. An alternative drug for amoebic liver 
abscess is chloroquine, which is an amoebicide in hepatic tissue alone.
1.1.6. Vaccine against amoebiasis
Researchers are using molecular biology techniques to try and develop a safe, reliable and 
efficient vaccine to prevent amoebiasis. Studies with the gerbil model of amoebic liver 
abscess have identified recombinant E. histolytica antigens that can protect animals from 
amoebic liver abscess (Zhang and Stanley, 1996). Successful oral administration of the 
vaccine has been achieved in the gerbils, with induction of mucosal immune responses. 
However, there are no data available on the efficacy o f this candidate vaccine in preventing 
intestinal amoebiasis. This is a problem mainly because there is no reliable animal model 
for intestinal amoebiasis. However an earlier study showed that guinea pigs infected 
intracaecally with a noninvasive strain of E. histolytica could be protected against 
subsequent challenge with a virulent strain (Jain et al, 1980). Several other studies have 
shown that rats, hamsters, or monkeys vaccinated with either intact amoebae or various 
forms o f complex amoebic antigens could be protected from amoebic liver abscess 
formation (Ghadirian and Meerovitch, 1978; Ghadirian et al, 1980; Jimenez Cardoso et al, 
1989; Martinez-Reyes et al, 1980; Sepulveda, 1980). The recent demonstration that the 
recombinant amoebic SREHP antigen can be mucosally immunogenic when delivered by 
attenuated Vibrio cholerae or Shigella typhi vectors provides additional evidence that the 
combination vaccine can be effective against multiple enteric pathogens (Zhang et al, 1995; 
Zhang and Stanley, 1996). Cheng and Tachibana (2001) and Lotter et al (2004) have 
reported protection of hamsters and gerbils, respectively, from amoebic liver abscess by 
immunization with surface lectin antigens of E. histolytica. Houpt et al (2004) have 
reported successful prevention o f intestinal infection by E. histolytica using the 
galactose/N-acetyl-galactosamine (Gal/GalNAc) lectin vaccine in a mouse model.
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1.1.7. Epidemiology
The worldwide prevalence of E. histolytica and E. dispar as separate species is not well 
studied. The prevalence of amoebic infection is high in the Indian subcontinent, Africa, the 
Far East, and areas o f South and Central America. In developing countries it depends 
largely on cultural habits, age, level of sanitation, crowding and socio-economic status. In 
developed countries, the infection is mostly due to E. dispar and is confined to certain 
group o f people: immigrants from or travelers to areas o f endemicity, homosexual males, 
patients infected with immunodeficiency virus, and institutionalized populations (Petri, 
1996). In Japan, however, carriage o f E. histolytica is more common (Martinez-Palomo, 
1993). Case studies of patients with amoebic colitis in Natal, South Africa, showed that 
there was a peak incidence of infection among children <14 years o f age and a second 
increase in infection in adults >40 years old (Gathiram and Jackson, 1985). Acuno-Soto et 
al (2000) after reviewing all the published reports from 1929 to 1997 found that the male to 
female ratios for invasive intestinal amoebiasis and asymptomatic carriage were 3.2:1 and 
1:1, respectively.
Some examples o f the prevalence of E. histolytica and E. dispar infection using different 
diagnostic methods are provided below:
Using microscopy:
• Thailand - 7.1% E. histolytica / E. dispar among the mentally handicapped 
(Sirivichayakul et al, 2003).
• Lebanon - 2.3% E. histolytica / E. dispar in adults (Saab et al, 2004).
• Gaza Strip, Palestine - 7.0% E. histolytica / E. dispar among 6 to 11 year-old 
children (Astal, 2004).
• Bat Dambang, Cambodia - 0.8% E. histolytica / E. dispar among school children 
(Park et, 2004)
• Korea - 1.8% E. histolytica / E. dispar among handicapped people (Lee et al 2000).
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Using isoenzyme analysis:
• South Africa -  1.0% E. histolytica and 9.0% E. dispar (Gathiram and Jackson,
1985).
• Ecuador - E. dispar 4-times more prevalent than E. histolytica (Gatti et al, 2002).
Using antibody detecting ELISA tests:
• Mexico - 8.4% of the population seropositive (Caballero-Salcedo et al, 1994).
Using antigen detecting ELISA tests:
• Bangladesh - 5% E. histolytica and 13% E. dispar among 2-5 year old children 
(Haque et al, 1999) and a 12-month follow-up revealed that only about 3% o f E. 
histolytica infected children developed symptoms attributable to amoebic dysentery 
(Haque et al, 2001).
Using species-specific PCR tests:
• Ethiopia - Only E. dispar among school children, prisoners and HIV patients 
(Kebede et al, 2003,2004).
• Japan - 56% of homosexual males carry E. histolytica (Ohnishi et al, 2004).
• Vietnam - 11.2% E. histolytica in asymptomatic adults and a 15-month follow-up of 
43 asymptomatic E. histolytica carriers revealed that none developed invasive 
intestinal disease, although one developed an amoebic liver abscess (Blessmann et 
al, 2003). Previously they showed the rate o f amoebic liver abscess infection in this 
community was 21 cases per 100,000 inhabitants (Blessmann et al, 2002).
• Iran - E. dispar 10-15 times more prevalent than E. histolytica (Hooshyar et al, 
2004).
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The association of amoebasis with HIV-positive individuals is not clear. A recent case- 
control study at Taiwan with 951-HIV infected individuals, 429 HIV uninfected but with 
gastrointestinal symptoms and 178 HIV uninfected healthy individuals shows that HIV 
infected individuals are at higher risk for invasive amoebiasis. Over 3% of HIV infected 
individuals had E. histolytica infections compared to only 1.4% in uninfected healthy 
individuals as detected by PCR and antigen detection ELISA (Hung et al, 2005). In 
contrast, Mohandas et al (2002) observed that only 2 of 120 HIV seropositive persons were 
positive for E. histolytica!E. dispar by microscopy in India. Since the information on 
infections with E. histolytica!E. dispar in a control group was not available it is not 
possible to predict whether HIV-positive individuals were at higher risk in India. However, 
two separate studies with children in India found a high prevalence of E. histolytica!E. 
dispar by microscopy. One, a microscopy investigation o f stool specimens of school 
children from Delhi, found that 11% of them were positive for E. histolytica / E. dispar 
(Kaur et al, 2002). The second, a study carried out in rural and urban locations in and 
around Chennai detected 4% and 10.6% oiE . histolytica / E. dispar, respectively, among 
school children by microscopy (Fernandez et al, 2002). Considering these study results it 
seems more likely that HIV-infected individuals are not at a higher risk for infection with 
E. histolytica ! E. dispar in India.
1.1.8. Diagnosis
From the epidemiological point of view specific detection o f E. histolytica and E. dispar is 
necessary to know the true prevalence of each species. Most of the epidemiological data for 
intestinal amoebiasis are based on the diagnosis of these two species in stool specimens by 
light microscopy. However, identification o f E. dispar and E. histolytica by microscopy is 
not precise. Microscopy is unable to differentiate E. histolytica from E. dispar, is at best 
60% sensitive, and can be confounded by false-positive results due to misidentification of 
macrophages and non-pathogenic species o f Entamoeba. Culture is more sensitive than 
microscopy (Gonzalez-Ruiz et al, 1994), and isoenzyme analysis of cultured amoebae 
enables the differentiation o f E. histolytica from E. dispar. However, culture and 
isoenzyme analysis requires a week to complete and is negative in many microscopy-
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positive samples due to delays in sample processing or due to the initiation o f antiamoebic 
therapy prior to stool collection (Gonzalez-Ruiz et al, 1994; Haque et al, 1997; Strachan et 
al, 1988). New approaches have been used to detect E. histolytica and E. dispar based on 
antigen detection in stool specimens (Abd-Alla et al, 1993; Haque et al, 1993; Haque et al, 
1995; Haque et al, 1997; Strachan et al, 1988). Although the detection of amoebic antigen 
in stool specimens is a simple and reliable method, there is one limitation: it cannot detect a 
mixed infection of both species simply because there is no E. dispar specific monoclonal 
antibody available at present. There are many reports on the successful species specific 
PCR amplification o f E. histolytica and E. dispar DNA (Britten et al, 1997; el-Hamshary et 
al, 2004; Katzwinkel-Wladarsch et al, 1994; Newton-Sanchez et al, 1997; Romero et al, 
1992; Sharma et al, 2003; Tannich and Burchard, 1991). Paglia et al (2004) reported the 
development of a diagnostic nested PCR to detect E. histolytica and E. dispar from both 
fresh and formalin-fixed stool samples. Recently Blessmann et al (2002) and Roy et al 
(2005) described two very fast and highly sensitive Real-Time PCRs for the detection and 
differentiation of E. histolytica and E. dispar in faecal samples. Serological tests, 
particularly in areas of endemicity, can provide little information, as they cannot 
distinguish between acute and past infections.
Furrows et al (2004) tried to assess the efficiency o f 3 diagnostic methods -  a commercial 
antigen detecting ELISA (TechLab, Inc.), a polymerase chain reaction-solution 
hybridization enzyme linked immunoassay (PCR-SHELA), and a Real-Time PCR (Artus) -  
for diagnosis of is. histolytica infection using 101 clinical samples. They concluded that all 
three methods performed adequately and choice of method should depend on the budget 
and timeframe of the study.
The diagnosis of amoebic liver abscess is sometimes difficult since its clinical 
manifestations are highly variable. Imaging techniques such as ultrasound, computed 
tomography, and magnetic resonance have excellent sensitivity for the detection of a liver 
abscess arising from any cause but cannot distinguish amoebic abscesses from pyogenic 
(bacterial) abscesses or necrotic tumors. Some studies have reported that amoebic liver 
abscess patients do not have concomitent amoebic colitis and therefore stool microscopy or
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antigen detection in stool specimens is not helpful for diagnosis: less than 10% patients 
have identifiable amoebae in stool (Haque et al, 2000; Katzenstein et al, 1982). Serological 
tests demonstrate the presence of antiamoebic antibodies in serum and are positive for most 
patients with amoebic liver abscess. Several groups have reported the detection of amoebic 
antigen in the serum of amoebic liver abscess patients (Abd-Alla et al, 1993; Haque et al, 
2000; Karki and Parija, 1999). For example, Abd-Alla and colleagues (1993) detected the 
Gal/GalNAc lectin, a major surface antigenic molecule in E. histolytica, in the sera o f 75% 
of South African patients with amoebic liver abscess. In Dhaka, Bangladesh, the TechLab 
E. histolytica II test detected Gal/GalNAc lectin in the sera o f 96% of amoebic liver abscess 
patients tested prior to treatment with the antiamoebic drug metronidazole.
In conclusion, the accurate diagnosis of E. histolytica and E. dispar is important for two 
reasons, one, to understand the worldwide distribution of the two species separately, and 
two, to prevent unnecessary chemotherapy in patients infected with E. dispar but wrongly 
identified as being infected with E. histolytica.
1.2. Entamoeba moshkovskii
Entamoeba moshkovskii, which is mainly considered to be a free-living amoeba, 
is indistinguishable in both its cyst and trophozoite forms from E. histolytica and E. dispar. 
Both E. polecki (associated with pigs) and E. chattoni (associated with non-human 
primates) which occasionally infect humans, have uninucleate cysts. E. coli and E. 
hartmanni have 8 and 4 nuclei each, respectively, but the size o f the E. hartmanni cysts and 
trophozoites is much smaller than E. histolytica and E. dispar. E. gingivalis, a parasite of 
human oral cavity, is a non-encysting species. As a result, as far as diagnosis of amoebiasis 
is concerned none of these species is a problem. E. moshkovskii has so far rarely been 
shown to infect humans but appears to be ubiquitous in anoxic sediments. Although the 
early isolations of this species were from sewage, E. moshkovskii can also be found in 
environments ranging from clean riverine sediments to brackish coastal pools (Clark and 
Diamond, 1997). It is osmotolerant, can be cultured at room temperature, and is resistant to 
emetine, all characteristics that distinguish it from E. histolytica and E. dispar (Clark and
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Diamond, 1997; Dreyer, 1961; Entner and Most, 1965; Richards et al, 1966). Human 
isolates o f£ . moshkovskii to date have come from North America, Italy, South Africa and 
Bangladesh, and they have never been associated with disease (Clark and Diamond, 1997; 
Haque et al, 1998a).
The morphological resemblance of the apparently innocuous E. moshkovskii to the disease- 
causing E. histolytica makes it important to differentiate the two species. In the clinical 
setting, for example, an E. moshkovskii infected patient could be diagnosed as infected with 
E. histolytica and be treated unnecessarily with anti amoebic chemotherapy. Most studies 
that have investigated the prevalence o f E. histolytica and E. dispar have not considered the 
possible presence of E. moshkovskii. This is partly due to a lack of tools to detect E. 
moshkovskii. The importance of this species is therefore unclear at present.
1.3. Inter- and intra-species genetic variation
There have been several studies of inter- and intra-species variation in E. histolytica and E. 
dispar. Sargeaunt et al (1978) first introduced isoenzyme electrophoresis to study 
polymorphism in intestinal protozoan parasites in humans. After studying approximately 
10,000 intestinal amoebic isolates Sargeaunt (1988) identified 20 different isoenzyme 
patterns (known as ‘zymodemes’): 9 proved to be those ofE.  histolytica (pathogenic 
zymodemes, PZ) and while the rest were E. dispar (non-pathogenic zymodemes, NPZ). 
However, recent studies suggest that there are only 4 principal zymodemes (those found in 
axenic cultures) that are reliable for isolate typing. These are E. histolytica zymodemes II, 
XIV, and XIX, and E. dispar zymodeme I (Jackson and Suprasad, 1997). The remaining 
zymodemes appear to be due to bacterial enzymes (present in xenic cultures).
A few PCR-based DNA typing methods have been reported for E. histolytica, making use 
of repetitive elements contained within both protein coding genes and non-coding DNAs.
In E. histolytica the rRNA genes are present on a highly repetitive extrachromosomal 
circular DNA, about 25 kb in size and 200 copies per genome (Bhattacharya et al, 1988, 
1989; Huber et al, 1989). The strain specific gene (SSG) (Burch et al, 1991) or Tr (Sehgal
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et al, 1994) has been described in the upstream region of the rDNA circle, for which a 
noncoding transcript has been detected. The SSG contains tandem repeats and PCR 
amplification shows variations in the number of repeat units among E. histolytica strains 
(Clark and Diamond, 1993). In some E. histolytica strains this gene is completely absent. E, 
dispar strains do not possess this gene.
Polymorphism has been investigated in the repeat-containing protein-coding chitinase gene 
in E. histolytica. The chitinase gene, expressed only in the cyst form of the amoeba, shows 
only very limited diversity (de la Vega et al, 1997a,b; Ghosh et al, 2000; Haghighi et al, 
2002,2003). Similarly the Gal/GalNAc lectin, a major amoebic virulence protein, showed 
only very limited diversity among strains of E. histolytica (Beck et al, 2002). Perhaps the 
most widely studied protein-coding gene is the serine-rich E. histolytica protein (SREHP) 
gene, which encodes an immunodominant surface antigen containing tandem repeats of 
related dodeca- and octa-peptides (Kohler and Tannich, 1993; Stanley et al, 1990). Repeat 
number, sequence and restriction site-derived variations have been observed among strains 
o f£ . histolytica (Ayeh-Kumi et al, 2001; Clark and Diamond, 1993; Ghosh et al, 2000; 
Haghighi et al, 2002 and 2003). A recent study in Bangladesh with E. histolytica DNA 
from clinical strains showed extensive SREHP polymorphism, and the polymorphic 
patterns observed in amoebic liver abscess strains were different from those of intestinal 
strains (Ayeh-Kumi et al, 2001). Homologous genes in E. dispar have also shown 
substantial polymorphism (E. Paez, 1997, unpublished MSc thesis).
Besides the rDNA and protein coding genes mentioned above, several classes o f tandemly 
repeated or dispersed multicopy DNAs located elsewhere in the genome have been 
identified (Azam et al, 1996; Cruz-Reyes et al, 1995; Huang et al, 1997; Lohia et al, 1990; 
Michel et al, 1992; Mittal et al, 1994). However, for the most part, the polymorphisms in 
these repetitive DNAs have not been tested.
Polymorphism has been investigated using random amplified polymorphic DNA (RAPD)- 
PCR in a few north Indian isolates (Prakash et al, 2002). Although this method showed a 
good degree o f polymorphism, each isolate invariably produced multiple products in PCR,
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which is not ideal for large scale surveys of genetic epidemiology as the analysis o f results 
will be difficult. Also, RAPD may amplify DNA from host and bacteria and therefore is 
problematic.
Recently Shah et al (2005) used a comparative genomic hybridization approach to 
investigate the genotypic differences among 4 reference strains o f E. histolytica and two of 
E. dispar. Between E. histolytica and E. dispar strains they identified a number of genes 
restricted to E. histolytica only. One of the drawbacks of this approach is that it requires a 
large amount o f genomic DNA (5 to 10 pg), which has so far restricted its use to laboratory 
strains only.
1.3.1. Transfer RNA (tRNA) genes in E. histolytica
One of the striking findings in the E. histolytica genome sequence is the abundance and 
unique organisation of the tRNA genes in the genome (Clark et al, 2005). Over 10% of all 
the sequence reads contained tRNA genes. tRNA genes are 71-87 base pairs long and rich 
in Gs and Cs. Almost all o f them are organised in tandem arrays with intergenic regions 
being rich in A+T (about 80%) and containing short tandem repeats (STRs). A total of 25 
distinct arrays were identified containing 1 to 5 tRNA genes in each. The unit lengths of 
arrays vary between 490 bp and 1775 bp. In 4 arrays, G+C rich regions other than tRNA 
genes were identified. Three of these have been identified as the previously unknown 5S 
RNA genes in E. histolytica, while the fourth is a suspected small nuclear RNA-encoding 
gene (Baneijee and Lohia, 2003). Outside the coding regions, apart from being A+T rich, 
there are no significant sequence similarities between the arrays. However there exists a 
compositional bias, i.e. one strand contains on an average about 70% pyrimidine. An 
example of a tRNA gene unit in E. histolytica containing four genes is shown in Figure 1.2.
1.3.2. Polymorphism in repeat loci containing tRNA genes
A number of non-coding loci in E. histolytica and E, dispar have been identified by 
different groups of researchers and each locus contains tandem repeat units. Three of these
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Figure 1.2. tRNA gene organisation in E. histolytica. (A) Schematic representation of a 4 
tRNA gene array unit [SQCK], Arrows represent the tRNA genes. STRs are found in 
intergenic regions and are represented by coloured boxes. (B) 3 tandem units of tRNA array 
[SQCK] are shown.
repeat loci were originally identified separately by other groups but their potential as 
polymorphic markers was investigated by Zaki and Clark (2001): locus 3-4, a 978 bp 
element described by Michel et al (1992) (GenBank accession number M77091); locus 9-4, 
a 931 bp DNA element isolated by Rosales-Encina and Eichinger (GenBank accession 
number AF265348); locus 16-17, a 964 bp element reported by Huang et al (1997). There 
was close similarity between locus 3-4 and locus 9-4. In addition, Zaki and Clark (2001) 
also isolated and tested locus 1-2 (GenBank accession numbers AF276055-9) and locus 5-6 
(GenBank accession numbers AF276060-5). All these polymorphic loci were later found to 
contain genes for tRNA (Clark, unpublished data).
Diversity in these loci among E. histolytica strains is mainly due to varying numbers of 
STRs (Zaki and Clark, 2001). Both 1 -2 and 5-6 contain a single STR block consisting of 
two types of related sequences arranged in tandem. In contrast, loci 3-4, 9-4, and 16-17 
contain two or more STR blocks with more than one type of related repeat sequence 
arranged in tandem. However, these loci varied not only in the number but also in the 
sequence and arrangement of STRs when the comparison was made between E. histolytica 
and E. dispar (Zaki et al, 2002). Haghighi et al (2002 and 2003) compared the polymorphic
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potential of loci 1-2 and 5-6 with those of the protein-coding chitinase and SREHP genes 
using samples from institutionalised and homosexual people from Japan and clinical and 
reference strains from some other countries. They observed that none of these loci alone 
could detect all the genotypes o f the E. histolytica strains they tested, and concluded that 
more than one locus should be used for strain typing. Clark et al (2002) have reviewed the 
present status of genetic diversity in E. histolytica and concluded that for strain typing 
amplification by PCR directly from stool DNA would be the method of choice over the 
alternative - labourious amoeba cultivation and sequencing o f DNA. They also emphasized 
the need for using multiple loci for reliable typing of amoeba strains.
What determines the outcome of an E. histolytica infection is still a mystery, but one 
possibility is that it is linked to the genotype of the infecting strain. To investigate this 
relationship a simple, sensitive and reliable method for strain identification is required.
There are many more STRs in the flanking regions of tRNA genes in E. histolytica that still 
need to be tested for their usefulness in detecting polymorphism in E. histolytica. It is at 
this point that the work described in this thesis began.
1.4. AIMS & OBJECTIVES
The key objective o f this study is to develop a reliable multilocus genotyping system for E. 
histolytica after screening all tRNA-linked STR sequences identified during the genome 
project.
The system developed will then be used to genotype clinical strains of E. histolytica from 
Bangladesh and other parts o f the world to investigate a possible association of genotype 
and clinical outcome o f infection.
The sequence diversity among clinical strains of E. histolytica at two o f the STR loci will 
be investigated to help understand the basis o f the polymorphism observed.
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Prevalence of E. moshkovskii and polymorphism in E. dispar strains will also be 
investigated. The specificity o f the genotyping system will be tested with both E. dispar 
and E. moshkovskii DNAs.
Finally, attempts will be made to estimate the copy number o f the tRNA-linked loci in the 
genome.
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CHAPTER 2
GENERAL METHODS
2.1. Axenic isolates of E. histolytica, E. dispar and E. moshkovskii
In this thesis, ‘species’ mainly refers to one of the three morphologically identical species 
of Entamoeba -  E. histolytica / E. dispar / E. moshkovskii. When samples are from stool 
and culture the organisms are referred to as a ‘strain’ and ‘isolate’, respectively. ‘Strain’ is 
also used as a general term where more than one type of sample is being discussed. Based 
on polymorphisms at one or more loci, individual strains or isolates are assigned to a 
specific ‘genotype’. The term ‘clone’ is used only in the context o f PCR products from that 
have been inserted into recombinant DNA vectors and not to cell lines.
E. histolytica HM-1:IMSS, E. moshkovskii Laredo and FIC are maintained in axenic 
medium and E. dispar SAW760 is maintained in both axenic and monoxenic medium in 
our laboratory. 7 other axenic isolates of E. histolytica were maintained elsewhere in the 
London School of Hygiene and Tropical Medicine (LSHTM). These 8 E. histolytica and 
one E. dispar were used in the initial testing of primers. Information about the patients’ 
history (except for E. moshkovskii FIC which was isolated from a sewage sample) is 
provided in the relevant Chapters.
Axenic isolates of E. histolytica were maintained in LYI-S-2 (Liver extract Yeast extract 
Iron-Serum) medium (Clark and Diamond, 2002). This medium is an alternative to the 
more widely used medium TYI-S-33 for axenic cultivation o f E. histolytica. LYI-S-2 
medium differs from TYI-S-33 in that it contains liver extract instead of casein. LYI-S-2 
consists of a nutrient broth, LYI, which is enriched with the addition o f a vitamin mix and 
15% heat inactivated adult bovine serum. Sub-culturing was done every 72 and 96 hours 
(usually Monday and Friday of the week) and cultures were incubated at 36°C. Entamoeba 
moshkovskii isolates Laredo and FIC were maintained axenically in LYI-S-2 medium
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(Clark and Diamond, 2002) with 10% adult bovine serum at room temperature and 
subcultured every 2 weeks. The monoxenic culture of E. dispar was maintained in LYI-S-2 
medium supplemented with 10% heat inactivated bovine serum and Crithidia fasciculata, 
and incubated at 36°C. Subcultures were performed at 72 hour and 96 hour intervals.
In the study o f genotyping we used many xenic culture and amoebic liver abscess (ALA) 
pus DNA samples which will be discussed in the relevant sections.
2.2. Isolation of DNA
2.2.1. CTAB method: This method was employed for the isolation o f DNA from all axenic 
and monoxenic isolates and pus specimens as well as from some xenic isolates o f E. 
histolytica and E. dispar (modified from Clark and Diamond, 1991; Clark, 1992):
Lysate preparation:
A) From axenic and monoxenic cultures: Cultures were chilled for 5 minutes in an ice- 
water bath and sedimented by centrifugation at 275 x g for 5 minutes. The 
sedimented trophozoites were washed with 1 X phosphate buffered saline (PBS) to 
remove traces o f medium and the washed cell pellets were resuspended in 250 pi of 
lysis buffer (0.25% SDS, 0.1 M EDTA, pH 8).
B) From xenic cultures: Sediment from a 72 hour culture in Robinson’s medium was 
transferred to a 1.7 ml microcentrifuge tube and the trophozoites were pelleted by 
brief centrifugation in a microcentrifuge, washed with 1 X PBS to remove traces of 
medium, and resuspended in 250 pi of lysis buffer.
C) From lyophilized ALA pus specimens: Approximately 0.05-0.1 g o f lyophilized pus 
was scraped into a microcentrifuge tube and re-constituted with 250 pi of lysis 
buffer.
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Lysates are stable for months at 4"C.
The rest o f the DNA isolation was same regardless of the type of specimen from which
the lysate was prepared:
1. Proteinase K was added at a concentration of 0.1 mg/ml of lysate and incubated at 
55°C for 20 minutes in a waterbath to get rid of all proteins including DNA- 
degrading DNase enzymes.
2. 75 pi of 3.5 M NaCl and 42 pi of 10% cetyl trimethylammonium bromide (CTAB) 
(prepared in 0.7 M NaCl) were added (final concentration of CTAB in lysis buffer 
is 1% in the presence of 0.7 M NaCl) and incubated at 65°C for 10 minutes. At this 
high salt concentration CTAB binds to carbohydrate molecules (that are abundent in 
these amoebas) and forms a CTAB-carbohydrate complex.
3. At room temperature, an equal volume (approximately 400 pi) o f chloroform was 
added, mixed well by inversion, and centrifuged at 14,000 x g for 8 minutes. At this 
stage the CTAB-carbohydrate complex forms an insoluble interface, leaving DNA 
in the aqueous supernatant.
4. The clear supernatant was transferred to a new microcentrifuge tube and extracted 
with an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) by inversion 
and centrifuging at 14,000 x g for 8 minutes.
5. The clear supernatant was transferred to a new microcentrifuge tube and DNA was 
precipitated by adding 2.5 volumes of absolute alcohol, mixed and left to stand for 5 
minutes, and centrifuged at 14,000 x g for 10 minutes.
6. The supernatant was removed carefully without disturbing the DNA pellet and the 
pellet was washed in 70% ethanol, centrifuged at 14,000 x g for 5 minutes, air-dried 
(about 1 hour) and dissolved in 50 pi deionised autoclaved water.
7. The resuspended DNA was passed over a Microspin™ Sephacryl S-200 HR column 
(Amersham Pharmacia Biotech Inc) to remove non-polysaccharide PCR inhibitors 
and salts.
8. RNA was removed by the addition o f RNase at a concentration o f 0.05 pg/ml of 
DNA solution.
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2.2.2. GlassMax method: This method was employed at International Centre for 
Diarrhoeal Disease Research, Bangladesh (ICDDR,B) for the isolation of DNA from some 
of the xenic isolates of E. histolytica and E. dispar grown in Robinson’s medium as well as 
from some stool specimens as previously described (Haque et al, 1998b; Katzwinkel- 
Wladarsch et al, 1994).
2.2.3. Qiagen method: The QIAamp DNA Stool Mini Kit was used according to the 
manufacturer’s instructions (Qiagen, UK) to isolate DNA at ICDDR,B and in Vietnam for 
some of the stool samples.
2.3. Polymerase Chain Reaction (PCR)
2.3.1. Design of prim ers
Basically two different types of primers were used in the polymorphism study, ‘tRNA
primers’ designed from tRNA gene sequences of E. histolytica IIM-1:IMSS to amplify E.
histolytica as well as E. dispar DNA, and ‘specific primers’ designed after the comparison
of homologous sequences from E. histolytica and E. dispar.
The following factors were considered when designing a primer:
1. It should comprise o f about 20-30 nucleotides.
2. It should contain about 50% G+C. For primers with low G+C content, a longer primer 
was chosen so as to avoid a low melting temperature.
3. Sequences with long runs (i.e. more than three or four) o f a single nucleotide were 
avoided, when possible.
4. Primers with secondary structure were avoided.
5. Complementarity between the two primers of a pair and self complementarity were 
avoided.
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For the tRNA primers both primers o f a pair were located within the tRNA sequence(s). 
The sequences of all primers will be provided in the appropriate Chapters.
2.3.2. PCR amplification
All the PCR reagents used in this study were from BioLine (UK). The total volume of PCR 
mix used for one reaction was 30 fil. In general, 1 pi o f DNA was used for each PCR. The 
final concentration o f components of each PCR reaction mix is given below:
Buffer IX (BioLine NH4 buffer)
MgCl2 1.5 mM
dNTPs 2.50 pM each
Taq DNA polymerase 1.5 U
Primer 2 pM each
The conditions for all PCRs for the study of polymorphism were similar except for the 
annealing temperatures. Standard cycling conditions consisting of 35 cycles were as in 
Table 2.1.
Table 2 .1. Thermal cycling conditions.
Cycling step Temperature and time No. o f cycles
Dénaturation 94°C for 30 seconds
35Annealing V°C for for 30 seconds
Extension (synthesis) 72°C for 30 seconds
Final extension 72°C for 5 minutes 1
V stands for variable temperature for different primers, which derived from the Tm value of the primers 
(mostly Tm minus 5°C)
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2.3.3. Nested PCR
Occasionally a nested PCR was necessary to achieve success in amplification particularly 
when the target DNA amount was very low as in a few stool and liver abscess DNA 
samples. In the nested PCR 1 pi of the tRNA primer-derived product was used as the 
template DNA. However all other PCR parameters remained exactly the same except that 
an increase of about 3 degrees in annealing temperature (Tm minus 2°C) was used. '
2.3.4. Visualization of PCR products by gel electrophoresis
All PCR products were separated in 1.5% Bio-Gene or 1.8% 3:1 Nu-Sieve (FMC) agarose 
gels in IX Tris-Borate-EDTA buffer and visualized after staining with ethidium bromide 
(1.0 pg/ml; Sigma). Gels were documented by photography and fragment sizes were 
estimated using the 100 bp DNA ladder (Promega, UK and Seegene, UK) run on the same 
gels.
2.4. Cloning of amplified products and plasmid isolation
2.4.1. Ligation
The cloning o f amplified products was achieved by the use o f the pGEM-T Easy Vector 
(Promega) and XL 1-Blue Competent Cells (Stratagene) according to the manufacturers’ 
instructions with proportionately reduced volumes. 1.0 pi of the PCR product was ligated 
to 0.5 pi of vector in a total volume of 5.0 pi. Then 2.0 pi o f the ligation reaction was used 
to transform 35 pi o f the XL-1 cells by heat-shock (45 seconds in a 42°C water-bath 
followed by immediate return to the ice for 2 minutes). The cells were then allowed to 
recover by the addition of 650 pi of chilled SOC medium (2% tryptone, 2% yeast extract,
10 mM NaCl, 0.25 mM KC1, and 20 mM glucose) and incubation for one hour at 37°C with 
shaking at 200-250 rpm. The transformed cells were then evenly spread on the surface of a 
LB agar plate containing ampicillin, IPTG (isopropyl J3-D-thiogalactopyranoside) and X- 
Gal (5-bromo-4-chloro-3-indolyl-B-D-galactoside) and incubated overnight at 37°C. The
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growth of blue and white colonies was observed the next morning. A white colony should 
contain the right insert, because a successful cloning interrupts the coding sequence o f the 
enzyme B-galactosidase that is responsible for the blue appearance o f colonies. IPTG 
served as the inducer while X-gal served as the substrate for the enzyme B-galactosidase. 
White colonies were picked and grown in 5 ml LB broth (Sigma) overnight at 37°C with 
shaking at 200-250 rpm.
2.4.2. Isolation of plasmid DNA by QIAprep Spin Mini Kit protocol
200 pi o f LB broth containing bacterial cells was preserved at - 20°C after mixing with an 
equal volume of 50% glycerol for future use. The isolation o f plasmid DNA from the 
remainder of the culture was according to the QIAprep Spin Mini Kit manufacturer’s 
instructions, which is basically an alkaline lysis procedure.
2.4.3. iicoRI digestion of plasmid DNA
The isolated plasmid DNA was digested with restriction enzyme EcoKl (Promega) 
according to the manufacturer’s instructions to reveal the size of the insert DNA and the 
digested products were run in a 1.2 % agarose gel (Bio-Gene, UK). Colonies with an 
appropriate insert were identified and selected for further analysis.
2.4.4. Rapid screening of plasmid by Sekar analysis
An alternative method for identifying recombinant plasmids was carried out using a 
screening method described by Sekar, 1987. This screening protocol was followed when 4 
white colonies failed to reveal the insert of interest with the conventional method as 
described above.
1. 10-20 white colonies from LB agar plates were inoculated into 200 pi of LB broth 
supplemented with 100 pg/ml o f ampicillin and incubated at 37°C for 5 hours on a 
shaker.
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2. A small volume of each LB cell suspension was frozen at -20°C until needed.
3. The remaining cells were harvested by centrifugation and resuspended in 10 pi o f 
Protoplasting buffer (30 mM Tris-HCl, pH 8.0,5 mM EDTA, 50 mM NaCl, 20% 
Sucrose, 50 pg/ml RNase A, 50 pg/ml Lysozyme).
4. A 0.8% agarose gel in 1 X TBE was prepared with the addition o f 0.05% SDS.
5. Gel wells were pre-loaded with 20 pi of Lysis buffer (1 X TBE, 2% SDS, 5% Sucrose 
and 0.04% bromophenol blue).
6. The protoplast suspension containing cells was then loaded into the wells.
7. Electrophoresis was carried out in 1 X TBE, initially for 15 minutes at 30 V and then 2 
hours at 120 V.
8. Gels were stained with ethidium bromide (1.0 pg/ml) and photographed under UV light.
An ‘empty’ plasmid DNA was used as a size marker. Those plasmids that showed slower 
migration on the gel, possibly due to possession o f additional ‘insert DNA’, were grown in 
LB broth, subjected to plasmid DNA isolation by the QIAprep Spin Miniprep Kit (Qiagen) 
as outlined above, and the size of the insert determined by ¿scoRI digestion.
2.5. Sequencing
Sequencing of the cloned insert was achieved using the ABI Prism® BigDye™ terminator 
cycle sequencing ready reaction kit according to the manufacturer’s instructions except at 
half volumes. The reaction contained one of the two M 13 primers shown in Table 2.2, and 
was prepared as follows:
BigDye reaction mix (v 3 .1) lp l
M l3 primer (1.6 pmol/pl) lp l
5X sequencing buffer 2 pi
Deionized distilled water 4  pi
Plasmid DNA 2 pi
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This mixture was then overlaid with 1 drop of mineral oil and subjected to 30 cycles in a 
thermocycler each consisting of 96°C for 30 sec, 50°C for 15 sec, and 60°C for 4 min. The 
cycle sequencing products were precipitated using 75% ice-cold isopropanol (final 
concentration 60%), washed in 75% isopropanol, and dried in a heating block at 94°C for 2 
minutes. The samples were then stored at -20°C until used. The reactions were analysed on 
a DNA sequencer ABI PRISM™ 377 (Perkin Elmer) by the LSHTM core facility and the 
output was examined for accuracy using Chromas software.
Table 2.2. Sequencing Primers.
Primer Name Primer Sequence (5' to 3 ')
M l3 forward GTTTTCCCAGTCACGAC
M13 reverse CAGGAAACAGCTATGAC
The direct sequencing of PCR products was achieved mostly by running the PCR products 
in a 1.5% agarose gel. The appropriate PCR product was excised from the gel and purified 
using the QIAquick® gel extraction kit (Qiagen, UK) according to the manufacturer’s 
instructions. Depending on the concentration (as judged by the relative intensities of 
products on the gel) 1-6 pi of the gel purified product was used in a total volume of 10 pi 
with one of the corresponding species-specific primers, if  possible, or one of the tRNA 
primers used in amplification, as above. Sometimes PCR products were purified using the 
QIAquick PCR Purification Kit (Qiagen, UK) according to the manufacturer’s instructions 
and used directly for sequencing as above.
The resulting sequences were assembled by either using the Multalin program (Corpet, 
1988) (http://www.prodes.toulouse.inra.fr/multalin/multalin.html), or manually by eye.
2.6. Probe labeling
PCR product to be labeled was first purified using the QIAquick® PCR purification kit 
(Qiagen, UK) according to the manufacturer’s instructions.
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The labeling o f the PCR product was achieved using the Prime-a-Gene® Labelling System 
(Promega, UK) according to the manufacturer’s instructions. To the heat denatured DNA 
template we added nuclease free water, labeling buffer containing random primers, a 
mixture of unlabelled dNTPs and nuclease free BSA (bovine serum albumin). This was 
followed by addition o f [a-32P]-dCTP and DNA polymerase I (Klenow fragment) and 
incubation for 1 hour at room temperature. The reaction was terminated by the addition of 
EDTA at a final concentration o f 20 mM and boiling. This labeled probe was then passed 
through a Sephacryl S-200 column (Amersham Bioscience, UK) to remove any 
unincorporated nucleotides.
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CHAPTER 3
DEVELOPMENT OF A GENOTYPING METHOD
3.1. Introduction
A few PCR-based DNA typing methods have been reported for E. histolytica, making use 
of repetitive elements contained within both protein coding genes and non-coding DNAs 
(discussed in Section 1.3). However no single polymorphic locus can be used to detect all 
genotypes oiE . histolytica and the need for using more than one locus for strain typing has 
been emphasized (Haghighi et al, 2002; Zaki and Clark, 2002).
To develop an optimal strain typing method, we decided to investigate the polymorphic 
potential of all tRNA-flanked STRs in E. histolytica using the raw sequences from the E. 
histolytica genome project, and then design and test species-specific primers for the most 
promising loci. We believed that the resulting method could give us the tools necessary to 
investigate the role o f parasite genotypes in the outcome o f infection with E. histolytica as 
well as to address other unanswered questions surrounding the epidemiology of this 
parasite.
3.2. E. histolytica and E. dispar samples
Eight axenic isolates ofis. histolytica and 1 of E. dispar were used in this study for initial 
testing and selection o f primers. Information on the patients' diagnoses and the origins of 
these is provided in Table 3.1.
In addition, DNA samples from 9 E. histolytica and 9 E. dispar isolates maintained 
xenically in Robinson's medium were received from ICDDR,B along with 2 DNA samples 
isolated directly from the aspirated pus of amoebic liver abscess (ALA) patients from
40
Bangladesh. These were used for subsequent testing of selected primers. The specificity o f 
species-specific primers was tested using two DNA samples from reference isolates of E. 
moshkovskii (Laredo and FIC) and two E. histolytica positive and 2 E. dispar positive 
faecal DNA samples received from Vietnam and Bangladesh, respectively.
Table 3.1. Information on axenic isolates.
Species Isolates Clinical diagnosis Suspected country of origin Year of isolation
E. histolytica HM-LIMSS Amoebic dysentery Mexico 1967
E. histolytica 200-.NIH Amoebic dysentery Isolated in the USA 1949
E. histolytica 1ULA.0593.-2 Diarrhoea, nausea, tenesmus, fever Venezuela 1993
E. histolytica H-303:NIH Amoebic dysentery Patient from Vietnam treated in the USA 1972
E. histolytica HB-301.N1H Amoebic dysentery Burma 1960
E. histolytica IULA: 1092:1 Diarrhoea, nausea, tenesmus, fever Venezuela 1992
E. histolytica HK-9 Amoebic dysentery Korea 1951
E. histolytica Rahman Asymptomatic Sailor from India isolated in England 1972
E. dispar SAW760 Asymptomatic England 1979
3.3. Isolation of DNA
The CTAB DNA extraction method described in Section 2.2.1 was employed for all axenic 
and xenic isolates, pus specimens, and the two stool specimens from Bangladesh.
3.4. PCR amplification
In PCR amplifications two different groups of primers were used, ‘tRNA primers’ designed 
from tRNA gene sequences of E. histolytica HM-1:IMSS that amplify both E. histolytica 
and E. dispar DNA (Appendix I) and ‘specific primers’ designed after the comparison of 
homologous sequences from E. histolytica and E. dispar (Table 3.2) to amplify DNA from 
one species only. Naming o f the STRs and primers was based on the single letter amino 
acid code for the relevant tRNA genes (or 5S RNA gene) flanking the STR being 
amplified.
41
The thermal cycler settings for all PCR reactions were the same as described in Section 
2.3.2 except for the annealing temperatures.
Table 3.2. Selected tRNA primers and the species-specific primers.
A) Selected tRNA primers.
Primer name Sequence (5' to 3') AT
A-L5
A-L3
GGATCGATACCCCTCATCTCCA
CGCATCTTGCGATAGCCGAG 64
D-A5 (EhRl)$ 
D-A3 (EhR2)$
CTGGTT AGT ATCTTCGCCTGT 
CTTACACCCCCATTAACAAT 56
N-K5
N-K3
CG A ACGGCT GTT A ACCGTT A 
TTCCTAGCTCAGTCGGTAGA 55
R-R5
R-R3
AGCATCAGCCTTCTAAGCTG
CTTCCGACTGAGCTAACAAG 55
S ‘ua-D5
Stga-D3
CTCTGGATGCGTAGGTTCAA
GTATCTTCGCCTGTCACGTG 58
S-Q5
S-Q3
GTGGTCTAAGGCGTGTGACT 
G AGATTCTGGTTCTT AGGACCC 56
B) E. histolytica specific primers.
Primer name Sequence (5' to 3') AT
AL-H5
AL-C
CATCTCCATTATTATCTAGATATCCTTTATTACT 
GGCACG AATGCTTTGATATAT A A 57
DA-H5 (Hspl)$ 
DA-H3 (Hsp2)S
G AGTTCTCTTTTT AT ACTTTT AT AT GTT 
ATTAACAATAAAGAGGGAGGT
50
NK2-H5
NK2-H3
G A AGCGTCTTTTTT ACTATT AGT G 
GGCGT ATTTTT AG A AT AGG AT A AG 59
RR-H5
RR-H3
GCGCCTTTTTATTCAATATACTCC
GGATGAAGATATCTTCACAGGG 57
SIGAD-H5
StgaD-H3
AAATCCTGCCACTGTCGTAA
AATCCCCGTTGAAGAGTTCT 58
SQ5
SQ-H3
GTGGTCTAAGGCGTGTGACT 
GTGGGACCACTTTTT ATACCTA 55
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C) E. d isp a r  specific primers.
Primer name Sequence (5' to 3') AT
AL-D5 CATCTCCATTATTATGTATCTATTTATCTATTTA 60
AL-C GGCACGAATGCTTTGATATATAA
DA-D5 (Dspl)$ TTG AAG AGTTC ACTTTTT AT ACT AT A
50
DA-D3 (Dsp2)$ TAACAATAAAGGGGAGGG
NK-D5 GCGG A AGCGTCTTTTTTACT ATT ATT A
58NK-D3 GGGCGTATTTTTATAATAAGAATAGGTGG
RR-D5 CATGAGGCGCCTTTTTATCA
58RR-D3 AGGGGATGATGATATTGAACACACTC
SlljAD-D5 AAATCCTGCCACTGTCGTAC
63
StgaD-D3 AATCCCCGTTGAAGAGTTCA
SQ-D5 AGCATAGGTGTATAGGTGTTAGG
53SQ-D3 GGTGGGACCATATTTTATACTTC
AT = Annealing temperature; suffixes: H = E. histolytica; D -  E. dispar; C = Common (used in both E. 
histolytica and E. dispar); $ = These primers were previously described by Zaki et al (2002) using different 
names given inside the brackets.
3.5. Results
3.5.1. PCR product length polymorphism
In over one-quarter (13/46) of the STRs, amplification produced multiple products in one 
or more E. histolytica isolates (Table 3.3). Some STRs using tRNA primers show multiple 
bands because there is length variation between units in the same array, but in other cases 
the multiple bands have other origins. For example, STRs C-K, K-S, N-K, and K-N give 2 
or more bands in HM-1:IMSS because the corresponding tRNA gene pairs are found in two 
distinct arrays. Similarly, V-5 amplification gives two bands because the primers amplify 
sequences from both [V5] and [VME5]. A second band is sometimes produced where the 
product is actually >1 array unit (e.g., T-R-T-R is amplified instead of T-R). These artifacts 
have been omitted from Table 3.3. Comparing the E. histolytica HM-1:IMSS and E. dispar 
SAW760 results, we observed a single product at 40 STRs in these two species, and of 
which 36 STRs are homologous.
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Table 3.3. Screening and selection of polymorphic STRs.
S T R E . h is to ly t ic a D e g re e  o f E. d i s p a r  S A W 7 6 0 F u r th e r
lo c u s N o . b a n d s S iz e  r a n g e  (b p ) p o ly m o rp h is m N o . b a n d s S iz e  r a n g e  (b p ) In v e s t ig a t io n
A -A K l ) 5 8 0 -6 0 0 + /- 1 7 5 0 N o
A -L ____ 1 (1 ) 5 8 0 -6 2 0 + 1 5 2 0 Y e s
L -A 1 ( 1 ) 6 1 0 -6 4 0 + /- 1 7 2 0 N o
A -S K D 5 0 0 -5 2 0 + /- 1 6 1 0 N o
S 0 C l-D ____ 1 ( 1 ) 3 2 0 -3 5 0 + /- 1 3 4 0 N o
D -A K D 3 9 0 -4 2 0 + 1 5 0 0 Y e s
~ G -G UUJ 1 ( 1 ) 8 1 0 • 1 8 1 5 N o
~ G - G lc c K D 4 5 0 _ 1 5 5 0 N o
H -H 1 (1 ) 6 3 0 -6 5 0 + /- 1 6 5 0 N o
L -S 1 ( 1 ) 5 0 0 -5 5 0 + 1 6 0 0 N o
S -L K D 5 0 0 -5 3 0 + /- 2 4 1 0 - 5 7 0 N o
L -T K D 3 9 0 -4 1 0 + /- 1 4 3 0 N o
T -L K D 5 8 0 -6 0 0 + /- 1 6 0 0 N o
M -R K D 4 8 0 -5 8 0 + /- 1 4 8 0 N o
R -M 1 ( 1 ) 6 3 0  o r  5 2 0 + /- 1 5 2 0 N o
N -K 1-2 (2 ) 5 4 0 -8 3 0 + + + 1 6 1 0 Y e s
K.-N 1-2  (2 ) 5 1 0 -7 0 0 + + 1 7 0 0 N o
P -P K l ) 7 2 0 -8 0 0 + /- 1 8 1 0 N o
R -5 1 - 2 ( 1 ) 3 6 0 -4 1 0 + 2 * * 3 5 0 -3 8 0 N o
5 -R ...1 ( D 4 4 0 -5 0 0 + 1 4 2 0 N o
R -R . 1 (1 ) 6 9 0 -7 3 0 + /- 1 6 9 0 Y e s
R -T K D 4 5 0 ¥ + /- 1 6 0 0 ¥ N o
T -R K D 5 7 0 -6 0 0 + 1 3 5 0 N o
S i<jA-D K D 2 7 5 -3 1 0 + 1 2 7 0 Y e s
D -S K D 5 4 0 -5 7 0 + /- 1 6 3 0 N o
S -P K D 4 9 0 -5 3 0 + + 1 5 9 0 N o
P -C K l ) 4 1 0 . 1 4 5 0 N o
C -K 2 -3  (3 ) 5 2 0 -6 0 0 +-H- 3 4 9 0 -6 3 0 N o
K -S 2 ( 2 ) 4 0 0 -5 8 0 - 2 4 9 0 -5 5 0 N o
s-o K l ) 3 9 0 -4 6 0 +++ 1 4 5 0 Y e s
_ Q-c ____ K D 2 3 0 _ 1 2 0 0 N o
T -Q 1 ( 1 ) 3 4 0 _ 1 4 2 0 N o
O -T K D 5 0 0 . 1 6 0 0 N o
T -X 1 ( 1 ) 5 9 0 1 7 0 0 N o
X -T K l ) 6 3 0 -6 5 0 + /- 1 7 5 0 N o
V -5 2 ( 2 ) 5 1 0 -5 3 0 + /- 1 5 1 0 N o
5 -V . 1 - 2 ( 1 ) 2 8 0 -3 5 0 + /- 2 3 1 0 -4 8 0 N o
V -F 1 - 3 ( 1 ) 4 5 0 -6 0 0 + + 2 5 5 0 -7 5 0 N o
F -V 1 - 2 ( 1 ) 3 3 0 -4 0 0 + 1 8 2 0 N o
V -M K l ) 2 2 0 . 1 2 2 0 N o
M -E K D 5 5 0 -7 1 0 + + 1 6 0 0 N o
E -V L  H D 6 0 0 + /- 1 8 0 0 N o
W -I - > - 2 ( 1) 5 3 0 -8 0 0 + + + 1 5 8 0 N o
I-W 1-3 (2 ) 3 4 0 -5 1 0 + + + 1 5 2 0 N o
Y -E 1 - 2 ( 1 ) 4 7 0 -5 3 0 + /- 1 5 5 0 N o
E -Y 1 - 2 ( 1 ) 6 3 0 -6 8 0 + 1* 6 2 0 * N o
All the size-ranges of the PCR products are approximate. Degree of polym orphism := n o n e ; = little;'+' 
-  some;'++' = high;'+++' = extensive. The rating is subjective.
No. bands: The numbers inside the brackets represent the number of band(s) observed in E. histolytica HM-
i non uS *A VCTy fmnt band WaS observed- **Tw0 very faint bands were observed. ¥  Another band at around 
1000 bp and 1200 bp o f unknown origin was observed in E. histolytica isolates and E. dispar SAW760 
respectively. ’
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3.5.2. Selection of polymorphic loci
The selection of polymorphic loci for further investigation was based on: 1) the degree of 
polymorphism they showed; 2) the number of amplification products they produced (loci 
that gave a single product were selected); 3) the relative success of PCR amplification in 
different DNA sample types; and 4) our ability to design species-specific primers. On the 
basis of these criteria we selected 6 out of the 46 loci for further investigation (Table 3.3).
The only exception to these criteria was N-K, for which we observed two bands in all 
isolates except two from Venezuela, which gave a single product (Figure 3.1). The smaller 
of the two E. histolytica HM-1:IMSS products (designated N -K l) was present and the same 
size in all others but absent from the Venezuelan isolates. Following cloning and 
sequencing of both PCR products from 2 isolates (HM-1:IMSS and H-303:NIH) we found 
the STRs and flanking sequences to be different. The primers were therefore amplifying 
two distinct STRs. The larger product is polymorphic and appears to be present in all 
isolates. We named this STR locus N-K2 and designed primers specific for this sequence. 
Unlike N-K, PCR amplification with N-K2 primers gave a single product.
Although the STR loci C-K, E-Y, F-V, I-W, K-N, and W-I showed substantial 
polymorphism, a majority of isolates gave multiple PCR products (Figure 3.2). Because 
multiple banding might complicate the future typing o f strains, we decided not to 
investigate these loci further. Likewise, the species specific primer pair o f STR locus R-T 
was producing multiple products with stool DNA and was excluded from further study. 
Similarly, although the loci M-E and S-P showed high polymorphism and produced a 
single product in a majority of the axenic E. histolytica isolates, we chose not to pursue 
these loci any further. We were unable to design reliable species-specific primers for locus 
M-E, despite repeated efforts, and we found amplification o f locus S-P to be unreliable 
even using DNA from xenic cultures. For example, an initial investigation using 76 xenic 
culture DNAs showed that S-P PCR was only about 76% successful in comparison with 
100% PCR success observed at loci A-L and S-D. It is possible that the copy number of
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Figure 3.1. Examples of polymorphism observed in tRNA-linked STRs of£ . histolytica. 
Panel A, 3 STRs showing little or no PCR product size polymorphism. Panel B, 3 o f the 
selected STRs showing low to moderate polymorphism. Panel C, the remaining 3 selected 
STRs showing moderate to high polymorphism. All samples are E. histolytica except for E. 
dispar SAW760.
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figure 3.2. Example of STR loci showing polymorphism but not selected because they 
produced multiple bands in PCR amplifications.
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these tandemly arranged loci in the genome is a factor in determining the success of PCR 
amplification. Alternatively, because the species-specific primers extend beyond the tRNA- 
coding regions amplification failure may be due to sequence divergence between isolates.
3.6. Polymorphism analysis using xenic DNA
PCR product size polymorphism at the 6 selected STRs was then tested using E. histolytica 
DNAs isolated from 9 xenic cultures and 2 lyophilised ALA pus samples. Similarly 9 
DNAs from xenic E. dispar cultures were also tested. This allowed us to investigate 
amplification efficiency and polymorphism using DNAs from other sample types and a 
geographically restricted region (Bangladesh). It is clear from the results that
(A) (B)
Figure 3.3. Examples of PCR product size polymorphism with (A) E. histolytica liver 
abscess (LAN-15 & LAN-39) and xenic culture DNAs and (B) E. dispar xenic culture 
DNAs at 2 of the selected STR loci (SrGA-D and S-Q) using tRNA primers.
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all STRs amplified well and showed polymorphism, with loci S-D and S-Q showing the 
most variation in E. histolytica (Figure 3.3A). However locus S-D showed almost no 
detectable polymorphism in E. dispar strains (Figure 3.3B).
3.7. Design and testing of the species-specific primers
In order to design species specific primers we sequenced the PCR products o f E. dispar 
SAW760 for all 6  selected loci. We also sequenced PCR products from a second isolate of 
E. histolytica to ensure that the specific primer sequences were conserved within the 
species. All species-specific primers were tested using two control DNAs, from axenic E. 
histolytica HM-1:IMSS and E. dispar SAW760, and with DNA isolated from 2 xenic E. 
histolytica and 2 xenic E. dispar cultures (Figure 3.4).
In E. histolytica, we were able to design both 5 ' and 3' species-specific primers for 4 loci. 
For the remaining 2 loci, we designed one species-specific primer, but we had to use either 
the original 5 ' primer (locus S-Q) or a new but common 5 ' primer (locus A-L) because the 
sequence flanking the STR was too AT-rich to be suitable for primer design. In E. dispar, 
we designed both 5 ' and 3 ' species-specific primers for 5 loci, requiring only a new 
common primer for locus A-L as above.
We observed specific products with all twelve pairs of species-specific primers (6  pairs for 
each species): E. histolytica species-specific primers gave products only with DNAs from 
E. histolytica, while the E. dispar species-specific primers gave products only with DNA 
from E. dispar isolates. However, at locus S-D the E. dispar species-specific primers gave 
faint and small (less than 100 bp) products with DNAs from the two xenic E. histolytica 
isolates (Figure 3.4). Because the correct product size for E. dispar using this primer pair 
ranges from 2 00  to 2 20  bp, we do not think that these smaller non-specific products will 
interfere with species identification.
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I'igure 3.4. Species-specific primer testing. Each of the DNA samples was amplified using 
both the E. histolytica- (suffix -H ) and the E. dispar-specific (suffix -D ) primers for 2 of 
the selected STRs (Table 3.2). E. histolytica HM-1:IMSS and E. dispar SAW760 were 
used as controls. 3 1 and 32 are known E. histolytica isolates while 121 and 122 are known 
E. dispar isolates from Bangladesh and the DNA was extracted from xenic cultures.
We also tested our species-specific primers with two E. moshkovskii reference DNAs: one 
was E. moshkovskii Laredo, an organism isolated from a human infection and the other was 
the E. moshkovskii FIC, an organism isolated from an environmental sample. No PCR 
amplification was observed with these E. moshkovskii DNA samples using the E. 
histolytica and E. dispar species-specific primers, except for 2 faint bands both with E. 
moshkovskii FIC DNA, one with the E. histolytica-specific S-P primers and the other with
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the E. dispar specific W-I primers (Figure 3.5). However these two loci were not among 
the final 6 selected.
We then tested the ability of the species specific primers to amplify E. histolytica DNA 
extracted from stool and liver abscess pus samples. For this, we used 2 ALA and 2 stool 
samples obtained from Bangladesh, which were extracted by the modified CTAB method 
(Section 2.2.1), and 2 stool DNA samples from Vietnam, which had been extracted using 
the QIAamp DNA Stool Mini Kit (Section 2.2.3). Both the liver abscess and the stool DNA 
samples, regardless of the country of origin or the method o f DNA isolation, were 
successfully amplified at all selected loci (Figure 3.6).
3.8. STRs in E. histolytica HM-l-.IMSS and E. dispar SAW760
From the alignment o f relevant sequences from E. histolytica and E. dispar isolates we 
examined the differences between the two species. We looked for short tandem repeats 
(STRs) in these sequences either by eye or by using Tandem Repeats Finder software 
(http://tandem.biomath.mssm.edu/trf.html). The sequence diversity among E. histolytica 
strains at two STR loci, R-R and S-D, is discussed in Chapter 7. Here we compared the 
extent of divergence between E. histolytica HM-1:IMSS and E. dispar SAW760.
Schematic representations o f a selection of STRs are provided in Figure 3.7. With the 
exception of locus S-D, in which we could not detect STRs in E. dispar SAW760 all other 
loci contained STRs in both E. histolytica and E. dispar.
In some loci we found more repetitive DNA elements in one species than the other. For 
examples, in loci A-L and W-I, we detected more types of STR in E. histolytica HM- 
1 :IMSS compared to E. dispar SAW760 whereas in locus N-K we found more STRs in E. 
dispar SAW760 compared to either N-Kl or N-K2 in E. histolytica HM-1:IMSS. In all loci 
the STR sequences themselves are completely different in these two species and even the 
flanking sequences of the STRs are very different from each other.
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Figure 3.5. Specificity of E. histolytica and£. dispar species-specific primers tested with E. 
moshkovskii DNA. Laredo is a reference human isolate and FIC is an environmental isolate 
of E. moshkovskii. E. histolytica HM-1 :IMSS and E. dispar SAW760 were used as the 
positive controls. Each of the DNA samples was amplified using both the E. histolytica- 
(suffix -H ) and the E. dispar-specific (suffix -D ) primers. Although the STR loci S-P and 
W-I are shown in the Figure they were ultimately not selected for further analysis.
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STGA-D
Figure 3.6. STR amplification using DNA extracted from faeces and liver abscess pus. E. 
histolytica species-specific primers (Table 3.2) were used. LAID-19 and LAID-31 are DNA 
samples extracted from liver abscess pus. 22027 and 29621 are faecal DNAs from 
Bangladesh isolated by the modified CTAB method. 231-1/4.00 and 484-1/4.01 are faecal 
DNAs from Vietnam isolated using the QIAamp DNA Stool Mini Kit.
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Figure 3.7 Schematic representation of STRs in E. histolytica HM-1 IMSS and E. dispar 
SAW760 at 3 loci -  A-L, N-K and W-I. The STR colours indicate different sequences in 
the same locus but are not the same between species or loci. Both STR loci N-Kl and N-K2 
are shown for E. histolytica HM-1:1MSS.
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3.9. Discussion
Tools that allow us to identify strains o f E. histolytica are important because they may help 
to address some of the unanswered questions surrounding the pathogenicity of this parasite. 
For example, are asymptomatic and symptomatic infections caused by genetically distinct 
strains and does organ tropism have a genetic component? The tools available to date for 
identification of individual strains have been limited (Section 1.3).
The STR-containing loci originally studied by Zaki and Clark (2001) have shown promise 
as strain identification markers (Haghighi et al, 2002, 2003; Zaki et al 2002, 2003a, b). In 
the present study, we have developed an extended set of polymorphic markers making use 
of the presence o f STRs adjacent to most tRNA genes in E. histolytica and E. dispar, a 
unique feature of these species (Loftus et al, 2005). The STRs selected for our optimal 
panel o f markers were chosen on the basis of their reliability, sensitivity and degree of 
polymorphism detected in PCR. We have also designed E. histolytica and E. dispar 
species-specific primer pairs for all the selected loci, which will eliminate the potential 
problems caused by mixed infections. The primers have been tested using DNA samples 
from diverse geographic locations, and they have successfully amplified DNA isolated 
directly from liver abscess pus and stool samples, eliminating the need for culture o f the 
amoebae. The DNA can be prepared for analysis using either a commercial kit or a 
modification o f an existing purification method.
Zaki et al (2003b) have shown that amplification of tRNA loci using DNA prepared from 
cultures reflects the patterns seen with DNA extracted from the original stool sample, 
indicating that while culture is not necessary it is not misleading either. Recently, some o f 
the STR loci were used to investigate the genotypes of is. histolytica and E. dispar in South 
Africa (Zaki et al 2003a). Among other things this study showed that the genotypes 
remained stable over time in the same infection. We have also observed no changes in the 
patterns obtained at any of the STR loci using DNAs extracted from E. histolytica HM- 
1:IMSS or E. dispar SAW760 at various times over the past several years. The markers 
therefore appear to be sufficiently stable to use for our intended purposes.
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We and others have observed a considerable degree o f STR-length polymorphism not only 
among axenic isolates of E. histolytica but also among isolates isolated from a restricted 
geographic location (Haghighi et al, 2002, 2003; Zaki et al, 2003a; and Chapters 4 and 5). 
Comparison of nucleotide sequences among E. histolytica isolates at many of the loci 
studied here revealed that the differences in PCR product sizes are due mainly to variable 
number of STRs, in agreement with earlier observations at two loci (Haghighi et al, 2003; 
Zaki and Clark 2001). Although the sequences o f almost all the tRNA genes themselves are 
identical between E. histolytica and E. dispar, the STR regions flanked by them are 
completely different in sequence.
Since the genotyping of strains from restricted geographic locations has detected a high 
degree of polymorphism (Haghighi et al, 2002; Zaki et al, 2003a), it is very surprising that 
the PCR product sizes for 3 axenic isolates o f E. histolytica (200:NIH, H-303:NIH, and 
HK-9) are identical at all 46 loci tested in this study. It is most likely that at some point the 
cultures of these isolates have been mislabeled. One of the unexpected applications o f our 
markers may therefore be to verify the identity of laboratory isolates and detect such mix- 
ups.
We use our markers to investigate the possibility of a correlation between parasite genotype 
and clinical outcome of infection using samples from Bangladesh and other countries in 
Chapters 4 and 5, respectively. We believe that these markers should also prove useful in 
studying the patterns o f transmission of this important disease and epidemiological links 
between individual infections.
56
CHAPTER 4
GENOTYPING OF BANGLADESHI E. HISTOLYTICA AND
E. DISPAR STRAINS
4.1. Introduction
As few as one in ten E. histolytica infections result in signs and symptoms o f intestinal or 
extraintestinal disorders in humans. What contributes to the variable virulence in this 
parasite is not clear. As a result, we still do not know whether a strain that is responsible for 
an asymptomatic infection in one individual has the potential to become invasive and to 
cause disease in another. In other words, are some E. histolytica strains intrinsically 
avirulent? It is possible that the genetic make up of the parasite is the determining factor for 
the clinical outcome in the infected individuals.
Duggal et al (2004) recently reported a potential association between a IILA class II allele 
and protection against E. histolytica infections in a cohort of Bangladeshi children, which 
they studied for 3 years. However, in the absence o f appropriate knowledge about the E. 
histolytica genotypes and their levels o f virulence in the host, it is difficult to know whether 
these study children were exposed to comparable E. histolytica strains. Therefore, we 
believe there is a need to investigate the existence of an association between parasite 
genotype and the clinical outcome of E. histolytica infections.
Genetic variation has previously been studied in two tRNA-gene linked loci in E. 
histolytica and E. dispar (Zaki and Clark, 2001; Zaki et al, 2002 and 2003a,b). Haghighi et 
al (2002 ) compared the polymorphic potential of these loci, 1-2 and 5 -6 , with those of 
protein-coding chitinase and SREHP genes. SREHP showed the most polymorphic patterns 
while chitinase was the least polymorphic.
However no association between the parasite genotypes and the outcome o f infections has 
been reported for E. histolytica. We therefore decided to investigate the genotypes of
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clinical strains of E. histolytica from Bangladesh using our multilocus genotyping system 
(Chapter 3) to see whether these show an association with the clinical outcome o f infection.
4.2. Materials and methods
4.2.1. E. histolytica samples
Three clinical groups of samples from Bangladeshi E. histolytica infections, i. e., 
asymptomatic, diarrhoeal or dysenteric, and amoebic liver abscess (ALA), were collected 
and studied here. All the asymptomatic and a majority of the diarrhoeal/dysenteric samples 
were received or collected from an ongoing field project in Mirpur.
Dr. Rashidul Haque, ICDDR,B, Bangladesh, and Prof. William A. Petri, Jr., University of 
Virginia, USA, are jointly studying preschool children (2-5 years old) for immunity to 
amoebiasis through a field based project in Mirpur, about 5 miles from Dhaka city, the 
capital of Bangladesh. The inhabitants of Mirpur are of Bihari ethnic origin and settled there 
after the liberation o f Bangladesh from Pakistan in 1971. The area is densely populated and 
has poor sanitary and hygienic conditions. They do not have water supplied directly to their 
houses neither do they have proper sanitary latrines in their house. They bring water from 
common water supply sources to their houses. There are several community latrines in the 
area which they use. Waste disposal is through Dhaka City Corporation but is maintained 
very poorly in this area. Most of these study children live in slums (in Figure 4.1, this is 
indicated by the household dots falling outside the small squares), but a small number of 
them live in small plots in the same area (Figure 4.1). Stool specimens are obtained every 
month (designated by a MS prefix; MS stands for monthly stool) for detection o f E. 
histolytica infection by antigen capture ELISA and culture. If a study child develops 
diarrhoea/dysentery then its parents contact the project personnel at the field clinic and 
children and their parents are visited and interviewed every other day by health care 
workers. When diarrhoeal disease is detected, a stool sample (designated by a DS prefix;
DS stands for diarrhoeal stool) is obtained and studied for enteropathogens, and the child is 
examined. All these samples are transported to the laboratory for processing within 2-4 h.
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In addition to the Mirpur project, diarrhoeal samples were also obtained from patients who 
visited the outpatient department of the ICDDR,B hospitals.
ALA patients were admitted to various clinics and hospitals in Dhaka city other than 
ICDDR,B hospital. The aspirated pus from the liver abscess (designated by a LA prefix) 
was sent to ICDDR,B for diagnostic purposes.
A total of 161 E. histolytica positive samples, as diagnosed by a stool ELISA and / or SSU 
rRNA gene amplification, were used in this study. They were received or collected in 4 
batches. The first batch o f samples was received as DNAs purified from xenic culture. The 
second batch o f samples was collected by me during my field trip to Bangladesh in April to 
July 2003. These were either stool or amoebic liver abscess pus samples. They were 
brought to LSHTM from Bangladesh in the form of lysates. A third batch containing more 
stool and liver abscess pus samples was received from ICDDR,B during December 2003 to 
February 2004. The fourth batch of samples was received as xenic culture DNAs during the 
third quarter of 2004.
These 161 samples include a total of 66  samples from 43 asymptomatic children including 
one from a child’s parent from Mirpur, 52 diarrhoeal/dysenteric samples from both 38 
children from Mirpur and 6 patients from the ICDDR,B hospital, and 43 liver abscess pus 
samples from 43 ALA patients. Only 9 of the 52 diarrhoeal/dysenteric samples were 
collected during an episode of dysentery (as opposed to diarrhoea). Eleven children were 
common in both asymptomatic and diarrhoeal/dysenteric groups.
In total, 70 children from Mirpur, both asymptomatic and with diarrhoea/dysentery, 
provided 112 samples, including 23 children who gave more than one (follow-up) samples.
4.2.2. E. dispar samples
A total of 68  E. dispar positive samples from 42 children, as diagnosed by a stool ELISA 
and / or SSU rRNA gene amplification, were received in the form of xenic culture DNA
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from Bangladesh. All but one of these samples was from 2-5 year old children from the 
same on-going Mirpur project. This includes 61 samples from 37 children with no 
diarrhoea/dysentery, while 7 stool samples were collected during an episode of diarrhoea 
from 6 children. The exception is from a parent of a child, ID 1369-FS7.2; prefix FS stands 
for family sample. One child (3744) is represented in both the asymptomatic and 
diarrhoeal/dysenteric group.
4.2.3. Isolation of DNA and PCR amplification
DNA from the culture, stool or ALA pus lysates was isolated as already described (Section 
2.2). PCR amplification was performed using the E. histolytica-specific primer pairs at 6 
loci given in Table 3.2. Occasionally PCR was performed using the tRNA primer first and 
this was then used in a nested PCR with the corresponding E. histolytica-specific primers.
4.3. Data analysis
4.3.1. Genotype assignment
Each unique amplification pattern for a given locus was assigned a different number. Using 
the combination of numbers for a particular isolate at all 6 loci, it was assigned a genotype 
number. Similarly, results from various combinations of 5 loci (6  combinations), 4 loci (10 
combinations) and 3 loci (20 combinations) were also used to assign a genotype specific for 
each combination.
4.3.2. Statistical analysis
4.3.2.1. Genotype distribution among clinical groups
Statistical analysis of the genotype distribution among 3 clinical population groups - 
asymptomatic, diarrhoeal/dysenteric and liver abscess - was done using a web based 
version of the analytical program GENEPOP (http://wbiomed.curtin.edu.au/genepop/). The
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Figure 4.1. Map of the Mirpur study area. The map shows the distribution of households of 
all children enrolled in the ‘Human Immunity to Amoebiasis’ study, courtesy of Dr. 
Rashidul Haque, ICDDR,B, Dhaka, Bangladesh. Big squares indicate primarily school, 
market, playgrounds, ponds, etc, while small squares indicate housing plots, however some 
of the slum houses were located inside big squares (personal communication with Dr. 
Rashidul Haque).
software takes each PCR pattern of a particular locus into account while doing the analysis. 
The data were ‘diploidised’ before analysis of genotypic differentiation among populations. 
An unbiased estimate of the P-value of a log-likelihood (G) based exact test is performed.
The association of particular genotypes with clinical outcomes was analysed using the Chi 
square test (Epi Info, version 6.04). A P value of <0.05 was considered significant. The 
total number of predicted genotypes was calculated using the Chao Estimator equation 
(Colwell and Coddington, 1994).
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4.3.2.2. Relationship among genotypes
The relationship among various genotypes was investigated using the eBURST program 
which is available at http://eburst.mlst.net (Feil et al, 2004). The eBURST algorithm was 
originally devised as a way o f displaying the relationships between closely-related isolates 
of a bacterial species or populations. The procedure was developed for use with the data 
produced by multilocus sequence typing, but using a suitable criterion for the definition of 
groups of related genotypes, it can be used with other types of data.
The first step in eBURST analysis is to define meaningful groups in the experimental data. 
In our case, we used the 6 locus genotype data and investigated the relationship among the 
genotypes. In our definition, two genotypes will only be linked to each other by the 
eBURST diagram if they are identical at all but one locus, that is, at 5 out of 6 loci. This 
type o f variant is called a single locus variant (SLV). If the difference between two 
genotypes is at two loci then each one is a double locus variant (DLV) to the other. The 
program automatically chooses a founder genotype, which by definition has the maximum 
number o f SLVs and DLVs. However, it is possible to change the founder genotype 
assigned by the program to a new one if the bootstrap support for the new one is strong. 
eBURST clusters related genotypes into groups containing two or more genotypes each. 
The major group contains the maximum number of genotypes and is represented in the 
centre of the eBURST diagram while the minor groups are often placed around the 
periphery of the diagram. The genotypes that do not have SLVs or DLVs are termed 
singletons and are displayed in the eBURST diagram as unlinked dots. The numbers shown 
in the eBURST diagram are the genotype numbers and the size of a dot representing a 
genotype is proportional to the number o f samples with this genotype. eBURST diagrams 
were also generated using 5 locus, 4 locus and 3 locus data sets.
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4.4. Results
4.4.1. PCR amplification
PCR amplification was successful for all samples regardless of the origin o f the DNA or the 
method of isolation o f the DNA. However, a nested PCR using the tRNA primer-derived 
PCR product as the template was employed for a few stool and liver abscess DNA samples. 
This was necessary because the amount of target DNA in these samples seemed to be too 
low to be amplified by a simple PCR (data not shown).
4.4.2. Genotypes based on PCR amplification patterns at 6 loci
In 9 out of 161 samples, we observed a second faint band in PCR amplifications o f some 
loci (most of these are shown in Figure 4.2), but for simplicity, we considered only the 
higher intensity band for genotype assignment.
In order to do the most meaningful analysis of association between genotype and clinical 
outcome of infection, we analyzed the genotypes of all Mirpur samples first since they were 
from a limited geographic area. We then compared these genotypes with those from liver 
abscess samples coming from different parts of Dhaka and often outside of Dhaka. We did 
not include the 6 ICDDR,B hospital samples as the number in this group was very low 
(only 6) and the geographic origin of these patients was unknown. As a result, they did not 
fit in with the Mirpur samples.
If the same genotype was identified in both asymptomatic and diarrhoeal samples from the 
same child it was considered to be ‘diarrhoea-causing’ and we removed it from the 
asymptomatic group. The total number of individuals, therefore, became 36 in the 
asymptomatic group. Two asymptomatic children showed 2 genotypes each in their follow­
up samples: IDs 0291 and 1325. The total number o f individuals in the diarrhoeal group of 
Mirpur children was 38, and again in this group follow-up samples o f some children
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Figure 4.2. Gel electrophoresis patterns with a selection o f E. histolytica samples (a) 
Mirpur samples at STR loci A-L, N-K2 and S-D, (b) liver abscess samples at STR loci D­
A R-R and S-Q. * -  indicates the transiently infected sample showing double bands at loci 
N-K2 and S-D.
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while ID 3570 displayed 3 genotypes. The total number o f individuals in the liver abscess 
group was 43, and no follow-up samples were available. Appendix II shows all the 
genotypes observed in asymptomatic, diarrhoeal/dysenteric (from both Mirpur and 
ICDDR,B) and liver abscess groups. Where multiple follow-up samples showed the same 
genotype only one sample was included in Appendix II.
Across all samples, a total of 26, 33 and 41 genotypes were identified among 
asymptomatic, diarrhoeal/dysenteric, and liver abscess patients, respectively.
4.4.2.1. Six-locus genotypes
(a) M irpur children
A total of 70 children gave asymptomatic and diarrhoeal samples and these produced a total 
of 48 genotypes. In the asymptomatic group, 36 children gave a total o f 26 genotypes, 
while in diarrhoeal group 38 children gave a total of 27 genotypes.
The two most common genotypes in the asymptomatic group are 51 (4 children), 13 and 
19 (3 children each). In the diarrhoeal group, the two most common genotypes are 66 (10 
patients), 50 and 51 (3 patients each; note that genotype 51 was also found in 4 children in 
the asymptomatic group).
(b) Liver abscess patients
A total of 41 genotypes were identified in 43 liver abscess patients. Only 2 genotypes were 
found in more than one ALA patient - 23 and 39, both found in 2 patients each.
(c) ICDDR,B hospital
In addition to those from Mirpur children, we also had 6 diarrhoeal/dysenteric samples 
from the ICDDR,B hospital, and all o f these showed distinct genotypes (Appendix II).
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4.4.2.2. Spatial distribution of M irpur children’s households infected by the two most 
common genotypes
The two most common genotypes using 6 loci were 66 and 51 (Appendix II). The location 
of households o f the children infected with these genotypes in Mirpur was investigated.
Figure 4.3a shows the approximate household locations for the 10 children infected by 
genotype 66. These households were dispersed across the Mirpur study area, though half o f 
the children seem to have lived close to each other. This probably suggests that this 
genotype has a widespread distribution in Mirpur. In contrast, the households of the 7 
children infected by genotype 51 were clustered in a small area (Figure 4.3b), suggesting 
that they might have acquired the infection from a common source.
4.5. Genotype distribution among clinical groups
Using the GENEPOP software we analyzed the distribution o f genotypes among clinical 
groups.
In Mirpur samples, using the PCR patterns at all 6 loci we found that the genotypes showed 
a statistically significant difference between the asymptomatic and diarrhoeal/dysenteric 
groups (Table 4.1). The individual loci contributing towards this difference were D-A and 
N-K2. In particular, two PCR patterns in locus D-A stand out- #2 found in 16 o f 38 
asymptomatic samples compared to only 4 of 44 diarrhoeal/dysenteric samples, and #3 
found in 38 of 44 diarrhoeal/dysenteric samples compared to only 19 o f 38 asymptomatic 
samples (Appendix II). Similarly, two PCR patterns in locus N-K2 -  #8 found in 23 of 44 
diarrhoeal/dysenteric samples compared to only 3 o f 38 asymptomatic samples, and #9 
found in 21 of 38 asymptomatic samples compared to only 9 o f 44 diarrhoeal/dysenteric 
samples (Appendix II) -  appear to be contributing the most to this result.
Across all Bangladeshi samples, using all the PCR patterns at 6 loci we found that the 
overall difference o f genotypes among the 3 pairs o f populations was statistically
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significant (Table 4.1). Between the asymptomatic and diarrhoeal/dysenteric populations 
the loci contributing the most towards this were again D-A and N-K2 (Appendix II and 
Table 4.1). Between the diarrhoeal/dysenteric and liver abscess populations the loci 
contributing most towards this significant difference were A-L (PCR patterns 2 and 3), N- 
K2 (PCR patterns 4 and 9) and S-Q (PCR patterns 3, 4 and 5). Between the liver abscess 
and asymptomatic populations the loci contributing most towards this significant difference 
were also A-L (PCR patterns 1 and 2), N-K2 (PCR patterns 4, 6, 8 and 9) and S-Q (PCR 
patterns 3 and 4).
It was not proven that the amoeba was responsible for the diarrhoea/dysentery in that 
population. However if they were not, we would expect that the genotypes detected in 
asymptomatic and diarrhoeal/dysenteric groups would show no significance difference in 
the GENEPOP analysis. Since the genotypes showed significant difference in distribution, 
we believe that the amoeba had a significant impact on the outcome o f the infection.
Table 4.1 Statistical (GENEPOP) analysis of genotype distribution among clinical groups.
Analysis Population
pair
No. of 
samples
Chi2 Overall P values
Loci showing significant 
differences (P values)
Mirpur
6-locus A & D
A = 38 
D = 44 41.531
<0.0001 Locus D-A (0.0005) Locus N-K2 (0.0001)
Bangladesh
6-locus
A & D A = 38 
D = 50
Infinity <0.0001 Locus D-A (0.0172) Locus N-K2 (<0.0001)
D & L D = 50 
L = 43
Infinity <0.0001
Locus A-L (0.0002) 
Locus N-K2 (0.0124) 
Locus S-Q (<0.0001)
L & A L = 43 
A = 38
Infinity <0.0001
Locus A-L (0.0224) 
Locus N-K2 (<0.0001) 
Locus S-Q (<0.0001)
A -  Asymptomatic, D = diarrhoeal/dysenteric, L = liver abscess.
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4.6. Association between individual genotypes and clinical outcome of infections using 
6 loci
Since the number o f total genotypes is very high and the number o f samples covered by a 
single genotype was low, we only tested two of the most common genotypes (66 and 51) to 
investigate whether they show an association with clinical outcome o f infection (Table 4.2). 
Genotype 66 showed an association with diarrhoeal/dysenteric infection in both Mirpur and 
across all Bangladeshi samples (P = 0.0030 in Mirpur and overall P = 0.0003 in across all 
Bangladesh), while genotype 51 showed no significant association with type of infection in 
Mirpur or across all Bangladeshi samples. However we should be careful in interpreting 
our data, because although genotype 66 showed a statistically significant clinical 
association with diarrhoeal/dysenteric samples it was found only in 10 of the 44 (22.72%) 
such samples in Bangladesh.
4.7. The predicted total number of genotypes using 6 loci
The Chao estimator equation was used to calculate the predicted total number o f genotypes 
(Colwell and Coddington, 1994) in the population. The equation used was
Si = S0bs+ (a2/2b)
Where, S0bs is the number of genotypes observed
a is the number of genotypes observed just once 
b is the number of genotypes observed just twice
a) Mirpur samples
From Appendix II, we can see that, S 0bs = 48, a = 33 and b = 9
So, the total predicted number of genotypes in Mirpur children is, Si = 108.5 more than
twice the number detected in this study.
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Table 4.2. Statistical (GENEPOP) analysis of the most common 6-locus individual 
genotypes among clinical groups.
Analysis Genotype
Population pair with 
corresponding frequency 
of the genotype
Chi2 P values
Mirpur
6-locus
66 A = 0/36 D =  10/38 8.82 0.0030
51 A = 4/36 D = 3/38 0.01 0.9401
Bangladesh
6-locus
66
A = 0/36 
D = 10/44 7.39 0.0066
D =  10/44 
L = 1/43
8.20 0.0042
L = 1/43 
A = 0/36
- -
Overall 16.11 0.0003
51
A = 4/36 
D = 3/44
0.08 0.7807
D = 3/44 
L = 0/43
1.33 0.2481
L = 0/43 
A = 4/36 2.99 0.0840
Overall 4.67 0.0968
A  -  Asymptomatic, D = diarrhoeal/dysenteric, L = liver abscess, - = no value for this could be calculated as 
the sample size was too small. P = <0.05 indicates that the association is statistically significant.
b) All Bangladeshi samples
From Appendix II, we can see that, S0bs= 93, a = 75 and b = 12
So, the total predicted number of genotypes in all Bangladesh is, Si = 327.4. This is 
probably an underestimate since sampling across Bangladesh was not comprehensive.
70
4.8. The association among genotypes by eBURST
4.8.1. eBURST with genotypes from M irpur children
eBURST clustered 29 of 48 genotypes into 3 minor groups (containing 2 to 3 genotypes in 
each group) and a major group at the centre of the diagram linking 22 genotypes. The 
remaining 19 genotypes were represented as singletons (Figure 4.4) as they did not have 
any SLVs or DLVs. These singletons can be divided into three categories -10 singletons are 
unique to the asymptomatic children, 7 singletons are unique to the diarrhoeal children, and 
the remaining 2 singletons are shared between the two clinical types. Those clusters that 
seemed to contain genotypes o f a particular clinical type are circled in the diagram (Figure 
4.4).
One o f the three smaller groups (pink circle in Figure 4.4) contained 2 genotypes and 
comprised asymptomatic children only. The remaining two small groups contained a 
mixture o f clinical samples (Appendix II). In the large group, there were three clinical 
clusters (inside the blue circles) -  two of these contained only diarrhoeal/dysenteric 
samples while in the remaining one, comprising 17 samples, all but one of the samples 
were from children with diarrhoea/dysentery. This latter cluster contains genotype 66 
shown above to be significantly linked to diarrhoea/dysentery.
4.8.2. eBURST with all samples from Bangladesh
The main purpose of investigating an eBURST association between genotypes and clinical 
outcomes was to see whether genotypes from a particular sample type were related to each 
other. For example, we wanted to see whether genotypes from asymptomatic children or 
from symptomatic patients tend to form mutually exclusive clusters in the eBURST 
diagram. Even though the liver abscess patients were from a wide geographic area we 
decided to investigate the relationships among genotypes across all samples from 
Bangladesh.
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Figure 4.4. eBURST relationships among the 6-locus genotypes in Mirpur children. The 
number of children found in the respective clusters is given in the square boxes: A = 
asymptomatic and D = diarrhoeal/dysenteric.
eBURST clustered 59 of 93 6 locus genotypes into 7 minor groups containing 2 to 6 
genotypes in each (shown along the periphery. Figure 4.5) and a major group with 35 
genotypes (shown at the centre of the diagram, Figure 4.5) with the auto-assigned founder 
genotype 67, which had 8 SLVs and 13 DLVs. The remaining 34 genotypes had no SLVs 
or DLVs and are represented as singletons surrounding the major group.
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Five of the 7 small groups comprised a mixture of genotypes o f all 3 sample types. O f the 2 
other small groups -  a and b (circled in the Figure 4.5) - one had 4 genotypes seen 
exclusively in liver abscess strains, while the other had 4 genotypes 3 o f which were from 
liver abscess strains (Appendix II and Figure 4.5).
In the large group, we identified 4 clusters (circled and labelled as c, d, e, and f  in the 
Figure 4.5). Clusters c and f  comprised predominantly diarrhoeal/dysenteric and liver 
abscess strains, while d and e comprised almost exclusively diarrhoeal/dysenteric strains 
and corresponded to clusters already seen in Figure 4.4.
4.8.2.1. The effect of shift of founder
From the statistical report generated by the eBURST software we noticed that the bootstrap 
support for the auto-assigned founder (genotype 67) was not very high (31%), so, we 
investigated the effect of changing the founder on the structure o f the 4 clusters (c, d, e and 
f) in the large group. There were 5 other candidate founder genotypes that had similar 
bootstrap supports (15-38%): genotypes 68 (38%), 64 (25%), 66 (16%), 53 (15%) and 56 
(20%).
Figure 4.6 (a-f) shows the effect of shifting the founder on those clusters. The change 
affected only the clusters in the major group since all the new founders were also located in 
this group.
If the new founder genotype was not part o f one of the 4 clusters, then the shift had no 
effect on these (Figures 4.6a and 4.6b). However, if  the founder was one of the genotypes 
in a cluster, then that cluster was affected (Figures 4.6c, d, e and f). For example, when the 
founder was genotype 64, 3 of the 12 genotypes in cluster c including 64 moved to another 
branch (Figure 4.6c), and when the founder was genotype 66, the cluster e (Figure 4.6d) no 
longer existed. We conclude that the 4 clusters are relatively stable and independent of 
choice of founder.
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Clinical
type
Cluster
a b c d e f Total
A 0 0 2 0 i 0 3
D 0 1 5 4 16 2 28
L 4 3 7 0 1 2 17
Total 4 4 14 4 18 4 48
Figure 4.5 eBURST diagram using all Bangladeshi E. histolytica strains at 6 loci.
All the clusters with genotypes of clinical relevance are circled (a to f). Table shows the 
clinical distribution of samples in these clusters.
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a) Founder 67
75
d)Founder 66
e)Founder 53
f) Founder 56
Figure 4.6. Effect of shift of founders on 4 clusters in the major group. The structure of 
clusters in the major group with (a) the auto-assigned founder 67, (b) founder 68, (c) 
founder 64, (d) founder 66, (e) founder 53, and (f) founder 56.
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4.9. Genotypes using various combinations of loci
Because by using all 6 loci for genotyping we obtained a very high number of genotypes,
93 out o f 119 individuals, and no obvious strong association of individual genotypes with 
clinical outcomes, we decided to investigate this association using the various combinations 
of 5, 4 and 3 loci to see if a subset of loci showed a stronger link. Table 4.3 summarizes the 
number of genotypes obtained using various combinations of loci with their clinical 
distributions.
From Table 4.3 we can see that the ranges of genotype numbers using various combinations 
of loci are 74 to 91, 54 to 72, and 30 to 67 for 5 ,4  and 3 loci, respectively, across all 
samples. Among the clinical groups, the liver abscess samples always produced the largest 
number o f genotypes.
The total number of genotypes obtained using any combination of 5 or 4 loci was again 
very high. For example, the minimum number of genotypes obtained using 5 loci (ADRSQ) 
was 68 and the minimum number of genotypes obtained using 4 loci (DARS) was 48. We 
did not find any association between genotype and clinical outcome of infection (data not 
shown).
However, the set of 3 loci -  D-A, A-L and R-R (DAR) - which produced the minimum 
number o f genotypes with 3 loci (30, Table 4.3) appeared to show an association with the 
clinical outcome o f disease so we investigated this further. Appendix III shows the 
genotypes obtained for all samples from Bangladesh using DAR genotyping.
4.9.1. DAR genotype distribution among clinical groups
As for the 6-locus results, in Mirpur samples using all the PCR patterns at DAR loci we 
also found a statistically significant difference between asymptomatic and 
diarrhoeal/dysenteric groups (Table 4.4) and again the individual locus that contributed 
significantly towards this result was D-A.
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Table 4.3. Summary of genotype numbers using various combinations of loci.
N o . o f  
lo c i u se d
G e n o ty p in g
n a m e
N o . o f  g e n o ty p e s
T o ta l  g e n o ty p e s  
( n = 1 2 3 )A s y m p to m a tic
(n = 3 6 )
D ia r rh o e a l
(n = 4 4 )
L iv e r  a b s c e s s  
(n = 4 3 )
6 A D N R S Q 2 6 33 41 93
5
A D N R Q 23 2 9 3 8 79
A D N R S 2 6 31 3 6 8 0
A D N S O 25 2 9 3 9 85
A D R S Q 24 2 5 4 0 7 4
A N R S Q 2 6 33 41 91
D N R S Q 25 32 4 0 87
4
A R S O 2 0 25 38 62
D A N Q 21 2 6 3 4 65
D A N R 19 25 31 58
D A N S 24 23 3 2 6 4
D A R O 19 19 3 2 5 6
D A R S 23 2 2 3 2 5 4
D A S O 21 2 2 3 5 63
D N R O 2 2 2 8 3 6 72
D N R S 25 2 9 3 3 71
D R S Q 2 2 24 3 9 6 7
3
A N Q 18 2 3 3 0 52
A N R 15 19 2 3 41
A N S 2 0 2 0 2 6 5 0
A R O 24 17 2 7 4 2
A R S 16 18 2 6 39
A S O 16 18 31 4 6
D A N 17 17 2 4 3 9
D A O 14 16 25 41
D A R 14 15 19 3 0
D A S 17 16 2 6 3 5
D N Q 18 2 4 2 9 5 4
D N R 18 2 2 2 6 4 8
D N S 21 21 2 7 53
D R Q 17 17 2 9 4 5
D R S 2 0 19 2 6 41
D S O 19 21 3 0 5 2
N R Q 18 2 6 33 5 9
N R S 2 0 2 6 3 0 5 6
N S Q 21 2 6 3 4 6 7
R S O 18 2 4 3 6 5 4
n  n u m b e r  o f  to ta l  in d iv id u a ls ;  a b b re v ia te d  fo rm  o f  lo c u s  n a m e s  h a v e  b e e n  u s e d  in  th e  n a m in g  o f  g e n o ty p in g :  A  =  A ­
L , D  =  D -A , N  =  N - K 2 ,  R  =  R -R , S  =  S -D , a n d  Q  =  S -Q .
Using DAR across all Bangladeshi samples we found an overall statistically significant 
difference between the diarrhoeal/dysenteric and liver abscess populations only (Table 4.4) 
and the only locus contributing significantly towards this result was A-L. In contrast using 
all 6 loci we previously found significant differences among all 3 pairs o f clinical 
populations. Other loci -  N-K2 and S-Q - contributed significantly towards these 
differences. Although overall the differences in DAR analysis were not statistically
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significant between the asymptomatic and diarrhoeal/dysenteric populations and between 
the asymptomatic and liver abscess populations, locus D-A and locus A-L did show a 
statistically significant difference in these 2 pairs of populations, respectively.
Table 4.4. Statistical analysis of DAR genotype distribution among clinical groups.
Analysis Population
pair
No. of 
samples Chi2
Overall 
P values
Loci showing 
significant differences 
(P values)
Mirpur
DAR A & D
A = 37 
D = 42 18.175
0.0058 Locus D-A (0.0011)
Bangladesh
DAR
A & D A = 37 D = 48 10.084
0.1212 Locus D-A (0.0200)
D & L D = 48 L = 43 24.450
0.0004 Locus A-L (0.0004)
L & A L = 43 A = 37 10.522
0.1043 Locus A-L (0.0264)
A -  Asymptomatic, D = diarrhoeal/dysenteric, L = liver abscess.
4.9.2. Association between individual DAR genotypes and clinical outcome of 
infections
We tested a few of the most common DAR genotypes (18, 6 and 17) to investigate whether 
they showed an association with clinical outcome of infection (Table 4.5). Genotypes 18 
and 6 showed an association with diarrhoeal/dysenteric and asymptomatic infections, 
respectively, both in Mirpur and across all Bangladeshi samples. However genotype 17 (the 
second most common in Mirpur with genotype 6 found in 12 children each) showed no 
significant association with the type of infection. Although genotypes 18 and 6 showed 
statistically significant clinical association with diarrhoeal/dysenteric and asymptomatic 
infections they covered only 50% and 28.6% of the samples in the corresponding clinical 
populations, respectively.
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Table 4.5. Statistical analysis o f the most common individual DAR genotypes among clinical 
groups.
Analysis Genotype
Population pair with 
corresponding frequency 
of the genotype
Chi2 P values
18 A = 6/35 D = 22/38 12.80 0.0003
Mirpur
DAR 6
A = 10/35 
D = 2/38 7.21 0.0073
17 A = 5/35 D = 7/38
0.23 0.6339
A = 6/35 
D = 22/44 9.20 0.0024
18
D = 22/44 
L = 5/43 14.96 0.0001
L = 5/43 
A = 6/35 0.14 0.7121
Bangladesh Overall 18.67 <0.0001
DAR A =10/35 
D = 4/44 5.07 0.0243
6
D = 4/44 
L = 4/43 0.11 0.7362
L = 4/43 
A = 10/35 4.86 0.0274
Overall 7.45 0.0241
A = Asymptomatic, D = diarrhoeal/dysenteric, L = liver abscess.
4.9.3. The predicted total number of DAR genotypes
a) In Mirpur samples:
From Appendix III, we can see that, S 0bs = 20, a = 10 and b = 5
So, the total number o f predicted DAR genotypes in Mirpur children is, Si = 30
b) Across all Bangladeshi samples:
From Appendix III, we can see that, S 0bs = 30, a = 10 and b = 9
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So, the total number of predicted DAR genotypes in Bangladesh is, Si = 35.6 indicating that 
most o f the variants had been detected. However sampling is not comprehensive.
4.10. Association between genotypes using a selection of 5 loci, 4 loci and 3 loci 
genotyping data
Although we did not see an obvious and strong association between an individual genotype 
and clinical outcome o f infection using any combination of 5 ,4  and 3 loci, except for DAR 
(where a few individual genotypes showed a good association), we were, however, 
interested to investigate the relationship among genotypes for a selection o f these 
combinations using the eBURST program. We investigated this for the maximum and 
minimum numbers o f genotypes obtained (Table 4.3): for 5 loci -  91(ANRSQ) and 74 
(ADRSQ), for 4 loci - 72 (DNRQ) and 54 (DARS), and for 3 loci - 67 (NSQ) and 30 
genotypes (DAR) and the results are provided in Appendix IV.
In summary, eBURST showed better association among genotypes when a greater number 
of loci was used. As we decreased the number of loci, it became easier for the eBURST to 
find genotypes that differed by one locus and as a result it was linking different types of 
clinical samples into the same clusters.
4.11. E. histolytica follow-up samples
Follow-up samples were available from 23 children (Table 4.6). We were interested in 
investigating the stability o f genotype patterns in these infections.
A maximum number o f 7 follow-up samples were available from one child (3402) over a 
period of 11 months and all showed the same genotype, except for one sample (MS33) 
which seemed to have a mixture of two genotypes. However the new genotype was not 
found in the subsequent follow-up sample (MS34) suggesting that it was a transient 
infection. Six and 5 follow-up samples were available from two children -  0015 and 1049, 
respectively. Both these children carried the same genotype throughout the follow-up
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period. Two and 3 follow-up samples were available from 13 and 6 children, respectively 
(Table 4.6).
From Figure 4.10 we can see that both 6-locus and DAR genotypes changed in 7 children. 
In 13 children all the corresponding follow-up samples from the same child showed same 
genotypes. In 3 children DAR genotypes remained the same while the 6-locus genotypes 
changed.
4.11.1. Number of loci changed during the new infection
We observed a total of 12 6-locus genotype changes in the follow-up samples o f 10 
children. Comparing the patterns between two consecutive follow-up samples, we 
observed a total o f 37 PCR pattern changes involving all 6 loci. Only one pattern 
changed at locus A-L, which is the least polymorphic o f the 6 loci. The maximum 
number o f pattern changes (9) occurred at locus S-Q, one of the most polymorphic 
loci. On average 3.08 loci changed when a follow-up genotype was different.
In most cases we ran all the follow-up samples from a particular child next to each 
other in the gel to detect the differences. In two children (1186 and 3679) we 
noticed that the PCR patterns of the follow-up samples changed at only one locus 
each. However, in both children the changes were easy to detect. In child 1186, the 
changed N-K2 patterns were 1 (500 bp) and 8 (630 bp) and in child 3679 the 
changed R-R patterns were 1 (480 bp) and 4 (590 bp). In conclusion even when 
changes occurred in only 1 or 2 PCR patterns in a few follow-up samples, they 
were real. In most cases the PCR pattern changes were extensive and loci with 
more polymorphism seemed to be affected more frequently.
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Table 4.6. Follow-up samples in E. histolytica infected children,
ID C lin ic a l  s ta tu s D -A A -L R -R N -K 2 S -D S -Q G e n o ty p e
0015-DS04 D 3 3 3 9 3 5 51
0015-DS05 D 3 3 3 9 3 5 51
0015-MS22 A 3 3 3 9 3 5 51
0015-MS24 A 3 3 3 9 3 5 51
0015-MS27 A 3 3 3 9 3 5 51
0015-MS32 A 3 3 3 9 3 5 51
0021-DS07 D 3 3 3 6 3 3 48
0021-DS10 D 3 3 3 8 4 3 50
0027-DS10 D 3 3 4 8 4 3 66
0027-DS13 D 3 3 4 8 4 3 66
0027-DS17 D 3 3 3 9 3 5 51
0055-MS21 A 3 3 3 9 3 5 51
0055-MS23 A 3 3 3 9 3 5 51
0064-DS06 D 3 3 4 9 3 3 67
0064-MS 17 A 3 3 4 9 3 3 67
0064-MS26 A 3 3 4 9 3 3 67
0199-MS31 A 2 3 4 6 6 3 13
0199-MS34 A 2 3 4 6 6 3 13
0291-MS32 A 3 3 4 3 2 3 58
0291-MS42 A 3 3 5 i 2 2 72
1036-DS01 D 3 3 4 4 4 3 62
1036-DS06 D 3 4 3 9 3 5 77
1036-MS59 A 2 4 5 9 3 2 24
1049-DS04 D 2 3 4 9 4 8 19
1049-MS29 A 2 3 4 9 4 8 19
1049-MS30 A 2 3 4 9 4 8 19
1049-MS31 A 2 3 4 9 4 8 19
1049-MS34 A 2 3 4 9 4 8 19
1057-DS11 D 3 3 4 3 2 3 58
1057-MS33 A 3 3 4 3 2 3 58
1186-DS19 D 3 3 3 8 3 3 49
1186-DS20 D 3 3 3 1 3 3 46
1292-DS05 D 3 3 4 9 6 4 70
1292-MS22 A 3 3 4 9 6 4 70
1325-MS22 A 3 3 3 9 4 3 52
1325-MS28 A 2 3 4 9 4 8 19
1325-MS33 A 2 3 4 9 4 8 19
1681-MS29 A 2 3 4 6 6 3 13
1681-MS34 A 2 3 4 6 6 3 13
3042-DS04 D 3 3 1 8 4 3 45
3042-MS19 A 3 3 i 8 4 3 45
3346-MS22 A 3 3 4 9 10 3 71
3346-MS32 A 3 3 4 9 10 3 71
3402-MS23 A 2 3 3 9 6 3 8
3402-MS27 A 2 3 3 9 6 3 8
3402-MS28 A 2 3 3 9 6 3 8
3402-MS30 A 2 3 3 9 6 3 8
3402-MS31 A 2 3 3 9 6 3 8
3402-MS33* A 2 3 3 9 6 3 8
3402-MS34 A 2 3 3 9 6 3 8
3484-MS21 A 3 3 4 6 4 3 63
3484-MS22 A 3 3 4 6 4 3 63
3497-DS02 D 3 3 3 9 3 5 51
3497-MS20 A 3 3 3 9 4 3 52
3570-DS04 D 2 3 i 8 3 5 5
3570-DS14 D 4 3 3 8 4 2 86
3570-DS28 D 3 3 4 i 3 4 54
3645-DS14 D 4 2 i 4 5 4 80
3645-MS31 A 3 2 i 6 4 3 34
3679-DS15 D 3 3 4 8 4 3 66
3679-MS21 A 3 3 1 8 4 3 45
3679-MS24 A 3 3 1 8 4 3 45
4247-DS05 D 3 4 3 5 4 5 764247-MS11 A 3 4 3 5 4 5 764247-MS12 A 3 4 3 5 4 5 76
♦This sample showed a transient infection with another genotype o f E. histolytica that was not 
found in the next follow-up sample (MS34).
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Figure 4.10. Genotypes identified in the follow-up samples from children infected with E. 
histolytica. Samples were collected monthly except when diarrhoea was present. Upper 
coloured bars represent the samples tested, white bars indicate that the sample was positive 
for E. histolytica but genotyping was not done, and changes in genotype are indicated by 
different colours and corresponding 6-locus genotype numbers. Lower bars represent 
asymptomatic (yellow) or diarrhoeal (red) status of the child, (a) Genotypes remained the 
same, (b) DAR genotypes remained the same but 6-locus genotypes changed from the 
earlier one(s), and (c) both 6-locus and DAR genotypes changed. *This sample was found 
to be transiently infected by a second strain of E. histolytica (child 3402).
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4.11.2. Rate of re-infection
We tried to calculate the rate of re-infection from the available data on 23 follow­
up children. The total follow-up period in 23 children was 223 months with an 
average period o f 9.7 months per child (ranged from 1-month to 38-months). In 
this period we noticed a total of 12 genotype changes (in 10 children; 2 being 
infected with 2 new genotypes each) or re-infections, which gives an average of 
18.6 months for a new infection to take place.
4.12. Results for E. dispar samples
4.12.1. PCR amplification
PCR amplification was successful for all samples using the E. dispar species specific 
primer pairs (Table 3.2) at all 6 loci (Figure 4.11)
4.12.2. Genotypes based on six PCR amplification patterns
Unlike E. histolytica, many E. dispar isolates produced multiple bands at STR locus N-K. 
Appendix V shows all the genotypes observed. If follow-up samples from the same 
individual shared the same pattern only one was included in the Appendix.
A total of 32 genotypes were observed among the 68 E. dispar isolates. 37 asymptomatic 
children produced 29 genotypes. Children 1805 and 3585 showed two genotypes each. 
Seven samples that were isolated during an episode o f diarrhoea/dysentery (from 6 children 
including one who gave 2 diarrhoeal/dysenteric samples) showed 6 different patterns. Only 
one of these 7 samples had a concomitant detectable bacterial infection (data not shown). 
The most common genotypes were 4, 22 and 24, found in 3 children each. In addition, 
another six genotypes were found in 2 children each (Appendix V).
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4.12.3. DAR genotypes with E . d is p a r  samples
Three locus DAR genotyping produced 16 genotypes across all E. dispar strains. The 
diarrhoeal/dysenteric samples showed 4 genotypes (data not shown).
4.13. The predicted total num ber of genotypes
Using the Chao estimator the total number of predicted E. dispar genotypes in Mirpur 
children using 6 loci was about 85, and using DAR was 48.
4.14. Follow-up samples in E. dispar
Multiple samples were received from 15 children including 1 present in both the 
asymptomatic and diarrhoeal/dysenteric groups. Only 2 children showed different E. dispar 
genotypes in follow-up samples (Table 4.7 and Figure 4.12).
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I-igure 4.11. Gel electrophoresis patterns for a selection of E. dispar samples from Mirpur 
at the selected STR loci.
88
Table 4.7. Genotypes o f follow-up E. d is p a r  strains using 6 loci.
Child ID Clinical
status D-A A-L R-R N-K S-D S-Q Genotype
1008-MS24 A 3 1 3 1 1 1 12
1008-MS25 A 3 1 3 1 1 1 12
1071-MS30 A 3 1 3 9 1 6 13
1071-MS32 A 3 1 3 9 1 6 13
1071-MS33 A 3 1 3 9 1 6 13
1194-MS22 A 4 3 3 8 1 3 17
1194-MS24 A 4 3 3 8 1 3 17
1194-MS25 A 4 3 3 8 1 3 17
1194-MS31 A 4 3 3 8 1 3 17
1627-MS22 A 5 2 3 10 1 1 26
1627-MS31 A 5 2 3 10 1 1 26
1805-MS22 A 2 1 1 5 1 6 6
1805-MS34 A 3 1 3 13 1 5 15
2899-MS22 A 8 1 1 2 1 2 31
2899-MS34 A 8 1 1 2 1 2 31
3046-MS21 A 2 1 3 6 1 1 7
3046-MS23 A 2 1 3 6 1 1 7
3146-MS22 A 5 2 3 5 1 3 22
3146-MS33 A 5 2 3 5 1 3 22
3146-MS35 A 5 2 3 5 1 3 22
3182-MS31 A 5 1 3 9 1 1 20
3182-MS32 A 5 1 3 9 1 1 20
3182-MS33 A 5 1 3 9 1 1 20
3193-MS22 A 5 1 3 7 1 1 19
3193-MS33 A 5 1 3 7 1 1 19
3247-MS22 A 5 2 3 5 1 3 22
3247-MS23 A 5 2 3 5 1 3 22
3499-MS26 A 5 2 3 7 1 3 24
3499-MS31 A 5 2 3 7 1 3 24
3499-MS33 A 5 2 3 7 1 3 24
3570-DS03 D 1 1 1 9 1 7 1
3570-DS04 D 1 1 1 9 1 7 1
3585-MS22 A 2 1 3 3 1 1 4
3585-MS33 A 5 2 3 7 1 3 24
3744-DS02 D 2 1 3 1 1 1 3
3744-MS 19 A 2 1 3 1 1 1 3
3744-MS20 A 2 1 3 1 1 1 3
3744-MS25 A 2 1 3 1 1 1 3
3744-MS26 A 2 1 3 1 1 1 3
3744-MS30 A 2 1 3 1 1 1 3
3744-MS33 A 2 1 3 1 1 1 3
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Figure 4 .12. Genotypes identified in the follow-up samples from children infected with E. 
dispar. Samples were collected monthly except when diarrhoea was present. Upper 
coloured bars represent the genotypes of samples tested, and changes in genotype are 
indicated by different colours and corresponding 6-locus genotype numbers. Lower bars 
represent asymptomatic (yellow) and diarrhoeal (red) status of the child, (a) Genotypes 
remained the same (only two children are shown as representative of 13 children in this 
group) and (b) both 6-locus and DAR genotypes changed in 2 children.
4.15. eBURST analysis with E. dispar genotypes
The relationship between E. dispar genotypes was investigated using eBURST. eBURST 
detected 4 groups: 2 contained only two genotypes each, a 3,d group contained 5 genotypes 
and the 4th (major) group contained 8 genotypes (Figure 4.13). In the major group, the 
founder genotype is 23, which has 3 SLVs (genotypes 19, 24 and 26) and 4 DLVs 
(genotypes 20, 21,22 and 25). Interestingly, no diarrhoeal samples were found in this 
group. In the 3rd group, the founder genotype is 3, which has 3 SLVs (genotypes 4, 7and 
12) and one DLV (genotype 5). It is noticeable that 3 out of 6 diarrhoeal samples were 
found in this small group. Fifteen genotypes were identified by eBURST as singletons.
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Figure 4.13. eBURST with Bangladeshi E. dispar isolates
4.16. Discussion
Our main objectives in this study were to evaluate our newly developed and species- 
specific tRNA-linked repetitive DNA markers (discussed in the previous Chapter) and to 
genotype clinical strains o f E. histolytica from Bangladesh. The reason for doing this 
genotyping was to see if genotypes correlate with the outcome of infection We were 
successful in genotyping all available Bangladeshi strains of£ . histolytica. PCR 
amplification for genotyping was successful using culture, stool and liver abscess DNA 
samples. Most importantly we found evidence of an association between genotypes and the 
clinical outcome of infection using both 6-locus and 3-locus (DAR) genotyping. eBURST 
analysis using six loci showed that many of the genotypes detected predominantly in
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diarrhoeal/dysenteric and liver abscess samples seemed to be related to each other as they 
were found to cluster in the eBURST diagram. We observed some clusters in the eBURST 
diagram that had clinical relevance. Most of the time symptomatic strains clustered in the 
same group. However, these clusters represented only a minority of the total samples in 
three populations. As a result the predictive value o f these clusters is low.
However we have some limitations in this study: (a) All our asymptomatic samples and 
most of our diarrhoeal/dysenteric samples are from preschool children from Mirpur and as 
a result we do not know whether they are representative o f all age group and strains from 
all parts of Bangladesh, (b) We judged the PCR fragment sizes in the gel by eye; as a result, 
some o f these sizes could be slightly different from those which were assigned. However, 
we tried to be as accurate as possible, (c) Since we had only 9 samples that were collected 
during an episode of dysentery (as opposed to diarrhoea) we did not establish a separate 
group (from the diarrhoeal group) to analyze these. However larger numbers o f dysenteric 
samples may have helped us to find a possible association between genotypes and 
dysentery as a clinical outcome o f infection, (d) Our genotyping is based on PCR fragment 
size differences in tRNA-linked loci. The same product size at a particular locus does not 
necessarily mean the same sequence and that is what we observed in our DNA sequence 
diversity investigation (Chapter 7). This might have some impact on the observed 
association between genotypes and clinical outcomes. We noticed that sometimes two 
strains with apparently identical genotype were linked to different clinical outcome in the 
infected individuals. It is possible that these are actually not same genotype. However, we 
would also expect to find some infections in asymptomatic individuals that would 
eventually give rise to invasive disease. So mixed clusters are to be expected.
Most o f the diarrhoeal/dysenteric samples were subjected to bacteriological tests for 
pathogens, however no viral tests were done (personal communication with Dr. Rashidul 
Haque). Tests were not done for 9 of 52 samples in the E. histolytica group. O f the 
remaining 43 samples, potential diarrhoea/dysentery-causing bacterial pathogens were 
detected in 12 (27.9%) samples only (data not shown). In the 3-locus DAR analysis, 
genotype 18 showed a statistically significant association with diarrhoeal/dysenteric
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infection, and we found that 6 o f 20 (30%) samples with this genotype, in which bacterial 
tests were done, contained a concomitant bacterial pathogen infection. Since the overall 
rate of concomitant bacterial infection in this sample group is very similar to that found for 
genotype 18, we do not think that the associated bacterial infections would have influenced 
our results. In the E. dispar group only one of the 7 diarrhoeal/dysenteric samples had a 
concomitant bacterial infection, so the cause of diarrhoea/dysentery in these children was 
not clear. It could be of viral or other unknown etiological origin.
Clark and Diamond (1993) observed 16 different genotypes using the combined results of 
SREHPA4M restriction digestion and SSG amplification in 18 isolates of E. histolytica 
isolated from diverse geographic location. We detected 93 genotypes in clinical samples 
from 123 individuals using 6 loci, which is comparable in terms o f the diversity of 
genotypes detected. Our results also showed similar trends to those in Ayeh-Kumi et al 
(2001) who studied clinical samples from Bangladesh using a nested SREHP PCR and 
found 25 genotypes in 42 intestinal isolates and 9 genotypes in 12 amoebic liver abscess 
strains. However, 8 out of 9 liver abscess genotypes were found to be unique among ALA 
patients investigated. We also noticed that most of our liver abscess genotypes were unique 
and not found among the intestinal strains.
Haghighi et al (2003) investigated the genotypes o f 79 clinical E. histolytica isolates from 
Japan (40, mainly from mentally retarded patients and homosexual males), Thailand (27), 
Bangladesh (5), and other countries (7, mainly reference isolates) using 4 loci -  two tRNA- 
linked loci, chitinase and SREHP -  but failed to find an association between the parasite 
genotype and the clinical outcome of disease in the host. There are several possibilities for 
this apparent lack o f association -  i) the sample size was too small for such highly diverse 
geographic samples, ii) they did not use the proper analytical approaches, and iii) perhaps 
the polymorphic loci they used were not appropriate.
There are several positive aspects to our genotyping method
1. It amplifies DNA extracted from culture, stool and liver abscess pus.
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2. If a nested PCR is required, particularly when the amount of DNA is too low in the 
biological samples, e.g., stool or liver abscess samples, it can be performed using 
the tRNA primers in the 1st PCR, and the species-specific primers in the 2nd 
amplification.
3. The amplifications are species-specific and as a result not influenced by the 
presence o f other Entamoeba DNA.
4. Unlike SREHP, it does not require a restriction endonuclease digest to detect all 
genotypes.
5. These PCRs are fast and take less than two hours to complete.
We investigated the relationships between genotypes by eBURST rather than by 
phylogenetic trees because eBURST identifies groups o f related genotypes in the 
population on the basis of a simple evolutionary model in which an ancestral genotype (i.e. 
the founding genotype in our case) is linked to other closely related genotypes to produce a 
cluster. While phylogenetic trees could be generated, the data from our 6 loci may only be 
considered as 6 separate characters (like 6 nucleotide or amino acid positions in an 
alignment) which are not adequate for this approach.
eBURST analysis of Mirpur samples (Figure 4.4) produced 4 clinically relevant clusters -  1 
with only asymptomatic samples and 3 others predominantly with diarrhoeal/dysenteric 
samples. When all other samples from Bangladesh (that is the ICDDR,B and the liver 
abscess samples) were included with the Mirpur samples, the previously mentioned 
asymptomatic cluster lost its integrity by incorporating a diarrhoeal/dysenteric sample from 
ICDDR,B of unknown geographic origin, although the other clusters continued to show the 
link to symptoms (Figure 4.5). This indicates that the symptomatic samples appear to be 
more closely linked to each other as liver abscess samples often tended to cluster with 
diarrhoeal/dysenteric samples in eBURST. The clustering may indicate that invasive strains 
arose a limited number of times.
We found that the 6-locus genotype 66 showed a statistically significant association 
(P<0.05) with diarrhoeal/dysenteric samples in both Mirpur and across all Bangladeshi
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samples. Since the total number o f individuals sharing any other single genotype was very 
small, none showed any significant associations.
In DAR genotyping, the total number o f individuals with the same genotype was relatively 
high. We found an association between 2 individual genotypes and the clinical outcome of 
infection -  genotype 6 is linked with the asymptomatic group and genotype 18 with the 
diarrhoeal/dysenteric group. It is worth mentioning that DAR genotype 18 essentially 
contained all the individuals belonging to 6-locus genotype 66 in addition to other 
individuals. In the liver abscess group we did not find any association simply because no 
individual genotype contained more than 5 of the 43 liver abscess samples. Genotype 14, 
which was found in 2 asymptomatic and 5 liver abscess samples (and not found in any of 
the diarrhoeal/dysenteric group) failed to show a statistically significant association with 
clinical outcome (P = 0.066). There are two explanations for why liver abscess strains 
produce a greater number of genotypes. One, the liver abscess strains were from a much 
greater geographic area and two, it is possible that liver abscess strains are more divergent 
compared to asymptomatic and diarrhoeal/dysenteric strains. However, which if either of 
these was contributing more towards the diversity we observed is impossible to tell from 
this study. Only a properly designed case control based genotyping study with 3 types of 
clinical samples from same geographic location can give a clear answer.
We noticed some differences between E. histolytica and E. dispar in their polymorphism at 
the 6 loci studied here. First, although locus S-D was highly polymorphic among E. 
histolytica strains, it was non-polymorphic in E. dispar. The S-D sequence from E. dispar 
SAW760 does not contain any STRs and this is the likely explanation for the lack of 
variation. Second, multiple bands were quite common for locus N-K in E. dispar, but we 
did not see this in E. histolytica.
The total number of genotypes observed using 6-locus and DAR for Mirpur children were 
48 and 20 for the 70 E. histolytica infected children (i.e. an average o f 1.46 and 3.5 children 
shared the same genotype on average, respectively) and 32 and 16 for 42 E. dispar infected 
children (i.e. 1.31 and 2.63 children shared the same genotype, respectively). So this
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suggests that a comparable number of genetically distinct E. histolytica and E. dispar 
strains circulate in Mirpur study area.
However, the Chao estimation for total predicted genotypes did not fully support the above 
findings as it predicted more DAR genotypes for E. dispar than E. histolytica (48 versus 
30, respectively), but fewer 6-locus genotypes for E. dispar than E. histolytica (85 versus 
109, respectively). The latter difference may be due to the lack o f polymorphism at locus S­
D in E. dispar.
In the follow-up samples we noticed that infection with a new genotype is more common in 
E. histolytica than E. dispar since 10 of 23 E. histolytica follow-up children seemed to have 
become infected with at least one other genotype compared to only 2 o f 15 children in E. 
dispar group.
GENEPOP analysis using all 6-locus data showed that all 3 pairs of clinical populations are 
different from each other in Mirpur as well as across all Bangladesh. However a similar 
analysis with the 3-locus DAR data showed that the some o f these significant differences 
among clinical populations do not persist any more. This is because the data from the other 
3 loci not included in DAR were contributing more towards the significant difference seen 
in 6-locus data. We conclude that overall genotypic difference detected among the various 
clinical populations increases with an increase in the number o f loci and therefore for 
population based analysis it would be more appropriate to use the greater number of 
polymorphic loci.
We observed a very large number of genotypes in Bangladeshi strains o f E. histolytica -  93 
and 30 in 119 individuals using 6 and 3-locus genotyping, respectively. This result was not 
a big surprise as Haghighi et al (2002 and 2003), Ayeh-Kumi et al (2001) and Zaki et al 
(2003a) also observed a high degree of polymorphism in E. histolytica. However too many 
genotypes can be a problem when looking for a strong association between strain genotype 
and clinical outcome.
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Nevertheless, we found that our overall genotype results using 6 loci showed a statistically 
significant difference between the 3 sample populations, suggesting that the overall genetic 
make up of the strains identified in the clinical populations is distinct. Other approaches 
need to be implemented to locate exactly what is causing the variable outcome o f diseases 
in the hosts as it is unlikely that these tRNA linked STR loci are directly responsible in any 
way.
We do not know whether the observed association between some of the individual 
genotypes in E. histolytica and clinical outcome of infection using 6-locus and DAR 
genotypes in Bangladesh also exist in other parts of the world. To address this question we 
extended our analysis to include a large number o f non-Bangladeshi E. histolytica samples.
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CHAPTER 5
DAR GENOTYPING OF NON-BANGLADESHI STRAINS OF E.
HISTOLYTICA
5.1. Introduction
In the previous Chapter we investigated the genotypes in clinical samples o f E. histolytica 
from Bangladesh in which all the asymptomatic samples were from children from Mirpur, 
diarrhoeal/dysenteric samples were also predominantly from Mirpur, and liver abscess 
samples were from a much broader area. We observed a high degree o f polymorphism in this 
restricted area using 6 locus tRNA-linked genotyping. In addition to finding genetic 
diversity, we found an association between some of the individual genotypes of the E. 
histolytica strain and the clinical outcome of disease using the 3-locus DAR genotyping. 
Moreover we noticed an overall difference in genotypes between asymptomatic and 
diarrhoeal/dysenteric samples in Mirpur as well as between diarrhoeal/dysenteric and liver 
abscess samples from across Bangladesh.
In this Chapter we extended DAR genotyping to some o f the available clinical strains o f E. 
histolytica from other parts of the world to find out whether the genotypes that were found to 
be associated with asymptomatic or symptomatic infections in Bangladesh were also found 
in similar clinical samples in other countries, whether genotypes that were common in 
Bangladesh were also common in other countries, and whether there was an overall 
difference between genotypes in samples from different clinical groups from around the 
world.
5.2. E. histolytica isolates
A total o f 87 E. histolytica DNA samples were available for investigation from 11 different 
countries. Appendix VI provides some background information on these samples.
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All 27 Vietnamese stool DNA samples and all 11 South African culture DNA samples were 
from asymptomatic adults. In contrast, all 9 Georgian culture DNA samples and 5 of 6 
Turkish stool DNA samples were from symptomatic diarrhoeal/dysenteric patients. Culture 
DNA samples were available from 26 individuals from Japan -  8 of them were 
asymptomatic, 7 had only diarrhoea/dysentery, 2 had only liver abscess, another 2 patients 
had both diarrhoea/dysentery and liver abscess (samples J7 and J8: cultures were established 
from stool specimens), while the clinical information was not available for the remaining 7 
DNA samples. Apart from the 4 liver abscess samples from Japan (mentioned above) only 
one more sample in this category was available, from Korea.
In summary 50 asymptomatic, 25 diarrhoeal/dysenteric, 3 liver abscess, 2 
diarrhoea/dysenteric plus liver abscess, and 7 samples with unavailable clinical information 
were studied here (Appendix VI).
5.2.1.3-locus PCR amplification
E. histolytica species-specific primers for 3 loci -  D-A, A-L and R-R (DAR) - were used to 
amplify the corresponding DNA fragments as described in Chapters 3 and 4.
5.3. Results
5.3.1. PCR amplifications
PCR amplification was successful for all samples, although occasionally a nested PCR was 
necessary (data not shown). However, in 12 samples we observed the presence of other 
fainter bands in one o f the 3 loci which we ignored for two reasons: one, in most cases we 
thought the faint band was non specific and two, for the simplicity of the analysis. Figure 5.1 
shows PCR product size variations in a selection of samples.
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(a) (b)
Figure 5.1. DAR PCR patterns of a selection of non-Bangladeshi samples, (a) 13 Japanese 
samples and (b) 15 Vietnamese samples.
5.3.2. DAR genotypes
In order to facilitate an easy comparison between DAR genotypes that were detected in 
Bangladesh and ones detected in other countries we kept the same genotype numbers 1 to 30 
(corresponding to Bangladeshi DAR genotype numbers) while 31 to 46 were new genotypes 
detected only in the non-Bangladeshi survey. A total o f 31 DAR genotypes were detected 
across all non-Bangladeshi samples (Appendix VII). However, 15 of 31 genotypes were 
previously detected in Bangladeshi samples (Chapter 4) and the 16 new genotypes 
(genotypes 31 to 46) comprised less than one-third of all non-Bangladeshi samples (27 of 87 
samples, Appendix VII). The two most common non-Bangladeshi genotypes were 15 and 17, 
found in 23 and 7 individuals, respectively.
1 0 0
Some genotypes appear to be common in either Bangladeshi or non-Bangladeshi samples. 
For examples, genotypes 6 and 18 were common in Bangladeshi samples while genotype 21 
was more common in non-Bangladeshi samples. Genotype 14 seemed to be common in both 
Bangladeshi and non-Bangladeshi samples. However genotypes 2, 5, 11, 20 ,24 ,27  and 30 
seemed to be rare in both Bangladeshi and non-Bangladeshi samples.
We previously found that in Bangladesh, genotype 6 was associated with asymptomatic 
infection (P<0.05), and the only sample found in non-Bangladeshi group with this genotype 
was also from an asymptomatic individual. In contrast, genotype 18, which showed 
association in Bangladeshi samples with diarrhoeal/dysenteric patients, was found in 5 non­
Bangladeshi samples, 4 of them from asymptomatic individuals and the remaining one from 
a diarrhoeal/dysenteric patient. However we should be aware that the sample sizes for the 3 
clinical types in any individual country, except for Bangladesh, were too small to investigate 
the association of genotype and clinical outcome.
5.4. DAR genotype distribution among clinical groups
Statistical analysis on genotype distribution among 3 clinical groups was done using the 
web based analytical program GENEPOP (http://wbiomed.curtin.edu.au/genepop/). Since 
the sample size of the liver abscess group in the non-Bangladeshi sample was too small (3 
samples) we compared the asymptomatic and diarrhoeal/dysenteric populations only.
In non-Bangladeshi samples, using all three PCR patterns, we found a significant overall 
difference (P<0.05) between the asymptomatic and diarrhoeal/dysenteric groups (Table 5.2). 
Two loci contributed significantly towards this difference, A-L and R-R. In particular, two 
PCR patterns in locus A-L -  #2 and #4 -  were found in 29 and 8 of 50 asymptomatic 
samples compared to only 7 and 1 of 27 diarrhoeal/dysenteric samples, respectively. Two 
PCR patterns in locus R-R, #3 and #4, were found in 16 and 6 of 27 diarrhoeal/dysenteric 
samples compared to 8 and 40 of 50 asymptomatic samples, also showing significant 
differences (Table 5.2 and Appendix VII). In contrast across all Bangladeshi samples there 
was no significant overall difference in DAR genotypes between the asymptomatic and
5.3.3. DAR genotypes found in both Bangladeshi and non-Bangladeshi samples
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Table 5.1. Clinical distribution o f the E. histolytica DAR genotypes from Bangladesh and 
other parts of the world.
DAR
genotype # Strain origin
Clinical status Frequency in
A D L NA Individualcountry Total
2 Bangladesh 0 0 1 0 1 2Japan 0 1* 0 0 1
5 Bangladesh 2 0 0 0 2 3South Africa 1 0 0 0 1
6 Bangladesh 10 4 4 0 18 19
Japan 1 0 0 0 1
11
Bangladesh 0 1 0 0 1
3Georgia 0 1 0 0 1
Turkey 0 1 0 0 1
14
Bangladesh 2 0 5 0 7
12Burma 0 2 0 0 2
South Africa 3 0 0 0 3
15
Bangladesh 0 0 2 0 2
25
India 1 0 0 0 1
Japan 1 0 1 4 6
South Africa 1 0 0 0 1
Vietnam 15 0 0 0 15
17
Bangladesh 5 7 1 0 13
20Georgia 0 3 0 0 3
Turkey 1 3 0 0 4
18
Bangladesh 6 22 5 0 33
38Mexico 0 1 0 0 1
Vietnam 4 0 0 0 4
19 Bangladesh 1 1 3 0 5 6Georgia 0 1 0 0 1
20 Bangladesh 0 2 0 0 2 3Turkey 0 1 0 0 1
21 Bangladesh 0 0 1 0 1 7Vietnam 6 0 0 0 6
24
Bangladesh 0 0 2 0 2
4Korea 0 0 1 0 1
Japan 0 1 0 0 1
27 Bangladesh 1 0 1 0 2 3South Africa 1 0 0 0 1
29 Bangladesh 1 1 0 0 2 5Japan 0 2* 0 1 3
30 Bangladesh 0 0 2 0 2 4South Africa 2 0 0 0 2
Total
A = asvmntomatir. n  — Hiot -^Vin^oi/,1..^
65
T -
55 29 5 154 154
, . ’ ««aiuiu^ai/uj'dciiiciIV/) i—< iivv i aiivi t i n  uv i avaiitiuiv« vyiic u i II1C ^
patients in genotype 29 and only Japanese patient in genotype 2 also had liver abscess, but we considered 
them in this clinical group since the DNA source was cultures isolated from stool samples.
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Table 5.2. Statistical analysis of genotype distribution among clinical groups.
Analysis Population
pair
No. o f 
samples Chi2
Overall 
P values
Loci showing 
significant differences 
(P values)
Non­
Bangladeshi A & D
A = 50 
D = 27 Infinity <0.0001
Locus A-L (0.0055) 
Locus R-R (<0.0001)
Combined
A & D A = 87 D = 75 25.366 0.0003 Locus A-L (0.0007)
D & L D = 75 L = 46
23.954 0.0005 Locus D-A (0.0199) 
Locus A-L (0.0050)
L & A L = 46 A = 87 16.786 0.0101 Locus R-R (0.0035)
A -  Asymptomatic, D = diarrhoeal/dysenteric, L = liver abscess.
diarrhoeal/dysenteric groups, although locus D-A on its own was still significant (Table 
4.4). In addition, the overall significant difference in DAR genotypes between 
asymptomatic and diarrhoeal/dysenteric groups in Mirpur children was due only to 
significant contribution by locus D-A compared to A-L and R-R in the non-Bangladeshi 
samples. The reason for different loci being significant in different parts of the world 
between the same pair o f sample populations is not clear.
When all sample data available were combined we found an overall significant difference 
among all 3 clinical populations (Table 5.2). Between asymptomatic and 
diarrhoeal/dysenteric population the only locus contributing towards this significant 
difference was A-L. Between diarrhoeal/dysenteric and liver abscess population the loci 
contributing towards this significant difference were D-A and A-L. Between liver abscess 
and asymptomatic population the only locus contributing towards this significant difference 
was R-R.
5.5. Association of individual non-Bangladeshi DAR genotypes with clinical outcome of 
infection
We also investigated whether some of the more common DAR genotypes showed an 
association with clinical outcome of infection. Since the number of liver abscess samples in
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non-Bangladeshi samples was low (only 3 samples with 3 different genotypes) we did not 
include them in the ‘non-Bangladeshi’analysis (although they were included in the combined 
analysis). We also ignored the 7 samples for which clinical information was not available. 
The two Japanese samples (J7 and J8) that were from individuals with both 
diarrhoea/dysentery and liver abscess were included in diarrhoea/dysentery group since the 
origin of DNA was stool samples, not liver abscess pus. Across all non-Bangladeshi samples 
- we detected 16 DAR genotypes in 50 asymptomatic individuals and 18 genotypes in 27 
diarrhoeal/dysenteric patients.
In non-Bangladeshi samples genotype 15 showed a strong association with asymptomatic 
infection (P = 0.0001) but was only found in 18 o f 50 non-Bangladeshi asymptomatic 
samples, showing almost no predictive value. Similarly although the genotype 17 showed 
statistically significant association (P = 0.0114) with diarrhoeal/dysenteric samples, it was 
found only in 6 of 27 samples o f this clinical type, showing no predictive value at all.
When we combined the DAR results o f both non-Bangladeshi and Bangladeshi samples, 
we found that the two most common genotypes now were 18 and 6. Genotype 18 showed a 
statistically significant association with diarrhoeal/dysenteric infection while genotype 6 
showed no association with any particular outcome of infection (Table 5.3).
We were also interested to know whether the association we observed for genotypes 15 and 
17 in non-Bangladeshi samples alone still existed. In fact, they maintained the similar 
clinical associations even after all samples were combined (Table 5.3).
5.6. Association between DAR genotypes by eBURST analysis
From eBURST analysis of all non-Bangladeshi samples we could detect 3 clusters that had 
some clinical relevance (Figure 5.2). Cluster a contained 5 samples, 3 of which were 
diarrhoeal/dysenteric samples. Cluster b contained almost exclusively asymptomatic 
strains, and cluster c contained predominantly diarrhoeal/dysenteric samples.
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Table 5.3. Statistical analysis of the most common individual DAR genotypes among
clinical groups.
Analysis Genotype
Population pair with 
corresponding frequency 
o f the genotype
Chi2 P values
Non­
Bangladeshi
samples
15 A = 18/50 D = 0/27 14.59 0.0001
17 A = 1/50 D = 6/27 6.40 0.0114
Across all 
samples
A A i _ . . •
18
A =  10/85 
D = 23/71 9.87 0.0017
D = 23/71 
L = 5/46 7.10 0.0077
L = 5/46 
A = 10/85 0.02 0.8780
Overall 13.24 0.0013
6
A = 11/85 
D = 4/71 2.38 0.1231
D = 4/71 
L = 4/46 0.07 0.7902
L = 4/46 
A = 11/85 0.530 0.4664
Overall 2.46 0.2924
15
A = 18/85 
D = 0/71 17.00 <0.0001
D = 0/71 
L = 3/46 2.50 0.1138
L = 3/46 
A = 18/85 4.76 0.0291
Overall 19.58 <0.0001
17
A = 6/85 
D = 13/71 4.58 0.0324
D = 13/71 
L = 1/46 6.90 0.0086
L = 1/46 
A = 6/85 0.61 0.4356
Overall 9.48 0.0088
A Asymptomatic, D — diarrhoeal/dysenteric, L = liver abscess.
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Figure 5.2. Non-Bangladeshi eBURST with genotype 30 as the founder (bootstrap support 
for this was 32% compared to next highest was 26% for 1 7).
eBURST analysis of combined non-Bangladeshi and Bangladeshi samples detected 3 
clusters that had some clinical relevance (Figure 5.3). Cluster a contained 4 samples, 2 of 
which were found in liver abscess samples and the remaining 2 (asterisk in the Figure 5.3) 
were from the stool of patients who had diarrhoea/dysentery as well as liver abscess. 
Cluster b contained a relatively higher proportion of asymptomatic strains, and cluster c 
contained higher proportion of diarrhoeal/dysenteric samples.
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Figure 5.3. eBURST with combined non-Bangladeshi and all Bangladeshi samples using 
DAR genotyping. Bootstrap support for the auto assigned founder genotype 17 - was 31% 
compared to next highest value for genotype 14 which was only 16%; *indicates that in 
cluster a one sample was from a liver abscess patient who also had diarrhoea/dysentery.
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The geographic distribution of genotypes using all samples revealed that there exists some 
evidence of a geographic component to the distribution of DAR genotypes world-wide 
(Figure 5.4). Cluster a (an ill defined cluster centred around the genotype 17 and its SLVs) 
contained most of the samples from Georgia and Turkey, which have a common border. 
Thirty-eight of 44 samples in cluster b were from 6 Asian countries, while the only other 
country in this cluster was South Africa. Since many individuals of Indian origin live in 
South Africa we were not surprised to see this. Cluster c contained only Asian and most of 
the American samples (although the sample size from American countries was very low) 
except for one South African sample. Like the South African samples, Japanese samples 
were found to be dispersed across the eBURST diagram, suggesting that these may have 
been imported from wider geographic regions.
Bangladesh = 41/116 
Japan = 1/26 
Vietnam = 10/27 
Brazil = 1/2 
Venezuela = 2/2 
Mexico =1/1 
South Africa =1/11 
Total = 57
Bangladesh = 30/116 
Japan = 3/26 
Georgia = 7/9 
Turkey = 5/6 
South Africa =1/11 
Total = 46
Bangladesh = 18/116 
Japan = 15/26 
Vietnam = 2/27 
Burma = 1/1 
India = 1/1 
Korea =1/1 
South Africa = 6/11 
Total = 44
Figure 5.4. Geographic distribution of non-Bangladeshi and Bangladeshi DAR genotypes 
using eBURST.
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5.7. Discussion
Three main aims of this study were to investigate -  i) diversity o f  DAR genotypes in other 
countries, ii) geographic links to global distribution of these genotypes, and iii) any 
association between genotypes and clinical outcomes in other countries. We were mostly 
successful in achieving these objectives although we had some limitations. These were of 
two kinds -  sample based limitations and time based limitations. Sample based limitations 
include: a) from 6 out o f 11 countries we had only one or two samples, so it was impossible 
to know the extent o f diversity in these countries, b) the number of liver abscess samples 
was very small, so it was impossible to make any conclusion about the non-Bangladeshi 
liver abscess genotypes, c) in 7 Japanese samples the clinical information was not available, 
which reduced our ability to analyze any associations. We had one experimental limitation 
-  we did not attempt PCR amplification of the remaining 3 of the 6-loci (N-K2, S-D and S­
Q) simply because there was not enough time, otherwise we may have seen a better 
association between genotypes in the eBURST analysis.
We observed some geographic links in the distribution of DAR genotypes. Most o f the 
isolates from two neighboring countries - Georgia and Turkey - shared the same genotypes 
or occurred close to each other in the eBURST diagram. Likewise the only Korean isolate 
showed an identical genotype to a Japanese isolate. We also noticed contradictions. The 
only isolate from Burma (Myanmar) shared its genotype with three South African isolates. 
Similarly, the only Mexican isolate shared its genotype with 4 Vietnamese isolates. 
However we noticed that isolates from several Asian countries clustered almost exclusively 
in the eBURST diagram (Figure 5.4).
Diversity in DAR genotypes
One of our main objectives was to investigate the diversity of DAR genotypes in other 
countries. Although we had only one or two samples available from 6 of the 11 countries 
six or more samples were available for each of the remaining 5 countries. The diversity of 
DAR genotypes varied from one country to another (Table 5.4). For example, the diversity
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was high among Georgian isolates but was much lower among the Vietnamese isolates.
The samples from Georgia were drawn from a large region as patients attended the Institute 
of Parasitology and Tropical Medicine or the Hospital of Infectious Diseases from a variety 
of locations in the country, so we were not surprised to see a high degree of polymorphism 
in these samples. Likewise, the Japanese samples showed a high degree o f polymorphism 
and these were from 5 different cities. In contrast, the samples from Vietnam were from a 
restricted geographic region and showed less diversity. The Vietnamese samples were from 
the Phu Cat commune of Hue City, which is more like the Mirpur study area in Bangladesh 
in size, and showed the least polymorphism. In contrast, samples from the restricted 
geographic region o f Sanliurfa, Turkey, showed high polymorphism. The 11 South African 
samples are from a relatively restricted geographic region but show a high degree of 
diversity. However the 11 South African samples in this study are not random, but actually 
represent a much larger sample. We selected these samples for study based on the previous 
results of Zaki et al (2003a), where they were shown to be all different using 11 pairs of 
primers. In general, genotype diversity seems to be linked to the size o f the geographic area 
from which the samples came.
We found association between some of the individual DAR genotypes and clinical outcome 
of infection in the non-Bangladeshi samples. Genotypes 15 and 17 showed association with 
non-Bangladeshi asymptomatic and diarrhoeal/dysenteric samples, respectively (not seen in 
Bangladeshi samples). This association was maintained even when we combined both non­
Bangladeshi and Bangladeshi samples, suggesting that this association has a worldwide 
distribution. Likewise, genotype 18 showed a significant association with 
diarrhoeal/dysenteric infection not only in Bangladesh but also in the combined sample 
population. In contrast, genotype 6 which had shown an association with asymptomatic 
infection in Bangladeshi samples lost its statistical significance in the combined samples. 
However, we should be careful in interpreting our data. A greater number o f non­
Bangladeshi clinical samples would give us a better view of the clinical associations.
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Table 5.4. Country wise diversity in DAR genotypes.
Strain
origin
Sample
area
No. of 
samples
No. of 
genotypes
Sample:genotype
ratio
Turkey Sanliurfa region of 
Turkey 6 3 2
Georgia
Attended one of 2 
hospitals -  *IPTM 
or 2HID
9 6 1.5
South Africa
Periurban area 
surrounding the city 
o f Durban
11 7 1.6
Japan
Tokyo, Kyoto, 
Okayama, Kanagawa, 
and Shizuoka
26 13 2
Vietnam
I — .-------: ------- ------------ -
Phu Cat commune of 
Hue City
27 5 5.4
IPTM — Institute o f Parasitology and Tropical Medicine, HID = Hospital of Infectious Diseases.
We were also interested to know how frequent the common Bangladeshi DAR genotypes 
were globally and vice versa. The first and third most common genotypes in Bangladesh 
(18 and 17 -  found in 33 and 13 individuals, respectively) were found to be 5th and 2nd most 
common in the non-Bangladeshi samples (found in 5 and 7 individuals, respectively). 
However, we also noticed contradictions. For examples, the most common non­
Bangladeshi genotype 15 (found in 23 individuals from 4 countries) was found only in 2 
liver abscess patients in Bangladesh, while the second most common Bangladeshi genotype 
(i.e. genotype 6; found in 18 individuals) was found in only one asymptomatic individual 
from Japan (who had a history of voluntary work in Ghana).
Although the links between genotypes as revealed by eBURST analysis of non-Bangladeshi 
samples was not very strong, we were not too surprised. In Chapter 4 using Bangladeshi 
samples we noted that eBURST showed better clinical association between genotypes when 
the number o f loci was higher and in fact we did not see any significant clustering of 
genotypes using DAR.
I l l
Perhaps the most exciting finding of this study was the detection of differences in DAR 
genotypes among the three clinical populations in non-Bangladeshi as well as in the 
combined samples. Although the large total number of genotypes means there is a very low 
predictive value for any individual genotype, the overall differences in the DAR genotypes 
among the clinical groups suggests that a genetic component of the parasite is linked to the 
outcome of infections worldwide.
Genotyping using all 6 loci and more clinical samples from countries other than 
Bangladesh will provide a better picture of the possible links between genotypes and the 
global distribution o f E. histolytica strains.
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CHAPTER 6
ENTAMOEBA MOSHKOVSKII INFECTIONS
6.1. Introduction
The free-living amoeba Entamoeba moshkovskii has so far been reported to infect humans 
very rarely. Its specific identification in stool specimens by microscopy is impossible 
because it is morphologically indistinguishable from the disease-causing E. histolytica and 
the non-pathogenic commensal E. dispar. However unlike E. histolytica and E. dispar there 
is no simple molecular technique available to detect E. moshkovskii. This has contributed to 
the fact that no study has investigated the prevalence of this species in a human population 
and thus raises the question about how precise the epidemiological data are on E. 
histolytica or E. dispar when the detection technique used was microscopy.
In this study we developed a simple and specific diagnostic technique and investigated the 
prevalence of E. moshkovskii in the Mirpur population. In addition we designed E. 
moshkovskii specific primers for the tRNA-linked STR R-R, which showed polymorphism 
in E. histolytica and E. dispar strains, in an attempt to study the diversity o f E. moshkovskii 
strains from Bangladesh, Georgia and Peru.
6.2. Materials and Methods
6.2.1. E. moshkovskii samples
6.2.1.1. Stool specimens from Bangladesh
Faecal specimens included in this study were from 109 pre-school children aged 2-5 years 
from Mirpur, and were provided by Dr. Rashidul Haque, ICDDR,B. Based on PCR results 
on stool DNA samples, thirty-nine were E. dispar positive, 17 were E. histolytica positive,
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and 1 was positive for both E. histolytica and E. dispar. O f the 52 samples negative by 
stool PCR, 18 were eventually found positive for E. histolytica and/or E. dispar either by 
PCR from culture DNA or by antigen detection tests performed on stool specimens and the 
remaining 34 samples were negative by all methods. Only 4 o f the samples were from 
children with diarrhoea.
The TechLab (Blacksburg, Va.) Entamoeba test (designed to detect but not differentiate E. 
histolytica and E. dispar antigen in stool specimens) and TechLab E. histolytica test 
(designed to detect specifically E. histolytica in stool specimens) were performed on stool 
specimens from Bangladesh according to the manufacturer’s instructions (Haque et al, 
1993).
All stool samples from Bangladesh were cultured for Entamoeba species in Robinson’s 
medium (Robinson, 1968) within 2-4 hours of collection and hexokinase isoenzyme 
analysis was performed when possible as previously described (Haque et al, 1993).
Stool DNA was isolated using a modified version o f the method of Katzwinkel-Wladarsch 
et al (1994) as previously described (Haque et al, 1998b). Culture DNA was extracted by 
the CTAB method described earlier (Section 2.2.1).
6.2.I.2. Culture samples from Georgia and Peru
Nine culture DNA samples from Georgia were tested. These were maintained in 
Robinson’s medium in Dr. Nino Trapaidze’s laboratory at the Institute of Parasitology and 
Tropical Medicine, Georgia. Initially these samples were positive for E. histolytica by the 
TechLab antigen detection test and all of these were from diarrhoeal patients (data not 
shown). DNA was purified by the CTAB extraction method (Section 2.2.1).
One xenic culture lysate was received from Dr. William Roldan, University of San Marcos, 
Lima, Peru. This culture was originally established in Pavlova’s medium from a stool
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sample of a child and was growing at room temperature. DNA was purified by the CTAB 
extraction method (Section 2.2.1).
6.2.1.3. Reference isolates
E. moshkovskii Laredo and FIC were maintained axenically as described (Section 2.1). 
Laredo is a human isolate and FIC is an environmental isolate. E. histolytica HM-kIMSS 
and E. dispar SAW760 were used as controls.
6.3. Small subunit rRNA gene amplification
Based on the sequence of the small subunit rRNA gene (SSU-rDNA) o f E. moshkovskii 
Laredo (GenBank accession number AF 149906), a nested set of primers, designated Em- 
l/Em-2, and nEm-l/nEm-2, was designed and used to detect E. moshkovskii in stool DNA 
(Table 6.1). In the initial PCR (total vol. 25 pi) 1.0 pi o f stool or culture DNA was used. 
Thermal cycler conditions were - 30 cycles each consisting of 92°C for 1 min, 55°C for 1 
min and 72°C for 1 min followed by a final extension of 7 min at 72°C. In the nested PCR, 
1.0 pi of the first PCR product was used as the template DNA and the annealing 
temperature was raised to 62°C, leaving the other parameters of the amplification cycle 
unchanged. E. moshkovskii-specific nested SSU-rDNA gene amplification products were 
digested with restriction endonuclease Xho I for 1 hour at 37°C according to the 
manufacturer’s instructions (Invitrogen,) to verify species identity.
Part of the SSU-rDNA gene was amplified from the Georgian and Peruvian culture DNA 
samples with the primer pair Entam 1 and Entam 2 described by Verweij et al (2001) and 
sequenced (Section 2.5).
6.4. R-R amplification
Although the R-R primer sequences were designed from E. histolytica HM-kIMSS 
sequence, they also amplified E. moshkovskii DNA. The R-R amplification products from
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E. moshkovskii Laredo, E. moshkovskii MS15-3646 (one of the infections detected) and E. 
dispar SAW760 were cloned into the pGEM-T Easy vector (Promega) and sequenced 
(MWG Biotech Ltd, UK). From the sequence results, an E. moshkovskii-specific primer 
pair, EmR-1 & EmR-2, was designed to amplify an E. moshkovskii R-R product 
specifically (Table 6.1). PCR amplification was performed at an annealing temperature of 
58°C as described above for rRNA gene amplification.
Some parts of this study were carried out at ICDDR,B. This included the culture of 
Bangladeshi Entamoeba species in Robinson medium, the isoenzyme analysis, the TechLab 
stool ELISA tests, and diagnosis oiE . moshkovskii by a specific nested SSU rRNA gene 
PCR. All the work on the Georgian and Peruvian strains and the R-R analysis of all 
samples was performed in London.
Table 6.1. Primers for E. moshkovskii analysis.
Primer
name
Primer sequence 
(5' to 3')
Annealing 
temperature (°C)
Em-1 CTCTTC AGGGGG ACT GCG 55Em-2 TCGTT AGTTT CATT ACCT
nEm-1 GAATAAGGATGGTATGAC 62nEm-2 AAGTGGAGTT AACCACCT
Entam 1 GTTGATCCTGCCAGTATTATATG 57Entam 2 C ACT ATTGG AGCT GG AATT AC
EmR-1 GGCGCCTTTTTTACTTTATGG
58EmR-2 GCT AAC AAGGCC AAT CG AT AAA
6.5. Results
6.5.1. Culture and Isoenzyme analysis in Bangladeshi samples
All 109 stool specimens were inoculated into Robinson’s medium for growth o f Entamoeba 
species. Incubation led to growth ofE.  histolytica/E. dispartE. moshkovskii in 33 and E. 
coli in 8 cultures (no growth of Endolimax nana or E. hartmanni was observed). 
Hexokinase isoenzyme analysis was possible only for 10 cultures; 4 of them showed the
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band pattern of E. histolytica, 5 E. dispar and 1 showed the band pattern of E. dispar with 
an extra band just behind the faster moving band, perhaps indicating a mixed culture.
6.5.2. Detection o f£ . moshkovskii by nested PCR in Bangladeshi samples
The reference isolate E. moshkovskii Laredo gave the expected band at ca. 260 bp with the 
E. moshkovskii-specific SSU-rDNA nested primers while control E. histolytica HM- 
1 :IMSS and E. dispar SAW760 DNAs were negative. Twenty-three out o f 109 (21.1%) 
stool DNA samples were positive by nested PCR for E  moshkovskii (Figure 6.1).
Seventeen of these E. moshkovskii positive samples were also positive for E. histolytica 
and/or E. dispar by either stool SSU rDNA PCR (13/17) or using the TechLab Entamoeba 
or E. histolytica tests (15/17) (Table 6.2). One of the 4 children with diarrhoea was positive 
for E. moshkovskii and was co-infected with E. dispar. The cause of his diarrhoea remained 
undetermined.
From a comparison o f SSU-rDNA sequences from E. moshkovskii, E. histolytica and E. 
dispar, it was found that the restriction endonuclease Xho I cuts exclusively in the E. 
moshkovskii specific 258-bp nested PCR product to produce 236 bp and 22 bp fragments. 
Products from all 23 positive stool samples and the Laredo isolate showed the presence of 
this site (Figure 6.1).
6.5.3. Amplification of locus R-R and sequence analysis
In an attempt to detect polymorphism among the E. moshkovskii samples, we studied STR 
locus R-R, which shows polymorphism in E. histolytica and E. dispar. The R-R primers 
amplify E. histolytica, E. dispar and E. moshkovskii DNA. The sizes o f the PCR products 
from E. histolytica HM-l.TMSS, E. dispar SAW760 and E. moshkovskii Laredo were 586 
bp, 586 bp and 323 bp, respectively. We never observed a band in the 250-350 bp region in 
any o f our E. histolytica and E. dispar strains with these primers (Chapters 4 and 5). 
Because 17 out of 23 E. moshkovskii positive samples were also positive for E. histolytica 
and/or E. dispar (by SSU-rDNA PCR or TechLab ELISA), we ignored products in the
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Table 6.2. Nested SSU rDNA PCR for E. histolytica and E. dispar and stool antigen 
detection test results of the 23 E. moshkovskii positive samples from Bangladesh.
Samples Stool antigen detection test 
results
SSU rRNA gene PCR fo
disi
r E. histolytica and/or E. 
oar
Stool DNA Culture DNA
Is E. histolytica E. dispar Mixed
2 E. dispar 0 NC
3 E. dispar E. dispar NC
4 E. histolytica 0 NC
5 E. dispar E. dispar E. dispar
6$ E. dispar Mixed E. dispar
7 E. dispar E. dispar NC
8 E. dispar E. dispar NC
9 E. dispar E. dispar NC
10 0 E. dispar NC
11 E. dispar E. dispar NC
12 E. dispar 0 NC
13$$ E. dispar E. histolytica NC
14 0 0 E. dispar
15 E. dispar 0 E. dispar
16 0 0 E. dispar
17 E. histolytica 0 NC
18 0 0 NC
19 0 0 NC
20 0 0 NC
21 0 0 NC
22 0 0 NC
23 0 0 NC
NC = no culture.; 0 = negative.
NB: All stool antigen tests that are positive for E. histolytica can also be mixed as no specific E. dispar 
antigen test exists.
$: It is most likely that subjects 1 and 6 were mixed infections with E. histolytica and E. dispar, where E. 
histolytica was much lower in number in the stool specimen. For subject 1, SSU rDNA PCR failed to detect 
E. histolytica, though both species grew in the culture. For subject 6, although SSU rDNA PCR could detect 
E. histolytica in stool DNA, the E. histolytica antigen detection test failed to detect E. histolytica and only E. 
dispar survived in the culture.
$$: The stool specimen of subject 13 was marginally negative by the E. histolytica antigen detection test (OD 
value was 0.13 where the cut off value for a positive result was 0.15).
500-600 bp region (assuming that they derived from E. histolytica and/or E. dispar DNA) 
and considered a sample positive for E. moshkovskii when it produced a band at around 300
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bp. By this criterion, we found 18 out of 23 samples positive for E. moshkovskii (data not 
shown) and they showed slight PCR product size variation. The PCR products from one 
stool sample, E. moshkovskii Laredo and E. dispar SAW760 were cloned, sequenced and 
aligned with that o f E. histolytica HM-1:IMSS, and E. moshkovskii specific primers (EmR- 
1 & EmR-2) were designed (Figure 6.2). In addition to significant PCR product size 
differences, analysis clearly shows that the E. moshkovskii sequence is completely different 
from those of E. histolytica and E. dispar and, unlike the E. histolytica and E. dispar 
sequences, it contains no short tandem repeat sequences (Figure 6.2C).
The EmR primers amplified the expected 265 bp fragment from E. moshkovskii Laredo 
DNA and did not amplify E. histolytica HM-l.TMSS or E. dispar SAW760 DNA.
However, they successfully amplified 10 E. moshkovskii positive stool DNA samples out of 
a possible 23. The most likely explanation for why they did not amplify the other 13 E. 
moshkovskii DNA samples is that they differed in sequence in the primer-binding regions. 
Although the PCR product size of these 10 isolates was slightly different from that o f 
Laredo, they were very similar in size to each other (Figure 6.3a). The DNA of the 
previously reported human E. moshkovskii ICDDRB:717 isolated from the same 
geographical location (Haque et al, 1998a) also gave a product of same size (Figure 6.3a). 
The EmR primers successfully amplified DNA from environmental E. moshkovskii isolate 
FIC but its product size was quite different from the Bangladeshi human isolates of E. 
moshkovskii (Figure 6.3a).
Both Georgian and Peruvian samples showed EmR amplification products similar in size to 
E. moshkovskii FIC (Figure 6.3b). Sequencing of PCR products revealed that the sequences 
were identical to that o f E. moshkovskii FIC (data not shown).
6.5.4. rRNA gene amplification in Georgian and Peruvian samples
We used a pair o f primers (Entam 1 and Entam 2) that were designed to amplify a part of 
the rRNA gene from all Entamoeba species (586 bp in E. moshkovskii Laredo and 584 bp 
in E. moshkovskii FIC). This primer pair amplified 5 o f the 9 Georgian DNAs and the
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Peruvian DNA (data not shown). Size differences in the amplified products were not 
obvious. We sequenced two Georgian and the Peruvian PCR products. Alignment of these 
sequences showed that the Georgian isolates were of E. moshkovskii Laredo type while the 
Peruvian isolate was of E. moshkovskii FIC type (Figure 6.4).
Figure 6.1. E. moshkovskii specific nested SSU rDNA PCR products followed by Xho I 
digestions. Data provided by Mohammad Bakhtiar Hossain, ICDDR.B-
1 2 0
A) 5'-end R-R sequence alignment:
1 50
HM1-IMSS a g ca tca g cc  t t c t a a g c t g  agggtcgcag  g ttc g a g c c c  tg ca tg a g g c
SAW760 AGCATCAGCC TTCTAAGCTG AGGGTCGCAG GTTCGAGCCC TGCATGAGGC
L a re d o  AGCATCAGCC TTCTAAGCTG AGGGTCGCAG GTTCGAGCCC TGCATGAGGC
3 6 4 6 -MS15 TTCATCAGCC TTCTAAGCTG AGGGTCGCAG GTTCGAGCCC TGCATGAGGC
51 100
HM1-IMSS GCCTTTTTAT TCAATATACT CCTATACCTA TCACATCTTT ATACACTCTA
SAW760 GCCTTTTTAT CATCCATAT. . CTATAACTA TAACTATACC TATAACTATA
L a re d o  G C C TT TT T TA  C TTTATG G AT  GTTATGTCTA CTATCTCTA. CTCGAATCTT
3 6 4 6 -MS15 G C C TTTTTTA  C TTTA TG G TT  GTTATGTCTA CTATCTCTA. CTCGAATCTT
101 150
h m i- im s s  t g t t t c t t AT ATGTATATTA c t t a t a c t a c  t t a t t a t c t t  a t a t g t t t a t
SAW760 CCTATCCAAC  TT TATACTCT. C TATGTTTCTT ATATGTATAT
L a re d o  CGTGTCTTTT A T .. . TCTTT CTTTCTCTTC CTTTTCTTTT TTCCTCTTCA
3 6 4 6 -MS15 CGTGTCTTTT A T ...T C T T T  CTTTCTCTTC CTTTTCTTTA TTTCTCTTCA
151 200
h m i- im s s  a t g t a t a t a t  c a c ta ta tg t  t t a t a t g t t t  a t a t g t t t a t  a t g t t t a t a t
SAW760 TACTTATTTC TACTACTTAT TATCAACTAT ACACCTATCC TATACTATAT
L a re d o  GAATTATTTT GAATATCTAT CTCTATATTT C.CTGCACTC GCTTTTATT.
3 6 4 6 -MS15 AAATTATTTT GAATATCTAT CTCTATTTTT C.CTGCACTC CCTTTTATT.
B) 3'-end R-R sequence alignment:
1 50
HMI-IMSS  T TTTATTATGT TCTTATGTTC TTATTTCTTT ATTTTATTAT
SAW760 ATTTTATTAT CCTATTATGT TATTATGTTA TTATGTTCTT ATTTTATTAT
L a r e d o  ................................................................................................................................. C A T T T T C  A T C T T C T T A C
3 6 4 6 - M S 1 5  ................................................................................................................................. C A T T T T C  A T C T T C T T A C
51 100
HMI-IMSS GTTCTTATGC TATTATTTCT TTATTTTATT ATGTTATTAT GTCCCTGTGA
SAW760 GTTCTTATGT TCTTATGTTA TTATGTTATT ATGTTATTAT GAGTGTGTTC
L a re d o  TCTCTTATAC CTATTCCTTT CTTCCCCTCT CTCTTCCTTT CTTCTTTCTC
3 6 4 6 -MS 15 TCTCTTATCC CTATTCCTTT CTTCC....................................TTT CTTCTTTCTC
101 150
HMI-IMSS AGATATCTTC ATCCCTTACC TATTTATACT ATAACCGATT GGCCTTGTTA
SAW760 A .ATATCATC ATCCCTTACC TATTTCTACT ATAACCGATT GGCCTTGTTA
L a re d o  ACCTAGGATC GTACTCTTGC ATCTTTTTCT T T T A T C G A T T  GGCCTTGTTA
3 6 4 6 -M SI5 ACCTAGGATC GTACTCTTGC ATCTTTTTCT T T T A T C G A T T  GGCCTTGTTA
151 164
h m i- im s s  g c tc a g tc g g  aag
SAW760 GCTCAGTCGG AAG
L a re d o  GCTCAGTCGG AAG
3 6 4 6 -MS15 GCTCAGTCGG AAG
121
C)
Entamoeba histolytica
u —umn— r a m
D TT AT AT GT Q TTATTTCT D TTATTTTA 
D TTATGTTA I  TTCTT ATTTCTTT ATTTT ATT AT GTTCTT AT G
□ AACTAT □ ACTATATT Q ACTATATG Q TTATTTTA
□ TTATGTTA I  TTATGTTC □ TT AT GTT ATT ATTTTA
Entamoeba moshkovskii
Figure 6.2. STR locus R-R R-R sequences from E. histolytica HM-1:1MSS,
E. dispar SAW760 (GenBank Accession number AF 525284), E. moshkovskii 
Laredo (GenBank Accession number AF 525285) and 3646-MS 15 (GenBank 
Accession number AF525286) were aligned at the 5' (A) and 3' (B) ends to 
design E. moshkovskii-specific primers. The EmR primer sequences are 
shown in italic and bold with E. moshkovskii specific positions underlined.
(C) Schematic representation of R-R from E. histolytica HM-1 1MSS, E. 
dispar SAW760, and E. moshkovskii. Locations of the primers used in PCR 
amplification are indicated by small arrows, the tRNA genes are indicated by 
large arrows and the short tandem repeats by shaded boxes. Not to scale.
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Figure 6.3. E. moshkovskii specific EmR PCR amplification, (a) Amplifications with a 
few Bangladeshi stool DNA samples and reference DNA samples. DNA samples from E. 
histolytica HM-1:IMSS and E. dispar SAW760 were used as negative controls, (b) 
Amplifications with culture DNA samples from Peru (PERU), Georgia (TBC#6 and 
1 BC#3), Bangladesh (ICDDR,B:15114 and ICDDR,B:717) and two reference isolates o f 
E. moshkovskii (Laredo and FIC).
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1
L a r e d o GTTGATCCTG
TBC#6 GTTGATCCTG
FIC GTTGATCCTG
PERU GTTGATCCTG
71
L a r e d o AGGATGAAAC
TBC#6 AGGATGAAAC
FIC AGGATGAAAC
PERU AGGATGAAAC
1 4 1
L a r e d o TGTGAATGAT
TBC#6 TGTGAATGAT
FIC TGTGAATGAT
PERU TGTGAATGAT
2 1 1
L a r e d o GAGTGCGAA
TBC#6 GAGTGCGAA
FIC GAGTGCGAA
PERU h GAGTGCGAA
2 8 1
L a r e d o TAACCAATGA
TBC#6 TAACCAATGA
FIC TAACCAATGA
PERU TAACCAATGA
3 5 1
L a r e d o CGAGGAATTG
TBC#6 CGAGGAATTG
FIC CGAGGAATTG
PERU CGAGGAATTG
4 2 1
L a r e d o CGCGTAAATT
TBC#6 CGCGTAAATT
FIC CGCGTAAATT
PERU CGCGTAAATT
4 9 1
L a r e d o TTCTTGAAGG
TBC#6 TTCTTGAAGG
FIC TTCTTGAAGG
PERU TTCTTGAAGG
5 6 1
L a r e d o CCGCGGTAAT
TBC#6 CCGCGGTAAT
FIC CCGCGGTAAT
PERU CCGCGGTAAT
CCAGTATTAT ATGCTGATGT 
CCAGTATTAT ATGCTGATGT 
CCAGTATTAT ATGCTGATGT 
CCAGTATTAT ATGCTGATGT
TGCGGACGGC TCATTATAAC 
TGCGGACGGC TCATTATAAC 
TGCGGACGGC TCATTATAAC 
TGCGGACGGC TCATTATAAC
AAAGATAATA CTTGAGACGA 
AAAGATAATA CTTGAGACGA 
AAAGATAATA CTTGAGACGA 
AAAGATAATA CTTGAGACGA
t g c c a t B c t g  a a t t g a a I a a
TGO:'AT1CTG AATTGAAlAA
t g c c a t I c t g  a a t t g a a I a a  
t g c c a t | c t g  a a t t g a a | a a
g a a t t t c t g a  t c t a t c a a t t  
g a a t t t c t g a  t c t a t c a a t t  
g a a t t t c t g a  t c t a t c a a t t  
g a a t t t c t g a  t c t a t c a a t t
g g g t t c g a c a  t c g g a g a g g g  
g g g t t c g a c a  t c g g a g a g g g  
g g g t t c g a c a  t c g g a g a g g g  
g g g t t c g a c a  t c g g a g a g g g
a c c c a c t t t c  g a c g t g a a g a  
a c c c a c t t t c  g a c g t g a a g a  
a c c c a c t t t c  g a c g t g a a g a  
a c c c a c t t t c  g a c g t g a a g a
AATGAGTAAG A A G T A A iM c  
AAT //■. iT.-V■. ■ AAG" ¡¡ .4
AATGAGI AAG AAGTAAaH c
AATGAGTAAG AAGTAAaH c
5 8 6
TCCAGCTCCA ATAGTG 
T CCAGCTCCA ATAGTG 
TCCAGCTCCA ATAGTG 
TCCAGCTCCA ATAGTG
TAAAGATTAA GCCATGCATG 
TAAAGATTAA GCCATGCATG 
TAAAGATTAA GCCATGCATG 
TAAAGATTAA GCCATGCATG
AGTAATAGTT TCTTTGGTTA 
AGTAATAGTT TCTTTGGTTA 
AGTAATAGTT TCTTTGGTTA 
AGTAATAGTT TCTTTGGTTA
TCCGGTTTGT ATTAGTACAA 
TCCGGTTTGT ATTAGTACAA 
TCCGGTTTGT ATTAGTACAA 
TCCGGTTTGT ATTAGTACAA
g g a t g g | a| g  ACAATTGTAG 
GGATGgIaI g AC/-.'-.I ¡'/TAG 
GGATGgIaI j ACAATTGTAG
GGATGg| a| g  ACAATTGTAG
TGTTGGTAGT ATCGAGGACT 
TGTTGGTAGT ATCGAGGACT 
TGTTGGTAGT ATCGAGGACT 
TGTTGGTAGT ATCGAGGACT
AGCTTTACAG ATGGCTACCA 
AGCTTTACAG ATGGCTACCA 
AGCTTTACAG ATGGCTACCA 
AGCTTTACAG ATGGCTACCA
GGTAGTGACG ACAAATAACT 
GGTAGTGACG ACAAATAACT 
GGTAGTGACG ACAAATAACT 
GGTAGTGACG ACAAATAACT
t c t t a c I a a a  TCAATTGGAG 
TCTTAc I aAA TCAATTGGAG
t c t t a c I a a a  t c a a t t g g a g  
t c t t a c | a a a  t c a a t t g g a g
7 0
t g t a a g t a t a  a a g a c c a a g t  
t g t a a g t a t a  a a g a c c a a g t
TGTAAGTATA AAGACCAAGT 
TGTAAGTATA AAGACCAAGT
1 4 0
GTAAAGTACA AGGATAGCTT 
GTAAAGTACA AGGATAGCTT 
GTAAAGTACA AGGATAGCTT 
GTAAAGTACA AGGATAGCTT
210
GTCGGCCACT I t CTt I aCGG 
GT CGCCCACT |T CTTBAclè
GTCGGCCACT BTCTtI a c GG 
GTCGGCCACT | t CTt| a CGG
2 8 0
AGCACACAGT GTTTAACAAG 
AGCACACAGT GTTTAACAAG 
AGCACACAGT GTTTAACAAG 
AGCACACAGT GTTTAACAAG
3 5 0
ACCAAGATTA TAACGGATAA 
ACCAAGATTA TAACGGATAA 
ACCAAGATTA TAACGGATAA 
ACCAAGATTA TAACGGATAA
4 2 0
CTTCTACGGA AGGCAGCAGG 
CTTCTACGGA AGGCAGCAGG 
CTTCTACGGA AGGCAGCAGG 
CTTCTACGGA AGGCAGCAGG
4 9 0
CTCGAGGTGG T T |a cB cAC 
f l i •• t t - . i  . .  r :!•••. -H  \.\ •
CTCGAGGTGG TT0 'HcAC 
CTCGAGGTGG Tt | a cH c a c
5 6 0
GGCAAGTCTG GTGCCAGCAG 
GGCAAGTCTG GTGCCAGCAG 
GGCAAGTCTG GTGCCAGCAG 
GGCAAGTCTG GTGCCAGCAG
Figure 6.4. Alignment of rRNA gene (Entam 1/2 products) sequences from E. moshkovskii 
strains. Only one of the two Georgian sequences was shown here as representative o f both 
as they were identical. All the nucleotide positions that showed differences are shaded.
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6.6 . D iscu ss io n
The main objectives o f this study were to develop simple tools to identify E. moshkovskii 
and to investigate its prevalence and diversity in humans. We were successful in 
developing a simple diagnostic technique - a nested SSU-rDNA PCR with verification by 
restriction endonuclease digestion. We chose to use nested PCR to detect E. moshkovskii 
infections because previous experience in this study area showed it to be much more 
efficient in amplifying stool DNA (Ayeh-Kumi et al, 2001). Our attempt to produce a 
species specific polymorphic marker was not completely successful. The EmR primers 
failed to amplify 13 o f 23 E. moshkovskii containing samples, probably because o f 
sequence differences in primer binding sites. However, the R-R primers, which were 
originally designed to amplify E. histolytica and E. dispar DNA, did amplify a majority 
of the E. moshkovskii samples producing a product distinct in size from those o f E. 
histolytica and E. dispar.
The present study has some limitations. Our Bangladeshi study subjects were 2-5 year old 
children, so we do not know whether they represent a true picture across all age groups. 
All previous human isolates o f E. moshkovskii have belonged to ribodeme 2 (Clark and 
Diamond, 1991). Our attempts to perform riboprinting on these infections were 
unsuccessful, probably due to the size o f the amplification target (ca 1.95 kb). Even if  
PCR had been successful, the presence o f mixed infections with other eukaryotes would 
have prevented successful typing because the primers used amplify the SSU-rRNA gene 
o f all eukaryotes. We did not attempt to sequence other E. moshkovskii R-R sequences 
simply because we did not find any STRs in sequences from E. moshkovskii Laredo and a 
Bangladeshi strain, and STRs are responsible for size variation in other species.
This study is unique and has several important findings. The overall E. moshkovskii 
prevalence in Mirpur (21%) suggests that E. moshkovskii infection is common among 
these children. It is also worth noting that E. dispar infected children were almost twice 
as likely to have a mixed infection with E. moshkovskii (35%) compared to those with 
(18%) or without E. histolytica (18%) infections. None o f the 6 children with E. 
moshkovskii monoinfections had diarrhoea or dysentery which suggests that E. 
moshkovskii is a non-invasive parasite. It is possible that the high prevalence o f E.
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moshkovskii infection remained unnoticed over the years because most o f them (74%) 
were mixed infections with E. histolytica and/or E. dispar. The high prevalence o f E. 
moshkovskii revealed in this study population gives us an indication that perhaps humans 
are a true host for this putatively free-living amoeba, and are not just transiently infected. 
It may also explain some o f the microscopy positive/antigen negative results obtained 
using the Entamoeba test kit (Haque et al, 1995). Likewise it may also explain the 
overdiagnosis o f E. histolytica/E. dispar in Ethiopia using the microscopy (39%) 
compared to specific PCR (9%) detection (Kebede et al, 2003). Likewise it gives a 
possible reason for why these authors failed to detect 27.8% (30 o f 108) o f the E. 
histolytica/E. dispar microscopy positive samples using a specific real-time PCR in a 
separate study (Kebede et al, 2004).
It is difficult to interpret the results o f E. moshkovskii infections in Georgian samples.
This is because they were detected in culture samples, and these cultures were originally 
positive for E. histolytica (and 4 o f the 5 E. moshkovskii positive cultures were still 
positive for E. histolytica as well). Laboratory personnel were unaware o f the presence o f 
E. moshkovskii in their cultures. Whether all 5 E. moshkovskii infections were real or just 
contamination from a single specimen is impossible to tell. It is unfortunate that we did 
not have the corresponding stool samples or stool DNA, which could provide better 
information on this. However, since we found a high mixed infection rate o f E. 
moshkovskii in Bangladeshi children, we would not be surprised if  all these Georgian 
infections were real. If these were indeed real infections, it is worth noting that these 5 E. 
moshkovskii were detected in 3 adults and 2 children, suggesting that infection is not only 
confined in children.
Based on the rRNA gene sequencing results, we found that the Georgian E. moshkovskii 
are o f E. moshkovskii Laredo type (ribodeme II), which was previously found in all other 
human infections. In contrast, the Peruvian isolate was o f E. moshkovskii FIC type 
(ribodeme III), which was so far believed to be a free-living environmental type o f E. 
moshkovskii.
Based on locus R-R amplification and sequence results, we found that Bangladeshi E. 
moshkovskii resembled E. moshkovskii Laredo, while both Georgian and Peruvian 
isolates resembled E. moshkovskii FIC. This clearly indicates that the Laredo type o f E.
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moshkovskii (based on rRNA gene sequences) may have FIC type R-R sequence, and 
vice versa.
The prevalence and diversity o f  E. moshkovskii needs to be investigated in other parts o f 
the world. In addition future epidemiological studies o f E. histolytica infection should 
include tools to diagnose all three o f these species individually, simultaneously and 
accurately.
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CHAPTER 7
DNA SEQUENCE DIVERSITY IN E. HISTOLYTICA STRAINS
7.1. Introduction
With the development o f new and simple techniques for DNA sequencing, the 
sequencing o f a particular gene o f interest or fragment o f DNA o f a pathogen o f  clinical 
importance is getting more and more popular. For example, DNA sequence diversity 
has been widely studied in malarial parasites (Da Silveira et al, 2001; Hoffmann et al, 
2001; Leclerc et al, 2004; Rayner et al, 2004; Safitri et al, 2003; Tonon et al, 2004), in 
Cryptosporidium parvum  (Gibbons-Matthews and Prescott, 2003; Strong et al, 2000), 
and in Trypanosoma cruzi (Machado and Ayala, 2002).
In Chapters 4 and 5 we investigated the PCR product based genotypes o f E. histolytica 
strains from Bangladesh and other parts o f the world and tried to establish a clinical 
association. However, very little is known about sequence diversity in this parasite.
Ghosh et al, (2000) sequenced the serine rich Entamoeba histolytica protein (SREHP), 
chitinase, superoxide dismutase, and actin 3 genes in a few reference E. histolytica 
isolates. Ayeh-Kumi et al (2001) sequenced part o f the SREHP gene in a few clinical 
isolates from Bangladesh. Zaki and Clark (2001) sequenced some o f the reference 
isolates at tRNA linked STR loci 1-2 (now known as locus D-A) and 5-6 (now known as 
locus I-W). Haghighi et al (2002 and 2003) sequenced a number o f clinical samples 
mainly from Japan, Thailand and Bangladesh at 4 loci: STR loci 1-2 and 5-6, SREHP, 
and chitinase. However, no association o f sequence type with clinical outcome was 
detected.
In this Chapter our objectives were to investigate the sequence diversity o f E. histolytica 
strains at two STR loci, namely R-R and S-D, in Bangladesh and also in a global context. 
We were particularly interested to see if  there were any associations between particular 
sequence types and the clinical history o f the strain. We were also interested to see 
whether some mutations were more common in particular types o f strain than others.
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7.2. Samples
We sequenced locus R-R in a total o f 84 Bangladeshi clinical samples including 22 
asymptomatic strains, 19 diarrhoeal or dysenteric strains, and 43 liver abscess strains and 
we sequenced locus S-D in a total o f 80 Bangladeshi clinical samples including 19 
asymptomatic strains, 17 diarrhoeal or dysenteric strains, and 44 liver abscess strains.
In addition we sequenced locus R-R in a total o f 52 non-Bangladeshi clinical samples 
from 11 countries including 39 asymptomatic strains, 9 diarrhoeal or dysenteric strains, 2 
liver abscess strains, and 2 samples for which the clinical information was not available.
We sequenced locus S-D in a total o f 48 non-Bangladeshi clinical samples from 11 
countries including 25 asymptomatic strains, 18 diarrhoeal or dysenteric strains, 1 liver 
abscess strain, and 4 samples for which the clinical information was not available.
7.3. Results
7.3.1. STR-based sequence types in locus R-R
Across all 136 Bangladeshi and non-Bangladeshi samples a total o f  12 distinct R-R 
sequence types were detected. These contained either 5 (first 9 types) or 4 (types 10-12) 
distinct STR sequences (Figure 7.1). Four out o f the 5 STRs were each 8 bases long 
and the 5th one (missing in the last 3 types) comprised 32 bases. The copy number in 
two STR blocks (Blocks 1 and 4) is constant across all samples (Figure 7.1). For the 
most variable STR block, the repeat copy number ranged from 3 to 7 (Block 2, Figure 
7.1).
a) In Bangladesh:
Eleven out o f the 12 sequence types were represented in Bangladeshi clinical samples; 
only sequence type 7 was not found (Figure 7.1 and Table 7.1). Five sequence types (1, 
2 ,3 ,9 , and 11) were represented by only one sample each, and all o f these were from 
symptomatic patients. The three most common sequence types (5, 6 and 10) included
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78.6% (66/84) o f all samples distributed across clinical types - asymptomatic (A) =
86.4% (19/22), diarrhoeal/dysenteric (D) = 73.7% (14/19), and liver abscess (L) =
76.7% (33/43) (Table 7.1). While sequence type 6 was distributed reasonably equally 
across all clinical types -  A = 31.8%, D = 26.3% and L = 23.3% - sequence type 5 was 
found in more A samples compared to D or L samples -  A = 45.4%, D = 10.5% and L = 
30.2%, and sequence type 10 was more common in D samples compared to A or L 
samples -  A = 9.1%, D = 36.8% and L = 23.3%. Three sequence types (9 ,11, and 12) 
were unique to Bangladeshi samples.
b) In other parts o f the world:
Non-Bangladeshi samples included 9 sequence types (Table 7.1). Some sequence types 
were more common than the others. Five (1, 3 ,7 , 8, and 10) were represented by only 
one or two samples each. The two most common sequence types (5 and 6) included 
67.3% (35/52) o f all samples including 74.3% (29/39) o f all asymptomatic samples.
Since the numbers o f other sample types -  diarrhoeal/dysenteric (9/52) and liver abscess 
(2/52) - were low, relative prevalence numbers would be misleading. Only 1 sequence 
type (7) was unique to the non-Bangladeshi samples (seen in two Japanese individuals - 
one asymptomatic and one diarrhoeal patient).
7.3.2. Analysis of R-R  sequence type among clinical groups
We analyzed whether the different sequence types show a statistically significant 
association among 3 clinical types of samples. Table 7.2 summarizes all the results. In 
Bangladeshi clinical samples we found only one statistically significant difference, which 
was between the asymptomatic and diarrhoeal/dysenteric groups (Table 7.2). This is due 
to sequence types #5 - found in 10 o f 22 asymptomatic samples compared to only 2 o f 19 
diarrhoeal/dysenteric samples - and #10 -  found in 7 o f  19 diarrhoeal/dysenteric samples 
compared to only 2 o f 22 asymptomatic samples.
In non-Bangladeshi samples we did not find any statistically significant association 
probably because o f small sample sizes in diarrhoeal/dysenteric (9 samples) and liver 
abscess (2 samples) groups (Table 7.2).
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Sequence type B lo ck  B lo ck  B lo ck  B lo c k  B lo ck
1 2 3 4 5
I I I- - - - - - - - - - - - - - - - 1 r
TTATATGT [] TTATTTCT []  TTATTTTA 
TTATGTTA |  TTCTT ATTTCTTT ATTTT ATT AT GTTCTT ATG
Figure 7.1. Schematic representation o f locus R-R sequence types. In sequence types, superscript ‘G ’ indicates that this type was found only in 
non-Bangladeshi samples and absent in Bangladeshi samples, and superscript ‘B’ indicates that these types were found only in Bangladeshi 
samples and absent in the others.
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Table 7.1. Clinical and geographic distribution o f R-R sequence types.
Seq.
type
Distribution among Bangladeshi strains Distribution among global strains
A D L Total A D L N/A Total
1 0 1 0 1 IB 1M 0 0 2
2 0 0 1 1 2 VT 1 VZ, 1 J 0 0 4
3 0 1 0 1 0 0 I K 1 J 2
4 2 0 2 4 5 VT 0 0 0 5
5 10 2 13 25 1 1 ,1 J, 1 GER, 4 S A ,5  VT 1 VZ 1 GER 0 14
6 7 5 10 22 10 SA, 7 G 4 T 0 0 21
7 0 0 0 0 0 0 0 1 J 1
8 1 0 4 5 I B 0 0 0 1
9 0 0 1 1 0 0 0 0 0
10 2 7 10 19 1 J 1 J 0 0 2
11 0 1 0 1 0 0 0 0 0
12 0 2 2 4 0 0 0 0 0
Total 22 19 43 84 39 9 2 2 52
A = asymptomatic, D = diarrhoeal / dysenteric, L = liver abscess, N /A  = not available, SA = South Africa, VT = Vietnam, J = Japan, T = Turkey, I India, B = 
Brazil, GER Germany, G = Georgia, VZ =  Venezuela, M = Mexico, and K = Korea.
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In combined samples we found statistically significant difference between asymptomatic 
and other two types o f clinical samples. This is due to sequence types 5 and 6, which were 
more common in asymptomatic samples than in other two clinical types, and 10, which was 
more common in liver abscess and diarrhoeal/dysenteric samples than in asymptomatic 
samples (Table 7.1).
Table 7.2. Statistical analysis o f R-R sequence type among clinical groups.
Sequences Population pair No. o f samples Chi2
Overall 
P values
A & D
A = 22 
D = 19 8.996 0.0111
Bangladeshi
D & L
D = 19 
L = 43 4.603 0.1001
L & A
L = 43 
A = 22 1.038 0.5951
A & D
A = 39 
D = 9
2.447 0.2941
Non-Bangladeshi D & L
D = 9 
L = 2
2.331 0.3118
L & A
L = 2 
A = 39
4.323 0.1152
A & D
A = 61 
D = 28
18.230 0.0001
Combined D & L
D = 28 
L = 45
4.644 0.0981
L & A
L = 45 
A = 61 7.628 0.0221
A = Asymptomatic, D = diarrhoeal/dysenteric, L = liver abscess.
7.4. Mutations in R-R sequences
After aligning all the Bangladeshi and non-Bangladeshi R-R sequences using a multiple 
sequence alignment software (http://prodes.toulouse.inra.fr/multalin/multalin.html) 
(Corpet, 1988) we identified point mutations in comparison to a consensus sequence 
(Table 7.3; alignment not shown). These mutations were identified in 11 asymptomatic 
samples (9 from Bangladesh, 1 from Brazil, and 1 from Japan), 12 diarrhoeal/dysenteric 
samples (10 from Bangladesh, 1 from Turkey, and 1 from Japan), 15 liver abscess 
samples (14 from Bangladesh and 1 from Korea) (Table 7.3) and in one Japanese 
sample for which the clinical information was not available. A total o f 94 mutations 
were detected with a distribution among clinical sample types: A = 19, D = 39, L = 34,
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and N/A = 2. All these mutations seem to be base substitutions except for a deletion at 
position 403 which occurred in 3 samples, 1 from each o f  the 3 clinical types (Table 7.3 
and Figure 7.2).
7.4.1. M utations in term s of positions in R-R  sequences
Table 7.3 shows all the positions where mutations could be detected in relation to the 
hypothetical consensus sequence (Figure 7.2). The 94 mutations were dispersed among 
68 positions in the consensus sequence. The frequency o f  a mutation at a particular 
position ranged from 1 to 9. In fact, for 59 out o f 68 positions, the mutation was 
observed in only one sample. At 4 positions mutations were observed in 2 samples and 
in 2 positions mutations were observed in 3 samples (Table 7.3).
Four out o f 5 mutations at position 35 (substitution o f G for A) occurred in 
asymptomatic samples (the 5th one was a diarrhoeal sample). Two particular positions 
were found to involve only liver abscess samples except one diarrhoeal/dysenteric 
sample - position 303 affecting 9 out o f 15 ALA samples and position 570 affecting 6 
out o f 15 ALA samples (4 samples were in common).
7.4.2. M utations in repetitive and non-repetitive sequences in R -R
In the hypothetical consensus sequence for locus R-R (Figure 7.2) we found that about 
39.4% o f the sequence (248 bases out o f total 629 bases) is made up o f the STRs and 
contained 21 o f 68 mutation sites (30.9%) (Table 7.4). O f the two most significant 
positions, 303 and 570, where we observed 15 mutations almost exclusively in 11 liver 
abscess samples, one was located in the non-repetitive region (position 303) while the 
other located in a STR region (position 570). Similarly for the other mutations we did 
not find any association with their occurrence in repetitive or non-repetitive regions in 
the sequence (data not shown). Overall the mutations are spread quite evenly across the 
sequence.
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7.4.3. Type of m utations in R -R  sequences
In R-R, we observed base substitution mutations only, except at one position where a 
base deletion occurred in 3 samples (Table 7.3). DNA substitution mutations are o f two 
types: transitions and transversions. Transitions are interchanges o f purines (A«-+G) or o f 
pyrimdines (C++T), which therefore involve bases o f similar shape. Transversions are 
interchanges between purine and pyrmidine bases, which therefore involve exchange of 
one-ring and two-ring structures. Although there are twice as many possible 
transversions, transition mutations are more common than transversions.
Although the predominant type of substitution mutation in asymptomatic (18 out o f 18 or 
100%) and diarrhoeal/dysenteric (32 out o f 38 or 84.2%) samples is transition, the 
situation is exactly opposite in the liver abscess samples where transversion (16 out 33 or 
57.6%) is the predominant type o f mutation (Table 7.5).
7.4.4. Multiple clones sequenced in R-R
PCR products were sometimes cloned and sequenced for two reasons. Firstly, occasionally 
we experienced difficulties in obtaining clean sequences from direct sequencing o f the PCR 
products. Secondly, we wanted to investigate the sequence variation among clones from 
same PCR products. In locus R-R, we sequenced 2 or more clones from 10 PCR products. 
Except for one sample (in two clones; data not shown), we detected sequence variation. A 
summary o f sequence differences among clones is given in Table 7.6.
From the Table 7.6, we can see that in 5 out o f 9 samples, the differences among cloned 
sequences were due to point mutations only at 1 (4 samples) or more (1 sample) 
nucleotide positions. Although the positions were variable, in all cases except one it was 
a ‘C ’ substitution f o r ‘T ’ (Table 7.3). In one (LAN-15) o f  the remaining 4 samples, the 
variation was due only to a variable number o f block 5 repeats. The remaining 3 samples 
contained both point mutations (mainly ‘C’ substitution for ‘T ’) and variation in repeat 
regions. No particular positions or STRs were involved at significantly higher 
frequencies.
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Table 7.3. Positions of all mutations detected in R-R sequences. All the positions correspond to the hypothetical consensus sequence.
ID / Pos.
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3402 MS33
3679-MS21
J06 c
RPS G
32311
1186(2a)-DS19
1207(7c)-DS27
1309(3a)-DS06
3042(8a)-DS08
3042-DS04
3570(3)-D522
3570(4)-DS22
3570(4a)-DS04
3570(5a)-DS10
3629(1f)-DS09
3629(1|)-DS09
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1 10 20 30 40 50 60
GCGCCTTTTT ATTCAATATA CTCC||ATACC TATCgCAUCT TTAffAC0CTC TATGTTTCTT
61 70 80 90 100 110
| t a ||g t a t a t  t a c t t a t a c t  a c t | a t t a t c  It t a t a t g i it  a t a t g t Ia t a t  a t c a c t a
120
riT
121 130 140 150 160 170 180
GT|TTATATGT TTATATGTTT K IjTGTTTAT ATGTTTATAT GTTTATATGT TTATATGT|CT
181 190 200 210 220 230 240
ATGTA|GCT| GCTTATTATT TATGTTATAT ATTTCflCTflT C||TATATTAT TTATGTgcffrj
241 250 ________ 2 6 0 ___  270___________ 280___________ 290 300
AHTTATTAT T TlilATTATTT (TTTA TlTCT TTATTTCT IT ATTTC[rTFAT TTTA[TTATCC
301 310
TAßTgTGTTC |T A
320 330 340 350 360
A T! C f l i  l’lfffÄ T  GTTATTATGT TATfTATGTTAl TTATCCTATT
361 370 380 390 400 410 420
ATAC!aTT@T ACiATTCTTg TGTTCTTATT |CTTGTTTTfl T T !aTGTTA! TATGTnCTTA
421 430 440 450 460 470 480
TlfCTTTATT TTAT^ATGl'! JTTA TG C ^T TATCCTATTA |Jt TTATTa! g TtSt TATgQ
481________ 490___________ 500___________ 5_10___________ 520___________530___________ 540
CTTATTTCTT TATTTTATTA TGTTCTTATG TTCTTATTTC TTTATTTTAT TATGTTCTTA
541 550 560 570 580 590 600
TGTTCTT ATT TCTTTATT1T ATTATGTT( f TATGIcTABt A T^TCHtTATT TTABTATGTT
601 610 620 629
ATTATGTCCC TGTGAAGATA TCTTCATCC
Figure 7.2. The hypothetical consensus R-R sequence with mutation locations. The positions of 
mutations are shown in highlighted with blue. Sequences inside yellow boxes are STRs. This 
hypothetical consensus sequence does not exist in any of our test isolates.
Table 7.4 Proportions o f repetitive and non-repetitive sequences and positions of mutations in 
the hypothetical consensus R-R sequences.
Sequence type Base pairs (%) Number of mutation positions (%)
Non-repetitive 381 (60.6) 47 (69.1)
Repetitive 248 (39.4) 21 (30.9)
Total 629 68
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Table 7.5. Type o f mutations in R-R sequences.
Mutation
type
Clinical types
Total
Asymptomatic
Diarrhoeal / 
dysenteric
Liver abscess *N/A
Transitions 18 32 14 2 66
Transversions 0 6 19 0 25
Insertion / 
Deletion 1 1 1 0 3
Total 19 39 34 2 94
* N/A = not available.
Table 7.6. Type o f variations in R-R cloned sequences from the same individuals. All mutation 
positions mentioned were relative to the consensus sequence. Only the mutations that differed 
between clones are mentioned.
ID Clone
identification
Differences between clones
1186-DS19
2a A point mutation at position 143
2b No point mutation
2c No point mutation
3570-DS10 5a
A point mutation at position 440
5b No point mutation
3042-DS08 8a
A point mutation at position 570
8c No point mutation
1143-MS34 5
A point mutation at position 473
9 No point mutation
3047-MS50
7 A point mutation at position 585
8 A point mutation at position 84
10 Two point mutations at positions 98 and 594
12 No point mutation
LAN-15 4i
Two repeats in block 5 (Figure 7.1)
4j Three repeats in block 5 (Figure 7.1)
3629-DS09
I f
Point mutations at positions 344 and 380, 
and 7 repeats in block 2 and 5 repeats* in block 3
lj
Point mutations at positions 237, 267, 286, 316, 448, and 578, 
and 5 repeats in block 2 and 6 repeats* in block 3.
3570-DS04
4a A point mutation at position 391 and 6 repeats* in block 3
4b 5 repeats* in block 3.
3570-DS22
3 Point mutations at positions 216 and 287 
and 2 repeats in block 5
4 Point mutations at positions 35 ,1 4 7 ,2 4 2 ,2 6 2 , and 423 
and block 5 repeats were absent
*STR sequence: TTATTTCT
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7.5. STR-based sequence types in locus S-D
Across all 128 samples a total o f 14 distinct S-D sequence types were detected 
containing either 3 (first 8 types) or 2 (types 9-14) distinct STRs (Figure 7.3). Two o f 
the STRs comprised 9 bases each while the 3rd comprised 8 bases and was present in 
a non-tandem fashion in some types (block 2 in Figure 7.3). The most variable STR 
type was repeated between 3 and 19 times (block 1 in Figure 7.3).
a) In Bangladesh:
Ten out o f the 14 sequence types were represented in Bangladeshi clinical samples 
(Figure 7.3 and Table 7.7). Some sequence types are more common than the others. 
Five sequence types (1, 2, 3, 11, and 14) were represented by only one or two 
samples each, and all o f these except one (11) were from symptomatic patients. The 
three most common sequence types, 7 ,10 and 12, covered about 75.0% (60/80) o f all 
samples with a fairly equal prevalence among clinical types - asymptomatic (A) = 
84.2% (16/19), diarrhoeal/dysenteric (D) = 70.6% (12/17), and liver abscess (L) = 
72.7% (32/44) (Table 7.7). Sequence types 6 and 12 seemed to occur in more L 
samples compared to A or D samples -  A = 10.5%, D = 11.8% and L = 29.5%. A 
similar association for either A or D samples was not found.
b) In other parts o f the world:
Non-Bangladeshi samples displayed 9 sequence types (Figure 7.3 and Table 7.7). 
Some sequence types were more common than the others. Five sequence types (4, 5, 
6, 9, and 13) were represented by only one or two samples each. The two most 
common sequence types, 10 and 12, covered 70.8% (34/48) o f all samples including 
83.3% (15/18) o f all D samples. Four sequence types (4, 8 ,9 , and 13) were unique to 
the non-Bangladeshi samples, and were not seen in any o f  the Bangladeshi samples.
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7.5.1. Analysis of S-D sequence type among clinical groups
We analyzed whether the different sequence types show a statistically significant association 
among the 3 types o f samples. Table 7.8 summarizes all the analysis results. In Bangladeshi 
clinical samples we did not find any statistically significant association (Table 7.8).
In non-Bangladeshi samples we found only one statistically significant difference, which 
was between asymptomatic and diarrhoeal/dysenteric groups (Table 7.8). This is due to 
sequence types 10 - found in 13 o f 18 diarrhoeal/dysenteric samples compared to only 4 o f 
25 asymptomatic samples, and 12 -  found in 10 o f 25 asymptomatic samples compared to 
only 2 o f 18 diarrhoeal/dysenteric samples. Since the number o f sample in the liver abscess 
group was too small (only one) it was not possible to find any statistically significant 
association with this group (Table 7.8).
In the combined samples we noticed that the differences among clinical population pairs 
were borderline negative -  suggesting an weak signal for the presence o f  distinctive 
sequence types among 3 groups (Table 7.8).
7.6. Mutations in S-D sequences
After aligning all the S-D sequences as before (Section 7.4) we identfied point mutations in 
comparison to a consensus sequence (Table 7.9; alignment not shown). These mutations 
were identified in 8 asymptomatic, 8 diarrhoeal/dysenteric, and 8 liver abscess samples, 
mostly from Bangladesh. In the diarrhoeal/dysenteric samples, 2 follow-up samples from a 
single patient (ID 3570) showed differences, while in another patient (ID 22027) 2 cloned 
sequences showed differences.
7.6.1. Mutations in terms of positions in S-D sequences
Table 7.9 shows all the positions o f the mutations that could be detected in relation to the 
hypothetical consensus sequence (Figure 7.4). The 65 mutations were dispersed among 35 
positions in the consensus sequence. The frequency of a mutation at a particular position 
ranged from 1 to 6. In fact, for 19 out o f  35 positions, a mutation was observed in only one
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*Sequence type
1
2
3
4g
5
6 
7
8g
9g
10
11B
12
13g
14b
Block Block
1 2
I------------------------- II----- 1
U  TAATAGAAA [] ATATAGAAA []  ATATAAAC
Figure 7.3. Schematic representation o f locus S-D sequence types. *Superscript ‘G’ indicates that these types were found only in non­
Bangladeshi samples, and superscript ‘B ’ indicates that these types were found only in Bangladeshi samples.
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Table 7.7. Clinical and geographic distribution o f S-D sequence types.
Seq.
type
Distribution among Bangladeshi strains Distribution among non-Bangladeshi strains
A D L Total A D L N/A Total
1 0 1 1 2 0 0 0 0 0
2 0 0 1 1 0 0 0 0 0
3 0 0 1 1 0 0 0 0 0
4 0 0 0 0 1 SA 0 0 0 1
5 2 2 1 5 1 SA 0 0 0 1
6 0 1 7 8 2 VT 0 0 0 2
7 7 4 14 25 1J,1 SA
1G , 
1 J 0 0 4
8 0 0 0 0 3 SA 0 0 0 3
9 0 0 0 0 2 SA 0 0 0 2
10 7 7 12 26 1 T, 1 1, 2 SA 2 G, 9 T, 2 VZ 0 0 17
11 1 1 0 2 0 0 0 0 0
12 2 1 6 9 2 SA, 5 VT, 2 B, 1 GER 1 M, 1 J* 1 K 4 J 17
13 0 0 0 0 0 1 0 0 1
14 0 0 1 1 0 0 0 0 0
Total 19 17 44 80 25 18 1 4 48
NB. *This Japanese isolate (J7) was from the stool specimen o f an amoebic dysenteric patient who also developed amoebic liver abscess.
A = asymptomatic, D =  diarrhoeal /  dysenteric, L = liver abscess, N/A = not available, SA = South Africa, VT =  Vietnam, J = Japan, T = Turkey, I = India, B = 
Brazil, GER = Germany, G = Georgia, VZ =  Venezuela, M = Mexico, and K = Korea.
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Table 7.8. Statistical analysis o f S-D sequence type among clinical groups.
Analysis Population pair No. o f samples Chi2 Overall P values
Bangladesh
A  & D
A = 19  
D = 17 0.137 0.9340
D & L
D = 17 
L = 44 1.239 0.5382
L & A
L = 44 
A = 19 2.593 0.2735
Non­
Bangladeshi
A & D
A = 25 
D = 18 12.194 0.0023
D & L
D = 18 
L = 1 2.322 0.3132
L & A
L = 1 
A = 25 0.000 1.000
Combined
A & D
A = 44 
D = 35 5.461 0.0652
D & L
D = 35 
L = 45 4.999 0.0821
L & A
L = 45 
A = 44
5.586 0.0612
A = Asymptomatic, D = diarrhoeal/c ysenteric, L = liver abscess.
sample. At 2 positions mutations were observed in 5 samples and in one position 
mutations were observed in 6 samples (Table 7.9).
7.6.2. Mutations in repetitive and non-repetitive sequences in S-D
About 40% o f the bases in hypothetical consensus sequence are in a non-repetitive 
region but these contained over 57% o f all mutations (Table 7.10). However, we 
did not notice any clinical association o f the distribution o f  mutations between 
repetitive and non-repetitive regions.
7.6.3. Type of mutations in S-D sequences
Unlike R-R, in S-D base insertion and deletion is relatively common -  17 out o f  65 
(26.2%) mutations are o f  this type. These included a total o f  11 insertion mutations that 
occurred in two positions in 6 samples, and 6 separate deletions o f a single base that 
occurred in 6 different samples (Tables 7.9 and 7.11). Although the most common type o f
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Table 7.9. Mutations detected in S-D sequences.
ID / Pos. CO cm
a . CO¿a cOLn co en COsn CO CM
CMCM COCM n-CM COCM CD■ rr'i COCNI
CMCO COCO «ncoCM
CO
1-0Pi
o
CM
CO■«J CMm cnm oCO c o O <o 03 coCO cnOs CD
Con. Seq. A A A A A A A A A A A A A T A A T A X X A A A G A A A I A A A A
T A T
0056-MS27 ' t
0291(i VMS32
1
1145 MS54
3570-DS22 G G
3570-DS10 G G
1309-DS06 G
29626 X
0015(bVDS05 G
34727 G
1049-DS04 T A
22027(4a) G
22027(40 X
0021-DS07 T A X A G T A T A
Ep
u iJ u u r
1
L li
U s
J Ê
1 10 20 30 40 ___________ 50________  60
AAATCCTGCC ACTGTCGTAA TCTTTTTgTA A^CATAGAAA It AATAGAAAT AATAGAAATA
61 70 80 90 100 110 120
ATAGAAATAA TAGAAATAAT AG A A AT A AT A GAAATAATAG AAATAATAGA AAT AATAGAA
12J__________130____________ 140____________ 150_____________ 160_____________170_____________ 180
ATAATAGAAA TAATAGAAAT AATAGAAATA ATAGAAATAA TAGAAATAAT AG A A ATA ATA
181________ 190 200 210 220 230 240
GAAATAATAG AAATAATAGA A ATA ATAG AA AATATAGAAA ATATAGAAAÍI AATA- - AAAA
241 250 260
GTTATf ATAT AG I AAGAA^A ñ
270 280_____________290 3()()
ATAGTATAg t |aTAT1AAIACA TATAAACÍTA TAAGGATAfA
301 310 320 330 340 341
SACATATAAA AGTATAAAAA GAGAACTCTT CAACGGGG AT T
Figure 7.4. Hypothetical consensus sequence for S-D with mutation locations. 
Sequences inside yellow boxes are parts of STRs The positions o f mutations are 
shaded blue.
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Table 7.10. Proportions o f repetitive and non-repetitive DNA in S-D sequence with 
corresponding proportions o f mutations.
Sequence type Base pairs (%) No. o f mutations (%)
Non-repetitive *136 (39.9) **20 (57.1)
Repetitive 205 (60.1) 15 (42.9)
Total 341 35
NB. *The actual number o f nucleotides in the non-repeat region was in fact 134 since in 2 positions there 
were no nucleotides. **The number o f mutations considered in terms o f positions involved. Insertion / 
deletion o f  two or more bases could have occurred at the same time, and therefore could be considered as a 
single event. Moreover, the frequency o f mutations at a particular position was not considered.
Table 7.11. Type o f mutations in S-D sequences.
Mutation
type
Clinical types
Total
Asymptomatic
Diarrhoeal/
dysenteric Liver abscess
Transitions 6 8 9 22
Trans versions 13 6 6 25
Insertion 4 4 3 11
Deletion 2 3 1 6
Total 25 21 19 65
substitution mutation in diarrhoeal/dysenteric and liver abscess samples is a transition (8 
out o f 14 or 57.1% and 9 out o f 15 or 60.0%, respectively), the situation is exactly 
opposite in the asymptomatic samples in which transversion is predominant (13 out o f 19 
or 68.4%) (Table 7.11).
7.7. M ultiple clones sequenced in S-D
In locus S-D, we sequenced 2 or more clones from the same PCR products for 19 
samples. We detected variation in one or more cloned sequences for 10 o f these samples. 
A summary o f sequence differences among clones is given in Table 7.12.
In 6 out o f 10 samples, the differences between cloned sequences were due only to 
point mutations. Clones from 3 samples showed differences due to variable number
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of STRs, while the remaining one showed differences due to both point mutations 
and copy number o f a STR (Table 7.12).
Table 7.12. Type o f variations in S-D cloned sequences from the same individuals. All 
mutation positions mentioned were in comparison with the consensus sequence 
position. Only the mutations that differed between clones are mentioned here.
ID Clone
identification
Differences between clones
4a A point mutation at position 32
4e No mutations
¿l\Jl /
4 f A point mutation at position 32 (but different from 4a)
4g N o mutations
i No mutations
ii A point mutation at position 299
a No mutations
LAID-11 b No mutations
c A point mutation at position 301
a N o mutations
AA1 c rvoA« b
A point mutation at position 278
UU1 J“U u Uj
c No mutations
d No mutations
i No mutations
LAiJJ*/4
ii 3 point mutations at positions 28, 84 and 259
5a Point mutations at positions 230 ,260,261 and 276
LAN-25 5e No mutations
5g No mutations
2c 9 repeats o f  type 1 STR’* in block 1
t a m  m 2d
8 repeats o f  type 1 STR* in block 1
LAIU'Uj
2e 9 repeats o f  type 1 STR* in block 1
2 f 9 repeats o f type 1 STR* in block 1
LAN-33
a 9 repeats total in block 1 and 2 copies in block 2
b **7 repeats total in block 1 and 3 copies in block 2
3a 18 repeats of type 1 STR* in block 1 and a mutation at position 75
LAID-04 3e 18 repeats o f type 1 STR* in block 1
3g 19 repeats o f  type 1 STR* in block 1
LAID-32
i 17 repeats o f  type 1 STR* in block 1
ii 19 repeats o f  type 1 STR* in block 1
*STR sequence: TAATAGAAA, """Missing one of each STR type.
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7.8. Discussion
Our main objectives in this study were: a) to investigate the nature o f sequence 
diversity in two tRNA linked STR loci using samples o f E. histolytica from 
Bangladesh and other parts o f the world, b) to investigate any association o f a 
particular sequence type with the clinical outcome o f infection, and c) to investigate 
whether some mutations are more common in particular type o f clinical samples. We 
were successful in achieving most o f these. However, we had some limitations in this 
study. For examples, we had relatively few clinical samples from other parts o f  the 
world, 52 and 48 samples from 11 countries other than Bangladesh in locus R-R and 
locus S-D, respectively, an average o f fewer than 5 samples from each country. In 
particular we had an extremely small number o f non-Bangladeshi liver abscess 
samples (only 2 sequences for locus R-R and 1 for locus S-D). Moreover, clinical 
information for some o f the Japanese samples was not available. We therefore were 
unable to find out whether an association between the outcome of an infection and a 
particular sequence type is the same in both Bangladesh and other parts o f the world.
The reasons for selecting loci R-R and S-D for sequencing were because R-R was one 
o f the largest and S-D one o f the smallest o f the 6 selected loci in our genotyping 
system. There are not many reports on sequencing o f polymorphic DNA from isolates 
o iE . histolytica. The only extensive study was carried out by Haghighi et al (2002 and 
2003). They studied 74 samples mainly from Japan, Bangladesh and Thailand plus a 
few reference isolates. They sequenced two tRNA linked loci, namely locus D-A 
(formerly known as locus 1-2) and locus I-W (formerly known as locus 5-6), and two 
protein coding loci, chitinase and SREHP. In terms o f polymorphism based on 
sequence types, they found that chitinase was the least polymorphic locus (9 types) 
while the SREHP was the most polymorphic (37 types). Locus D-A showed 13 types 
and locus I-W showed 15 types.
Total number o f sequence types observed in our study was comparable to the above 
studies. We found 12 and 14 sequence types for locus R-R and locus S-D from 136 
and 128 clinical samples, respectively.
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Some o f the main findings on sequence types are:
Locus R-R:
• In Bangladesh, 3 sequence types (9, 11 and 12) were found only in 
symptomatic samples (3 diarrhoeal/dysenteric and 3 liver abscess). These were not 
found in any other countries, suggesting that this is a unique Bangladeshi but relatively 
rare type that may be linked to symptomatic infection. However, since the number o f 
samples with these types is small, we should be careful in over interpreting these data.
• Sequence types 5 and 6 seem to be common in asymptomatic samples 
worldwide. In Bangladesh 77.2% (17/22) and in other countries 74.4% (29/39) o f the 
asymptomatic samples were o f these types.
• Sequence type 10 seems to be common in symptomatic samples in Bangladesh. 
In 89.5% o f cases (17/19) it was found in either diarrhoeal/dysenteric or liver abscess 
samples. Outside o f Bangladesh, it was found only in Japan infecting 1 asymptomatic 
individual and one diarrhoeal/dysenteric patient (Table 7.1).
• Sequence type 1 which was found in reference isolate HM-1 :IMSS from 
Mexico in a diarrhoeal/dysenteric patient, was also found in one o f the two Brazilian 
samples (in an asymptomatic individual) and only one o f the 84 Bangladeshi samples 
(in a diarrhoeal/dysenteric patient) suggesting that this type is rare but occurs 
worldwide.
• Three sequence types were found in 4 or more countries: type 2 (found in 
Bangladesh, Japan, Vietnam and Venezuela), type 5 (found in Bangladesh, India, 
Japan, Vietnam, Germany, South Africa and Venezuela), and type 6 (found in 
Bangladesh, Thailand, Germany and South Africa).
Locus S-D:
• Two sequence types were common in Bangladesh, type 7 and type 10. Only 
type 10 was also common in other countries, e.g., India, Thailand, Germany, 
Venezuela and South Africa infecting 17 individuals, while type 7, although found in
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3 other countries (Japan, Georgia and South Africa), was found in only 4 individuals 
(Table 7.7).
• Type 12, which was the third most common type in Bangladesh (found in 9 
samples) was also found in samples from 7 other countries (Japan, Korea, Vietnam, 
Germany, Venezuela, Brazil and South Africa). This is the most widely distributed S­
D type in terms o f the number o f  countries in which it was found.
Some findings based on mutation data:
• In locus R-R, mutations were detected in 33 Bangladeshi samples and in 5 
samples from 4 other countries (Japan, Korea, Turkey and Brazil). A total o f 94 
mutations were detected at 68 positions o f the hypothetical consensus R-R sequence.
• In locus S-D, mutations were detected in 22 Bangladeshi samples and in other 3 
samples, all from Vietnam. A total o f 65 mutations were detected at 35 positions o f the 
consensus sequence.
• The length o f the hypothetical consensus sequences in R-R is 629 bp and in S-D 
is 341. So, in terms o f total number o f mutations detected in two loci, 94 in locus R-R 
and 65 in S-D, it seems that S-D is more susceptible to mutation than R-R.
• In locus R-R, two different mutations seemed to be linked with liver abscess 
samples. Fifteen point mutations affecting positions 303 and 570 (with relation to the 
hypothetical consensus sequence) were found only in liver abscess samples, except for
• one diarrhoeal sample (Table 7.1). Many o f these were A/T transversions which 
occurred 19 out o f 21 times in liver abscess samples (Table 7.5). However, only 11 out 
o f 45 liver abscess samples showed these mutations overall.
• In S-D, the situation is different. Transversions are more common in 
asymptomatic samples (68.4%) compared to diarrhoeal/dysenteric (42.9%) and liver 
abscess (40.0%) samples. Overall no strong mutational links to any o f the clinical 
sample type was observed in locus S-D sequences.
• Insertion or deletion mutations appeared to be more common in S-D sequences 
than in R-R: 26.2% (17 out o f 65 mutations) o f all mutations in S-D were o f this type 
compared to only 3.2% (3 out o f  94 mutations) in R-R (Tables 7.4 and 7.9).
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We cloned some o f the PCR products into vectors and then sequenced them. We did 
this for two reasons. One, we wanted to know if  there were any differences in the 
clones coming from the same PCR products, and two, direct sequencing o f some o f the 
PCR products was not possible for a few samples, as the sequences could not be read 
in the chromatogram (data not shown). In locus R-R, variation among cloned 
sequences was observed in 9 out o f 10 samples. However, variation in cloned 
sequences was relatively less common in S-D sequences as only 10 out o f 19 samples 
showed variations among the clones. Both point mutations and STR number variation 
were observed in both loci.
It was very surprising to find such a high degree o f variation between cloned 
sequences from the same PCR product. The difference in sizes o f some clones was 
sufficient to be detected in the gel electrophoresis, however, we never noticed 
additional bands, suggesting that their relative frequencies in the genome are low and 
we observed only the major products in the gel. It is unlikely that the mutations were 
introduced by Taq polymerase during PCR amplification, since the maximum sizes o f 
these loci were only about 630 bases for R-R and 340 bases for S-D. Moreover, when 
we repeated the sequencing we observed the same results. Point mutations and size 
differences were also evident in raw genome sequences for tRNA-linked array units 
from isolate HM-1:IMSS, which were generated directly from genomic DNA and no 
amplification was involved. For example the STR regions in the arrays [YE], [VF] and 
[WI] show length variation, although the sequences are very closely related (Clark et 
al, 2005). However, the significance o f this clonal difference is not clear.
In summary, we found some evidence that certain sequence types were more frequent 
in certain sample types. Likewise, certain mutations also showed a link to certain 
sample types. Overall, however, no clear predictive value could be attached to any 
particular feature o f  the sequences generated here.
As expected the PCR product size variation observed by gel electrophoresis was 
largely due to variation in STR number. However not all PCR products o f the same 
size had the same sequence and not all STRs showed variation in number. The factors 
that determine the length and organization o f these loci are still not clear. We believe
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that sequencing of more clinical samples from other parts o f the world other than 
Bangladesh may confirm some o f these findings.
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CHAPTER 8
DETERMINATION OF COPY NUMBER OF STR LOCI IN THE
E. HISTOLYTICA GENOME
8.1. Introduction
Repetitive DNA sequences have been utilised in the study o f E. histolytica 
polymorphism for about the last two decades. Some o f these DNAs code for proteins 
and some do not. The most polymorphic locus in E. histolytica is the serine rich 
Entamoeba histolytica protein (SREHP) gene (Stanley et al, 1990; Kohler and Tannich, 
1993; Clark and Diamond, 1993; Ghosh et al, 2000; Ayeh-Kumi et al, 2001; Haghighi 
et al, 2002 and 2003). The chitinase gene (de la Vega et al, 1997a,b; and Haghighi et al, 
2002 and 2003) is also polymorphic. Non-coding DNA sequences, for example, the 
strain specific gene (SSG) (Burch et al, 1991), also known as Tr (Sehgal et al, 1994), 
have also been used to study polymorphism in E. histolytica (Clark and Diamond,
1993). The repeated nature o f the DNA in all these loci has been well characterised, and 
the number o f  these genes in the genome has been established. SREHP and chitinase are 
both single copy chromosomal genes while the extra-chromosomal SSG is maintained 
on the ribosomal episome at about 200 copies per genome.
We have been investigating the polymorphism of STRs linked to tRNA genes in E. 
histolytica for the study o f genetic diversity (Chapters 4 and 5). We have also 
investigated in detail the sequences o f two tRNA linked STRs, namely R-R and S-D 
(Chapter 7). However the copy number of these loci in the genome is still unknown.
From the raw sequence data from the E. histolytica genome sequencing it was 
impossible to estimate accurately the copy number o f these tRNA arrays in the genome. 
This is mainly because the two genome sequencing projects (The Institute o f Genome 
Research, USA and The Wellcome Trust Sanger Institute, UK) used 4 different types o f 
libraries, 2 with short inserts o f about 2 kb each and 2 with relatively larger inserts of 
about 8 kb each. The cloning vectors were also propagated in different bacterial hosts. 
As a result, although tRNA containing sequences were abundant in all cases, their 
relative numbers differed significantly between these different libraries. Therefore we
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have undertaken a small scale investigation to estimate the copy numbers o f these tRNA 
loci in the E. histolytica HM-1:IMSS genome.
8.2. Materials and methods
We used a quantitative hybridisation method to determine the copy number o f  a 
selection o f the tRNA arrays. The principle steps involved in this experiment are 
outlined in Figure 8.1 and are described briefly below.
8.2.1. Amplification of STR locus to be estimated
The STR locus for copy number estimation was first amplified using species-specific 
primers, where possible, or tRNA primers. The amplified products were then purified to 
get rid o f primers using the Qiagen PCR purification kit according to the manufacturer’s 
instructions.
8.2.2. Quantification of amplified products
We used Hyperladder II (Promega, UK) as a standard to quantify the PCR products 
(since its fragment sizes and the corresponding amounts o f DNA were known) after 
running them together in a 1.5% agarose gel (Figure 8.2). The levels o f fluorescence 
produced by the PCR products were compared to those produced by the fragments o f 
the standard DNA using the Phoretix software (Molecular Dynamics/Amersham 
Bioscience).
8.2.3. Counting of E. histolytica trophozoites and isolation of DNA
E. histolytica isolate HM-1:IMSS was the source o f genomic DNA. Before extracting 
the genomic DNA, the E. histolytica trophozoites were counted using a 
haemocytometer. The genomic DNA was isolated using the CTAB method (Section 
2.2.1).
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8.2.4. Blotting of PCR products and genomic DNA
A range o f dilutions o f both PCR products (106 -  104 copies) and genomic DNA (106 -  
5xl04 cells) were boiled and then fixed to a nylon membrane using a slot blot apparatus. 
In addition, 107 copies o f PCR products representing all STR regions were included on 
a separate control membrane to evaluate cross-hybridisation.
8.2.5. Hybridisation with STR locus specific probes
The membranes were hybridised with a probe prepared using the corresponding locus- 
specific PCR product. This was produced either using the corresponding tRNA primers 
or, where possible, using species specific primers in order to minimise the inclusion o f 
tRNA gene regions; this is because certain tRNA genes show a significant degree o f 
sequence similarity.
8.2.6. Exposure to Phosphorlmager screen
After hybridisation with a 32P labelled specific probe, the membranes were exposed to a 
Phosphorlmager screen and the results were quantified using ImageQuant 5.0 software 
(Amersham Biosciences).
8.3. Results
8.3.1. Quantification of amplified products
Pooled PCR products o f different sizes were separated in a gel containing different 
amounts o f the Hyperladder II standard (Figure 8.2). An example o f the calculated copy 
number o f  PCR products is given in the Table 8.1.
8.3.2. Cross hybridisation
In addition to blotting a known amount o f PCR product and genomic DNA, we also 
included all STR locus-specific PCR products on a separate membrane (including the 
test locus), approximately 107 copies o f each, to evaluate any cross hybridisation. The
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tRNA array unit
•PCR amplification o f the STR 
locus
(Big arrows = tRNA genes 
Small arrows = PCR primers)
[ • 4 ------------------- ■ ♦ ]
—  —  —  —  PCR products
•Quantification o f  
amplification 
products using 
standard marker
E. histolytica trophozoites
• Counting o f  total 
number o f  cells in 
the culture
• Isolation o f  
genomic DNA
Genomic DNA
•Blotting o f  known 
numbers o f  amplification 
products onto membrane
Nylon membrane
Blotting o f  DNA  
from know n 
numbers o f  cells 
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• Hybridisation with STR 
locus specific probe
• Exposure to phosphor- 
imager screen
Figure 8.1. Principal steps involved in the determination o f STR locus copy number.
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(a) (b)
Hyperladder II Hyperladder II
1 2 H i  b  c 1 3 4 5 6 H i  b  c P  7 8
Hyperladder II
1000 bp 
800 bp
600 bp 
400 bp
200 bp
Figure 8.2. Gel electrophoresis o f STR-locus specific PCR products (a) with the 
standard, Hyperladder II (b). The specific PCR products shown are identified in Table 
8 . 1.
hybridisation signals obtained in Phosphorlmager analysis were measured as relative 
(%) signals in comparison to the test locus. For example, using the E. histolytica 
species-specific S-D probe on the control membrane, we observed that 80% of the 
signal was due to locus S-D hybridisation and the remaining 20% was due to locus D- 
STGA (10.4%) and locus D-A (9.6%) products. In this case there is an obvious 
explanations for the cross hybridisation. D-S1GA gave 10.4% signal because the same 
two tRNA genes are present - both loci (D-S1GA and S-D) are derived from the same 
array, [SD], On the other hand, although S-D and D-A are found in two different arrays 
([SD] and [ASD], respectively) the Asp tRNA genes are identical in sequence and this 
is probably the basis for the 9.6% of cross hybridization signal seen. However, in many 
cases, we could not find any obvious explanations for the sometimes high degree o f 
cross hybridisation observed at other loci (data not shown). We tolerated up to 30% of
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cross hybridisation for any particular locus and the Table 8.3 shows the cross­
hybridisation values observed for some loci.
Table 8.1. Quantification o f PCR products.
Gel
lanes
STR
locus
Neat volume 
applied (pi)
Amount
(ng)
PCR product 
cone, (ng/pl)
PCR product 
size 
(bp)
Copy numbers 
per pi o f PCR 
product 
(x 10u)
1 R-5 1.5 69 46 838 0.49
1 R-R 1 89 89 686 1.18
1 E-V 2 66 33 581 0.52
1 S-L 3 61 20.3 480 0.38
1 *L-S 1 68 22.6 426 0.48
1 T-L 1.5 53 35.3 373 0.86
1 Q-C 1 86 86 222 3.52
2 I-W 5 28 5.6 702 0.07
2 V-F 1 52 52 492 0.96
2 G-Gtcc 1 45 45 461 0.89
2 S-Q 1 71 71 392 1.64
2 S 1UA-D 1 64 64 257 2.26
3 P-P 0.5 51 102 738 1.25
3 K-N2 0.5 45 90 642 1.27
3 L-T 1.5 48 32 561 0.52
3 T-Q 2 23 11.5 473 0.22
3 D-A 1 48 48 402 1.08
4 H-H 1 52 52 631 0.75
4 R-T 1 72 72 559 1.17
4 E-Y 1 46 46 492 0.85
4 N-Kl 3 27 9 422 0.19
5 T-X 0.5 48 96 620 1.40
5 A-A 0.5 45 90 559 1.46
5 S-A 0.5 42 84 490 1.56
6 M-R 0.5 50 100 610 1.49
6 V-5 1.5 55 36.6 510 0.65
6 T-R 5 28 5.6 441 0.12
7 *L-A 0.5 67 134 522 2.31
7 S-P 0.5 76 152 473 2.92
8 G-Gocc 1 97 97 810 1.08
8 D-S 1 99 99 550 1.63
8 N-K2 1 98 98 489 1.82
NB. The formula used for the calculation o f copy number o f PCR product was: 
1 pg o f a 1000 bp DNA = 9.1 x 10u molecules.
* The amplification was done using species specific primers.
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10x104 5x104 1x104 .75x104 ,5x104 ,25x104
HM-1:IMSS cells -► 
S-D PCR products-►
10x106 5x106 1x106 .5x106 1x10s 1x104
Figure 8.3. Signals from Phosphorlmager screen for genomic DNA and locus S-D PCR 
products. The inserted line indicates the similar intensity bands.
Hybridisation signals on 
Phosphorlmager
Figure 8.4. Relative (%) hybridisation signals on Phosphorlmager with locus S-D probe. 
The signals from genomic DNA from various cell numbers are showing linear 
correlation except for two lowest numbers o f cells. The horizontal dotted line indicates 
the signal from PCR products used for the estimation o f copy number o f the STR locus 
S-D (18.7%, Figure 8.3), which fell in the linear range o f the signals produced by cells.
Table 8.2. Relative (%) signals due to genomic DNAs from HM-1:1MSS cells and locus 
S-D PCR products at various dilutions. All signals should add up 100%.
10 X 104 
cells* 
41.8%
5 x  104 
cells 
19.8%
1 x 104 
cells
3.8%
0.75 x 104 
cells 
2.7%
0.50 x 104 
cells 
1.1%
0.25 x 104 
cells 
1.0%
S-D
10 x 106 copies 
18.7%
S-D
5 x 106 copies 
8.8%
S-D
1 x 106 copies 
1.7%
S-D
0.5 x 106 copies 
0.3%
S-D
1 x 105 copies 
0.3%
S-D
1 x 104 copies 
0.0%
♦Indicates the number cells from which genomic DNA was isolated.
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Table 8.3. Relative (%) signals on Phosphorlmager screen due to cross hybridisation.
STR locus Signal due to cross-hybridisation
G -G ICC 7.7%
H-H 15.2%
G-Gucc 30.0%
S-D 20.0%
T-Q 28.0%
R-T 20.0%
V-F 2.0%
A-A 30.0%
L-S 30.0%
I-W 5.0%
R-R 28.0%
S-Q 25.0%
Table 8.4. The estimated STR locus (or array) copy number.
STR locus Array name Copy number per cell
G-Gtcc [Gtcc] 134
H-H [Hgtg] 126
G-Ggcc
1----1
uCJoO
120
s tga-d [SD] 264
Q-T [TQ] 125
T-R [RT] 80
V-F [VF] 110
A-A [Aagc] 70
L-S [LS] 81
W-I [WI] 209
R-R [Rtc t ] 92
S-Q [SQCK] 147
8.4. The estim ation of copy num ber of the arrays
An example o f the relative hybridisation signals for genomic DNA originally isolated 
from a variable but known numbers o f  cells are plotted in Figure 8.4. Except for the 
signals from low number o f cells (e.g., 0.25 x 104 and 0.50 x 104 cells), cell numbers
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gave rise to linear hybridisation signals. From the relative (%) hybridisation signals due 
to i) genomic DNA, ii) STR locus-derived PCR product, and iii) cross-hybridisation on 
the control membrane, we estimated the copy number o f the STR locus (or array) in the 
genome. For an example, for the STR locus S-D, the 80% specific signal (because the 
cross-hybridisation was 20%, Table 8.3) shows that 5 x 104 cells contain approximately 
10 x 106 copies o f  S-D (Figure 8.3). Taking into account only the specific signal, each 
cell contains 264 copies o f S-D. So the copy number o f STR locus S-D (which is same 
as array [S-D]) is approximately 264 per genome (Table 8.4). The Table 8.4 shows the 
results o f the estimated copy numbers for a selection o f loci.
8.5. Discussion
The overall prevalence o f tRNA containing sequences as well as o f a particular array in 
the two E. histolytica sequencing projects differ significantly (data not shown). This is 
likely to be because different sized inserts and different vectors were used. In addition, 
the cloned fragments were also propagated in different bacterial hosts. So the variation 
in prevalence may be due to variable stability o f  the array units in the different libraries. 
We have independently seen this when we cloned part o f  the [SD] array from different 
strains as PCR products and noticed that clones in only one orientation were ever 
recovered. So it is impossible to estimate the actual copy number o f these arrays from 
the genome sequence data. Therefore it was decided to investigate the true number o f  
these array units in the E. histolytica genome.
There were several limitations in our experimental procedures. One, during the genomic 
DNA isolation there will be some loss o f DNA, but it is impossible to know the exact 
amount o f this loss. Two, in the cross hybridisation control we included all the STR 
regions adjacent to tRNA genes. However, any cross hybridisation outside o f  these STR 
regions, although highly unlikely, was not considered. Three, not all the probes were 
produced using species-specific primers; this was simply because we did not have 
species-specific primers available for all STR loci. Otherwise, we might have prevented 
some undesired cross hybridisation due to sequence similarities among tRNA genes. 
However it is worth mentioning that most o f  this cross hybridisation was random, no 
sequence relevance was detected (data not shown).
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Nevertheless, we have some evidence that our experimental results are reliable. Firstly, 
for one array ([VF]) the predicted array length based on pulsed-field gel electrophoresis 
using a frequent cutting restriction endonuclease that does not cut in the array unit 
(Zaki, unpublished) matches well with the copy number estimated by this quantitative 
hybridization (100 copies versus 110 copies, respectively). Secondly, taking an average 
o f about 130 copies (Table 8.4) and an average array unit length o f 975 bp (Clark et al, 
2005) for the 25 arrays gives a value o f 12.1% o f the estimated 26.13 Mb genome 
(including tRNA-linked sequences) being made up o f the tRNA arrays, which is close 
to their percentage representation in the total raw sequence data, which is just under 
11% (B. Loftus, personal communication and Loftus et al, 2005).
Based on the available experimental data the projected copy number o f tRNA genes in 
the E. histolytica genome is approximately 6500, using a value o f 2 tRNA genes per 
array (since the total tRNA genes in 25 arrays was 49) with an average o f 130 copies 
each. This is over 36 times the number found in the Schizosaccharomyces pombe 
genome and about 10 times the number in the human genome (including pseudogenes). 
The significance o f this high copy number in E. histolytica is unclear. In addition, the 
difference among the copy number o f different tRNA genes is just over 3.8-fold (70 to 
264 copies) in E. histolytica, compared to a projected 6-fold (1 to 6 copies) difference 
among Trypanosoma brucei tRNA genes (Tan et al, 2002).
Preliminary analysis o f tRNA gene organization in other Entamoeba species has 
revealed that arrays are present, although their organization varies (Tawari and Clark, 
unpublished). Clustering o f tRNA genes is known from T. brucei (Tan et al, 2002) but 
no tandem arrays or associated STRs have been observed. No evidence for clustering o f 
tRNA genes is found in Dictyostelium (Glockner et al, 2002), a distant relative o f 
Entamoeba (Bapteste et al, 2002).
PCR amplification success at a particular locus in E. histolytica may be directly linked 
to its copy number in the genome. As a result, PCR amplification o f the multi-copy STR 
loci was found to be more successful than amplification o f the single-copy SREHP gene 
in stool DNA and liver abscess DNA (Roy S, personal communication). Moreover, in
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the same sample sets, the amplification o f STR locus S-D (about 264 copies per 
genome) was more successful than locus R-R (about 92 copies per genome).
A comparison o f tRNA gene copy numbers in a selection o f E. histolytica isolates may 
provide information on whether the copy numbers o f these tRNA genes are variable 
among strains. Similarly, a comparison could also be made with non-pathogenic 
Entamoeba species that infect humans, like E. dispar or E. moshkovskii, to investigate 
whether there are quantitative differences in these arrays between them.
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CHAPTER 9
COMPARISON OF INTESTINAL AND LIVER ABSCESS STRAINS 
OF E. HISTOLYTICA FROM SAME PATIENTS
9.1. Introduction
It is well established that variable clinical outcomes result from E. histolytica infections. 
Most infections remain asymptomatic, some develop intestinal diseases like diarrhoea 
and dysentery, and only a few develop extra-intestinal complications like liver abscess. 
In Chapters 4 and 5 we investigated the association between the genotypes o f strains 
and the clinical outcomes of infection. We found that associations do exist, although we 
also noticed contradictions, for example, a genotype which was identified as linked to 
asymptomatic infection in Bangladesh was found in diarrhoea or liver abscess cases in 
other countries, and vice-versa.
Liver abscess is the most common extra-intestinal infection o f£ . histolytica, and is 10 
times more common in men than in women but is a rare disease in children (Haque et al, 
2003). There are variable reports on the proportion o f amoebic liver abscess patients 
who had concomitant presence o f E. histolytica in stool specimens, ranging from less 
than 10% (Katzenstein et al, 1982) to as high as 70% (Irusen et al, 1992). However, in 
E. histolytica, there have been no reports comparing the genotypes o f strains identified 
in stool with those identified in the liver abscess o f the same patients. We therefore were 
interested in whether the E. histolytica strain that was detected in the stool sample, that 
is ‘the intestinal strain’, was different from that detected in the liver abscess pus sample 
o f the same ALA patient.
9.2. Samples
Eleven amoebic liver abscess (ALA) patients provided both liver abscess and stool 
specimens during 1998-99 (Haque et al, 2000). They were admitted to different private 
and public hospitals and clinics in Dhaka city with symptoms o f ALA.
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9.3. Results
9.3.1. PCR amplifications and gel electrophoresis results at STR loci
At first, a simple PCR amplification was attempted at all 6 loci using the tRNA primers 
for all 11 pairs o f samples. However the success o f PCR was very low, especially with 
stool DNAs (data not shown), and therefore we decided to use nested PCR (Section 
2.3.3) using the first PCR product as the template for the nested PCR with species- 
specific primers. However PCR still was not successful for all loci. Locus S-Q showed 
multiple band patterns for almost all o f these samples for unknown reasons. In most 
cases, amplification o f the stool derived DNA was unsuccessful, while the 
corresponding liver abscess DNA was amplified successfully. PCR results for 5 loci, 
omitting locus S-Q, are shown in Table 9.1. The STR PCRs for D-A, A-L and S-D were 
the most successful, while the R-R and N-K2 PCRs were least successful.
The combined gel electrophoresis patterns for all 5 loci showed that the intestinal and 
the corresponding liver abscess patterns were different in all 11 pairs o f samples 
(Figures 9.1 and 9.2, Table 9.1). However, the degree o f difference was variable. Only 
one pair o f samples, LAN-11, showed PCR pattern variation in only one locus (N-K2) 
out o f 5, whereas the remaining pairs showed much greater differences. Four pairs o f 
samples showed variation at 2 out o f 3 loci, another 4 pairs showed variation at all 3 
positive loci and the remaining 2 pairs (LAN-47 and LAN-61) showed variation at all 4 
positive loci.
O f the seven pairs o f products selected for sequencing 4 pairs o f products were different 
in size from each other, 2 pairs appeared to be the same and for the remaining pair it 
was difficult to be sure whether there was a size difference (Figure 9.2b, lanes 1 and 2).
9.4. Sequence results of PCR amplified products
We have been able to sequence 7 pairs o f PCR products obtained from these samples, in 
which one product o f the pair was derived from the LA DNA and the other from the
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stool DNA of the same patient. Table 9.2 summarizes a comparison between PCR 
patterns and sequence results.
Sequence results verified all the corresponding gel observations, and in addition clearly 
revealed that the pair o f samples that were too close in size to be differentiated by gel 
electrophoresis were indeed different in sequence (Figure 9.3f). In this pair, we found 
that the size difference in STR locus D-A from the liver abscess DNA and the stool 
DNA was 9 base pairs.
Table 9.1. PCR patterns with DNA samples from liver abscess and stool specimens of 
same ALA patients.
Patient
ID
$Gel
lane serial
DNA
source
PCR patterns: same (s) or different (d)
A-L D-A R-R N-K2 S-D Overall
LAN-11 Fl-1 LA s s s d s D
Fl-2 ST
LAN-15 F2-1 LA d d?(seq) - - d D
F2-2 ST
LAN-25 F 1 -3 LA * s d? * d D
F l-4 ST
LAN-33 F2-3 LA d (seq) d - - s (seq) D
F2-4 ST
LAN-37 F2-5 LA d d - - d (seq) D
F2-6 ST
LAN-42 F2-7 LA d s (seq) - d£ d DF2-8 ST
LAN-46 F2-9 LA d d - - d DF2-10 ST
LAN-47 Fl-5 LA d d d * d DF l-6 ST
LAN-51 F2-11 LA d s - - d DF2-12 ST
LAN-61 F2-13 LA d d (seq) - d£ d DF2-14 ST
LAN-62 F2-15 LA d d (seq) - - d DF2-16 ST
NB. FI = Figure 9.1; F2 = Figure 9.2; LA = liver abscess; ST = stool; * = stool DNA did not amplify; 
‘£’ = not shown in the Figure; ‘- ‘= negative for both samples; d? = difference was unclear; (seq) = these 
products have been sequenced.
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(a)
Locus A-L Locus R-R Locus N-K2
M dl 2 3 4 5 6 * 1  2 3 4 5 6 1 ! 2 3 4 5 6  '¡VI
(b)
Locus D-A Locus S-D
M r \ 2 3 4 5 6 ' Ï  2 3 4 5 6 1
500 bp — «
Ml
#  Ml Ml Ml
«M i <».» «M l *  "* * *
Figure 9.1. PCR fragment size polymorphism at 5 STR loci using DNA samples from 
liver abscess (odd numbered lanes) and stool specimens (even numbered lanes) o f  3 
amoebic liver abscess patients: LAN-11 (1 & 2), LAN-25 (3 & 4) and LAN-47 (5 & 6).
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500 bp
Locus A-L
(b)
Locus D-A
Locus S-D
Figure 9.2. PCR fragment size polymorphism at 3 STR loci using DNA samples from 
liver abscess (odd numbered lanes) and stool (even numbered lanes) specimens o f 8 
amoebic liver abscess patients: LAN-15 (1 & 2), LAN-33 (3 & 4), LAN-37 (5 & 6), 
LAN-42 (7 & 8), LAN-46 (9 & 10), LAN-51 (11 & 12), LAN-61 (13 & 14) and LAN- 
62 (15 & 16).
In STR locus A-L, we sequenced only one pair, and these showed variation only in the 
number o f STRs except for one position where an additional nucleotide ‘A ’ was found 
in the liver abscess sequence. A schematic representation o f STRs is provided in Figure 
9.3a and this also highlights the only base insertion or deletion seen in the 
chromatograms of the two sequences.
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At STR locus S-D, one pair o f  sequences showed a difference in having one extra STR 
of 9 bases in the stool sample while the other pair was identical (Figures 9.3b and 9.3c, 
respectively).
At STR locus D-A, 3 out o f 4 pairs o f samples showed differences in sequence. There 
were no sequence differences in LAN-42 (Figure 9.3d). In LAN-61, the difference is 
due to both variable number and organisation o f two types o f  STRs (Figure 9.3e). 
However, most striking finding of this sequence analysis is that for the remaining two 
pairs o f samples (LAN-15 and LAN-62), the patterns o f sequence differences are 
identical between the two liver abscess and two intestinal strains (Figures 9.3f and g). In 
other words LAN-15Land LAN-62Lare identical as are LAN-15S and LAN-62S.
Table 9.2. The comparison between PCR patterns and sequence results o f liver abscess 
versus stool DNA from ALA patients.
ID STR locus PCR pattern Sequence
LAN-33 A-L different different
LAN-15 D-A different? different
LAN-42 D-A same same
LAN-61 D-A different different
LAN-62 D-A different different
LAN-33 S-D same same
LAN-37 S-D different different
different? = difference was unclear.
168
LAN-33S Ala‘ <;<
I TATAAAGG 
] TATAAAAG 
] AGTATAGA
] ATAAAGTG 
I ATAAAGTA 
I GATATAAA
(b)
LAN-37S
(c)
LAN-3 3 L
I TAATAGAAA []  ATATAAAC
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(cl)
LAN-421
(e)
LAN-611
( f)
LAN-1 5l
LAN-15
A s p 1
A s p I D
)--------------------------- ■ A i a
A l a
TGC
(g )
LAN-62l
LAN-62S
A s p '
GTC
A s p
GTC
E -
A I a TGC^--------------------
AlaTGC
| CTTTATTAT [] CTTTATTA 
TTTT ATT AT []  TTTT ATT A
Figure 9.3 (a-g). Schematic representation o f sequences of PCR products from liver (L) 
abscess DNA and stool (S) DNA from the same ALA patients.
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9.5. Locus D-A sequence com parison with 10 G enBank sequences
Since we observed something very striking in locus D-A sequences - two ALA patients 
showed identical sequences in their intestinal strains and also showed identical identical 
but distinct sequences in their corresponding liver abscess strains, we aligned our 
sequences with those o f 10 available D-A (formerly locus 1-2) sequences deposited in 
GenBank by Haghighi et al (2002 and 2003; GenBank accession numbers AB075701-7 
and AB096653-5, respectively; alignment not shown) in order to know how common 
these sequence types were compared to others. Four samples, 3 from liver abscess 
(LAN-15,42 and 62) and one from stool (LAN-42), showed identical sequence to each 
other and to 26 o f the Haghighi sequences. Three samples, all from stools (LAN-15,61 
and 62), showed identical sequence to each other and to one Thai isolate (TM27) from 
an amoebic colitis patient. The remaining D-A sequence (LAN-61L) showed identical 
sequence to two isolates, one isolated from an asymptomatic Ghanaian individual and 
the other from a Japanese ALA patient’s stool who had amoebic colitis at the same 
time. This finding suggests that all these sequence types are globally distributed.
9.6. Discussion
In this study, 11 pairs o f E. histolytica DNA samples isolated from stool and liver 
abscess o f the same ALA patient were analysed genotypically in order to determine 
whether strains that had metastasized to liver tissue differed from those in intestinal 
sites. We believe that this is the first investigation o f this type in E. histolytica and the 
results we found were very interesting: the intestinal strain was different from the liver 
abscess strain in all 11 ALA patients investigated. This observation was supported by 
another: in the same samples, although the nested SREHP PCR was successful for only 
three pairs, all three revealed that the intestinal and liver abscess strains were different 
from each other (S. Roy, ICDDR,B, personal communication). There are two possible 
explanations for these findings. First, the E. histolytica intestinal population contains 
multiple genotypes, and only a subpopulation has migrated to the liver via blood 
circulation and caused a liver abscess. It must be a minor subpopulation since the ‘liver 
abscess’ bands are not visible in the stool sample patterns. However we do not know
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why only a minor variant in each o f eleven patients’ infections would show a preference 
for the liver tissues, while the major population remained in the intestine. Second, there 
may be DNA reorganisation or recombination events taking place when the amoebae 
migrate from the intestine to the liver. As more than one locus was usually observed to 
differ this recombination would have to be extensive and widespread in the genome.
In order to genotype these strains we used all 6 STR-locus based PCRs, but some 
amplifications were more successful than others. For example, D-A and S-D PCRs were 
successful for all 22 samples but R-R and N-K2 were unsuccessful for a majority o f the 
samples. In addition, locus S-Q showed some unusual multiple band patterns with these 
samples. There are two possible explanations for this. One, these samples had been 
preserved in freezers for the last 5-6 years and may have undergone repeated freezing 
and thawing, which resulted in random degradation o f the DNA. Two, it is possible that 
the variable success in PCR amplifications is a direct consequence o f the variable copy 
number o f these loci in the genome. For example, the most successful PCR, S-D, has 
about three times as many copies as R-R in the genome (approximately 264 copies 
versus 92 copies, respectively; Table 8.4, Clark et al, 2005). In general, PCR 
amplification was more successful in liver abscess DNA compared to corresponding 
stool DNA. This is possibly because the number o f parasites in the stool samples was 
fewer than in the corresponding liver abscess samples.
One o f the reasons for sequencing some o f the PCR products was to better understand 
the nature o f the differences between intestinal and liver abscess strains in the sample 
pairs. Although the overall degree o f difference we observed was high, in two particular 
ALA patients (LAN-15 and LAN-62) we noticed something very striking. In these two 
patients, their intestinal strains showed identical sequences in locus D-A, and both liver 
abscess strains showed identical sequences to each other but different from the intestinal 
ones, suggesting that during the metastasis from intestine to the liver the same event 
(either subpopulation selection or DNA reorganisation) took place in two unrelated 
ALA patients. However the following facts strongly argue against the two patients 
being infected by the same mixture o f E. histolytica:
One, there was a more than 7 month gap between the two sample collection dates of 
LAN-15 (1.4.1999) and LAN-62 (18.11.99), so there is almost no chance that the two
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patients were infected from the same source with the same mixture o f  E. histolytica 
strains.
Two, there was no identity in PCR product sizes between these two pairs o f samples at 
locus A-L (Figure 9.2a, lanes 1&2 and 15&16) or locus S-D (Figure 9.2c, lanes 1&2 
and 15&16), which clearly suggests that all 4 o f these strains o f E. histolytica are 
genetically different from each other.
We were then interested to see how frequently we might expect the two sequence types 
(the intestinal type and the liver abscess type) to be found i f  they were in 2 unrelated 
samples. In order to investigate this we compared our sequence types with those 
observed by Haghighi et al (2002 and 2003). They detected 13 sequence types from 74 
patients in locus D-A (formerly known as locus 1-2). If  we assume that their result is 
also a reflection o f sequence types in Bangladeshi strains then we can see that the 
frequency of the LAN-15 and LAN-62 liver abscess type, (i.e. type D o f Haghighi et al, 
2002 and 2003) was 26 out o f 74. Similarly, the frequency o f the LAN-15 and LAN-62 
intestinal type, (i.e. type K o f Haghighi et al, 2002 and 2003) was only 1 out o f 74. 
Therefore, the probability o f  these two types being found in two samples is 26/74 x 1/74 
or 0.0047 (i.e. less than a 0.5% chance). This suggests that it is very unlikely that this 
identical change o f  DNA sequence in this locus has happened simply by chance. 
However, we failed to find a similar change o f DNA in other loci, based on comparison 
o f gel patterns at other STR loci for these two patients. So, it seems more likely that the 
DNA reorganisation during metastasis is somewhat random - it does not affect all loci 
in the same way -  if  that is indeed what is occurring.
In Leishmania ( Viannia), a very similar investigation using genotypic analysis o f 
kinetoplast DNA RFLP patterns in ten pairs o f strains isolated from mucosal and 
cutaneous lesions o f the same patients found that each o f the 10 cutaneous strains was 
different from their counterpart mucosal strains. The authors suggested that the 
population that had reached the mucosal tissue may have been a subpopulation o f the 
original inoculum (Cuervo et al, 2004). However, some information on the sequences o f 
the relevant loci could add some vital support to their conclusion. Nevertheless, their 
results show a striking parallel to those found here for E. histolytica.
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In a study by Haque et al (2000), lectin antigens were detected in the serum o f 32 out o f 
98 ALA patients in Bangladesh. This indicates it might be possible to amplify E. 
histolytica DNA from the whole blood of ALA patients. It might be possible to 
investigate the genotypes o f strains in the stool, blood and liver abscess o f the same 
ALA patient. Such an investigation could provide vital additional information on 
whether the observed differences in the genotypes of intestinal and liver abscess strains 
in this study are the consequence o f DNA recombination or a variable intestinal 
population.
Finally, in the absence o f a suitable animal model for the production o f ALA following 
oral or caecum inoculation o f amoebae, we believe that it will be very difficult to prove 
what is actually happening during the metastasis o f the amoebae from intestine to the 
liver, unless we see many more recurrent patterns o f DNA differences similar to those 
we observed for patients LAN-15 and LAN-62 in locus D-A. We also believe that it is 
worth investigating whether this observation is common in pairs o f samples from ALA 
patients in other parts o f the world.
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CHAPTER 10
CONCLUDING REMARKS AND FUTURE PROSPECTS
Despite an annual death toll o f up to 100,000 people from E. histolytica infection, the 
epidemiology and virulence pattern o f E. histolytica is not very clear at present. In this 
study we wanted to address some of the important gaps surrounding the organism’s 
genetic epidemiology: one, how many genetically distinct E. histolytica strains circulate 
in a geographically restricted population?, two, is the asymptomatic or symptomatic 
outcome o f an E. histolytica infection linked to the genotype o f the infecting amoeba?, 
and three, do E. histolytica strains show organ tropism?
Firstly, we have investigated the organism’s genetic diversity not only in samples from 
a restricted area in Bangladesh but also in samples from some other countries using the 
multilocus genotyping system we developed. In general, the diversity among strains was 
high, increased as we studied more loci, and liver abscess strains showed the most 
variation.
Secondly, the analysis o f results clearly showed that the E. histolytica genotypes 
detected in 3 clinical populations -  asymptomatic, diarrhoeal/dysenteric and liver 
abscess -  are indeed different from each other, suggesting that the outcome o f infection 
is somehow linked to the genotype o f the infecting strain. In addition a few individual 
genotypes showed a specific association with the outcome o f infection, although the 
number o f samples covered by these genotypes is not very high and therefore their 
predictive value is low.
Thirdly, it is not clear from our results whether E. histolytica strains show organ tropism 
although we noticed that the strains identified in stool samples and the corresponding 
liver abscess pus samples from the same ALA patient were different. The exact basis o f 
this observed difference is not clear. H E. histolytica in the gut is a polyclonal 
population, then we do not know why it is always only a minor population that 
possesses the ability to migrate to the liver. Alternatively if  DNA reorganization events 
are taking place during metastasis o f the amoeba, then we do not know why it occurs or 
what the trigger is.
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Unique organization and abundance o f tRNA genes are two distinctive features o f E. 
histolytica. About one-tenth o f all genomic sequences contain tRNA genes and they are 
organised in 25 distinct units that are repeated tandemly in the genome. The intergenic 
STRs have not been identified in any other species except for E. dispar. So it is unlikely 
that similar tRNA-gene linked genotyping approaches may be applied to other 
Entamoeba species, thus making this a novel approach unique to E. histolytica and E. 
dispar.
The advantage o f our genotyping system over the most widely used polymorphic 
marker in E. histolytica -  SREHP - is that it does not require any restriction 
endonuclease digestion to reveal all the variants and produces a single major product for 
each locus in the amplification. In addition, our tRNA-gene linked arrays are multicopy 
compared to single copy SREHP gene, and this presumably makes it easier to detect the 
amoeba in biological samples, e.g., stool and liver abscess pus. Most importantly our 
genotyping has shown some links between genotype and outcome o f infection which no 
other typing methods in E. histolytica have ever shown.
In some protozoan parasites microsatellite markers have been used successfully in the 
genotyping o f species and strains. For example, the Plasmodium falciparum  genome has 
an abundance o f microsatellite loci: 1 such locus is found in every 2-3 kb o f genome. 
They have been used to analyse traits that are inherited in progeny o f an experimental 
cross, and to analyse the genetic structure o f parasite populations around the world 
(Machado et al, 2004). Microsatellites have also been used in genotyping o f species of 
Cryptosporidium (Widmer et al, 2004), Toxoplasma (Ajzenberg et al, 2005; Blackston 
et al, 2001), Leishmania (Bulle et al, 2002; Schwenkenbecher et al, 2004) and Giardia 
(Huetink et al, 2001). However, despite experimental efforts by Zaki and Clark (2001) 
no microsatellite was isolated from E. histolytica and the genome sequence revealed 
that they were almost absent from this species. Since the tandem repeat DNA element is 
short in microsatellites, e.g., 2-3 bases, it often requires special equipment such as 
sequencing gels to detect the size variation among samples. In our tRNA based 
genotyping system, the STRs are often 8 bases or longer, making it easier to detect the 
size variation in a conventional gel.
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As mentioned above the most exciting finding of our study is that the genotypes o f E. 
histolytica found in asymptomatic, diarrhoeal/dysenteric and liver abscess samples are 
significantly different from each other. All asymptomatic and a majority o f 
diarrhoeal/dysenteric samples were from children o f a similar age from Mirpur. So, the 
observed differences in these two sample groups are more like those that could be 
expected from a case-control study. However the liver abscess samples were from adult 
patients and from a much larger area o f Bangladesh. As a result there is a possibility that 
some o f the observed differences in genotypes between liver abscess and other two 
clinical groups are due to geographical variation. So we believe that more appropriate 
samples, e.g., 3 types o f clinical samples from individuals from same age-group and 
living in the same geographic area, would be more informative.
Although our tRNA-linked genotyping data found (i) significant differences in genotypes 
between clinical populations, (ii) an association o f a few individual E. histolytica 
genotypes with the clinical outcome of infections, and (iii) that transversion mutations are 
more common in locus R-R o f liver abscess strains, it is highly unlikely that these tRNA 
genes or arrays are directly involved in the virulence process o f the parasite. However the 
findings suggest that these tRNA-gene arrays are somehow linked to factors that are 
responsible for determining the outcome o f infection. One possibility is that these arrays 
and the factors determining the outcome may be physically linked to each other, for 
example they may occur on the same chromosome in the genome. As a result, 
investigation can be narrowed down to those corresponding chromosomes to search for 
factors influencing the outcome o f infection. Other approaches such as microarray-based 
comparative genomic or mRNA hybridisation could then be used to identify such 
determining factors.
We observed that some o f the tRNA-linked loci showed little or no polymorphism in both 
E. histolytica and E. dispar strains and these were not selected for genotyping. Two such 
loci, E-V and X-T, however, showed significant PCR product size differences between 
the two species (Figure 10.1). Although locus E-V showed some variation among E. 
dispar isolates the product size difference with!?, histolytica isolates is always about 100 
bp. Similarly there is about a 100 bp size difference between E. histolytica and E. dispar 
locus X-T products. So, either o f these two PCRs could potentially be used as a
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diagnostic tool to detect E. histolytica and E. dispar simultaneously in a single PCR 
reaction.
A B
E-V E-V
Figure 10.1. PCR product size variation between E. histolytica and E. dispar isolates. (A)
11 E. histolytica isolates showing almost no PCR product size differences at either locus E- 
V or locus X-T. (B) 9 E. dispar isolates are showing some PCR product size variation at 
locus E-V but not locus X-T.
Multiple strains o f E. histolytica infecting the same individual are probably a rare event as 
we detected only one such case in a Mirpur child. In consecutive months, follow-up 
samples o f this child revealed that it had gained and lost a transient infection. This finding 
probably contradicts the hypothesis that symptomatic infections o f  E. histolytica may be 
linked to multiple strains being involved in the infection process (Zaki et al, 2002), as the 
child that showed the multiple strains remained asymptomatic throughout.
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One o f the extraordinary findings o f  this study is the high prevalence o f E. moshkovskii in 
Mirpur children. Most but not all o f these E. moshkovskii infections were identified in 
association with an E, histolytica or E. dispar infection. I f  this is true for other parts o f the 
world, then epidemiological data which were and are based on microscopic identification 
of these parasites will be under serious question. Furthermore many o f the DNA based 
investigations o f E. histolytica and E. dispar did not check the specificity o f  their methods 
with E. moshkovskii DNA. However, our species-specific genotyping method should not 
amplify E. moshkovskii DNA.
The follow-up samples in this study have shown that these tRNA-linked markers are 
generally stable in the same individual, for up to 11 months. A longitudinal study in 
Vietnam using 2 o f the tRNA-linked loci -  I-W and N-K - also found that the patterns 
mostly remained genetically stable during asymptomatic infection, over an observation 
period o f about 15 months (Blessmann et al, 2003). However it is not clear how such a 
large number o f genotypes can be detected in a small geographic area like Mirpur despite 
this observed genetic stability in the host. This seems to be a contradiction. How the 
genotype diversity is generated needs to be investigated.
We believe that the multilocus genotyping method described in this study will provide the 
necessary tools to answer many of the questions that still exist surrounding the 
epidemiology and variable virulence o f E. histolytica infection worldwide, e.g., 
are any E. histolytica strains intrinsically invasive for all individuals?, do invasive E. 
histolytica strains differ in their capacity to produce disease?, do E. histolytica strains show 
variablity in their capacity to elicit an immune response in the host?, are epidemics / 
outbreaks o f E. histolytica ever caused by a single strain o f E. histolytica? To address such 
questions will require significant additional work and samples that are not currently 
available.
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APPENDIX I
Appendix I. tRNA primers.
Array name STR name§ Primer name§ Sequence (5' to 3') AT
[Aagc] A-A
A-A5 CATTCGCTTAGCATGCAGGG
54
A-A3 GCTCTCCATCTGAGCTACAT
[ALL]
A-L
A-L5 GGATCGATACCCCTCATCTCCA
64
A-L3 CGCATCTTGCGATAGCCGAG
L-A
L-A5 TCTAAGGGGGCCGATTTAAGCT
62
L-A3 CTTCGCATGCGAAGCGAA
[ASD]
A-S
A-S5 GGGGGTGTAGCTCAGATGGTA
59
A-S3 CTGCTAAGGAGTTTCCATTTGG
Sgct-D
Sgct-D5 CCAAATGGAAACTCCTTAGCAG
58
Sgct-D3 CACGTGACAGGCGAAGATAC
D-A
D-A5 (EhRl)$ CTGGTTAGTATCTTCGCCTGT
56
D-A3 (EhR2)$ CTTACACCCCCATTAACAAT
[Ggcc] Ggcc-G
Ggcc-G5 TTCGATTCCCGGCAAGTGCA
59Ggcc-G3 GGCAGGG AT ACGTCAT ACC A
[Gtcc] g tcc-g
Gtcc-G5 GTTCGAGTCCCGGCAAAT
62Gtcc-G3 TGCCCTTAGACCACAAATGC
[Hgtg] H-H
H-H5 GATTCCTGGTGTGAGCATC
56
H-H3 GCCACAATCTGATGTACTACCTC
[LSI
L-S
L-S5 TACGGATCTCTTCGGAGGCG
61
L-S3 CACACGCCTTAGACCACTCG
S-L
S-L5 CGAGTGGTCTAAGGCGTGTG
62
S-L3 AGACCACTCGGCCACTCTTG
[LT]
L-T
L-T5 CCCACCTCTTGCATTTTA
55
L-T3 CCATCTATGCTAAGAGGCC
T-L
T-L5 AGGCCTCTTAGCATAGATGG
54
T-L3 CCTCCGAAGAGAACAGTACC
[MR]
M-R
M-R5 TACGCTCTACCAACTGAGCTAC
56
M-R3 TCGATCCCTGCTATGCTC
R-M
R-M5 CAATGGAACCGCATCAGACT
58
R-M3 TGAGTATCGAACTCAAGACC
[NK]
N-K
N-K5 CGAACGGCTGTTAACCGTTA
55N-K3 TTCCTAGCTCAGTCGGTAGA
K-N
K.-N5 TCTACCGACTGAGCTAGGAAGG
60K-N3 TTCGCTCTGCCGACTGAG
[PTGG] P-P
P-P5 GTGGTAAAATACCCGCTTTGGGTGCG
59P-P3 GGAATCGAACCCGGGCCACC
[R5]
R-5
R-5 5 CTGGGGATTGCAGGTTCGATC
64R-5 3 TCACACAGATGGGAACGTCAGG
5-R 5-R5 CCTGACGTTCCCATCTGTGTGA 645-R3 CGTTTCCATTGCGCCACA
[Rtc t] R-R R-R5 AGCATCAGCCTTCTAAGCTG 55R-R3 CTTCCGACTGAGCTAACAAG
[RT]
R-T R-T5 CCTAAGCAGAAGATCGTGGGTTCG 64
R-T3 GAATCGAACCCACGACCTTTCC
T-R T-R5 GGGTTCGATTCCCGCAGAGG 65
196
T-R3 CGAACCCACGATCTTCTGCTTAGG
[SD]
Stga-D Stga-D5 CTCTGGATGCGTAGGTTCAA 58
Stga-D3 GTATCTTCGCCTGTCACGTG
D-S
D-S5 C ACGTG AC AGGCG AAG AT AC
58
D-S3 TTGAACCTACGCATCCAGAG
[SPPCK] & 
[SQCK]
S-P S-P5
TCTGGAGGCGTAGGTTCGAA
61
S-P3 GTGGCATAATACTTGCTTCGGG
P-C
P-C5 ATCGAACCCAGGCCACTTGC
63
P-C3 GCGGT AGAGCATAGGACTGCAG
C-K
C-K5 AATCGGATTTGAACCAATGA
54
C-K3 TCCTAGCTCAGTCGGTAGAG
K-S
K.-S5 CCCACGACCTTACGGTTAAA
59
K-S3 AACGGCAGGATTCGAACCTA
S-Q
S-Q5 GTGGTCTAAGGCGTGTGACT
56
S-Q3 G AG ATTCT GGTTCTT AGG ACCC
Q-C
Q-C5 CTGCCACTACACCATGGAAC
56
Q-C3 GTGGTCATTGGTTCAAATCC
[TQ]
T-Q
T-Q5 GGTCCCATGACCTTCTCTTT 56
T-Q3 ATTCGAACTGGGGTCCTAAG
Q-T
Q-T5 TAGGACCCCAGTTCGAATCT 57
Q-T3 AAAGAGAAGGTCATGGGACC
[TX]
T-X
T-X5 GGCGGTTT AGCTT AGCGGTAG A
62
T-X3 CTCACGCAGTACCCTGTTCGT
X-T
X-T5 ACGAACAGGGTACTGCGTGAG
62
X-T3 GGCGACTATGGGGATCGAAC
[V5]
V-5
V-55 CACATCACTTTT ACGT AGTG AGG
55
V-53 ATAATGGTACTGATCAGGCTCT
5-V
5-V5 AGAGCCTGATCAGTACCATTAT
55
5-V3 AACCAACTACACCATGAAACC
[VF]
V-F
V-F5 GGTTTCATGGTGTAGTTGGT
55
V-F3 G A ACTTCAGT CT AACGCTGC
F-V
F-V5 TAAAAGGGGGAAGAATAGGAA
55
F-V3 GGTTTCATGGTGTAGTTGGT
[VME5]
V-M
V-M5 CACTTTCACGTAGTGAGGGTCC
59
V-M3 CAGGTCGGTTGATCGAAACT
M-E
M-E5 AGTT AT GAGCCTGCCGCG
62
M-E3 GTAACATGCAAGCCTCTCACG
E-V
E-V5 GTGAGAGGCTTGCATGTTACC
59E-V3 GG ACCCTC ACT ACGTG AA AGTG
[WI]
W-I
W-I5 GCCGGTCAGTGGTTCAATCC
63W-I3 GCGACCCTGGCGTTATTAGC
I-W
I-W5 (R6A)$ CTCAGTCGGTAGAGCATGGT
56I-W3 (R5A)$ CTAAAGCCCCCTTCTTCTATAATT
[YE]
Y-E
Y-E5 CCTTAGGTCACTGGTTCGAA
55Y-E3 CACAAACGTGAAAGGCTTGT
E-Y E-Y5 TACATAAGTCGTGGTAAAGAGAAG 52E-Y3 CTACATCTACAGTCCTCCGCT
§ = The anticodon sequence o f  the tRNA is used in the identification where necessary; AT = Annealing 
temperature; X = G+C rich region o f  unknown function; $ = these primers were previously described by Zaki 
et al (2002 and 2003a) using the different names given inside the brackets; ¥ = this primer is adjacent to but 
not within the tRNA indicated.
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APPENDIX II
Appendix II. Genotypes o f all Bangladeshi E. h is to ly tic a  using 6 loci.
S e r ia l ID
C lin ic a l
s ta tu s
E . h is to ly t ic a  s p e c if ic  P C R  a t 
S T R  lo c u s
G e n o ty p e
D - A A -L R - R N - K 2 S -D S -Q
1 1 3 5 4 -M S 6 9 A 2 3 3 9 4 2 7
2 * 3 4 0 2 - M S 3 4 A 2 3 3 9 6 3 8
3 3 3 4 6 - F S 7 .2 A 2 3 4 4 6 3 12
4 3 7 9 2 - M S 2 0 A 2 3 4 4 6 3 12
5 0 1 9 9 - M S 3 4 A 2 3 4 6 6 3 13
6 1 2 9 6 -M S 3 4 A 2 3 4 6 6 3 13
7 1 6 8 1 -M S 3 4 A 2 3 4 6 6 3 13
8 0 0 4 1 - M S 3 4 A 2 3 4 9 3 3 18
9 3 6 0 0 - M S 3 4 A 2 3 4 9 3 3 18
10 1 0 0 4 -M S 3 1 A 2 3 4 9 4 8 19
11 1 3 2 5 -M S 3 3 A 2 3 4 9 4 8 19
12 3 3 9 4 -M S 3 1 A 2 3 4 9 4 8 19
13 1 0 3 6 -M S 5 9 A 2 4 5 9 3 2 2 4
14 1 6 3 1 -M S 6 1 A 2 4 5 9 3 2 2 4
15 4 3 0 9 - M S  10 A 2 4 5 9 9 5 2 5
16 4 1 9 8 - M S 1 0 A 2 5 5 9 3 2 2 6
17 3 6 4 5 -M S 3 1 A 3 2 1 6 4 3 3 4
18 3 5 9 9 - M S 3 3 A 3 2 1 7 4 4 3 5
19 4 1 9 4 -M S  10 A 3 2 2 11 5 4 3 7
2 0 0 0 2 4 -M S 5 1 A 3 2 3 8 3 6 4 0
21 3 0 4 6 - M S 5 0 A 3 2 3 8 3 6 4 0
2 2 3 6 7 9 - M S 2 4 A 3 3 1 8 4 3 4 5
23 0 0 5 5 - M S 2 3 A 3 3 3 9 3 5 51
2 4 0 0 5 8 - M S 2 7 A 3 3 3 9 3 5 51
2 5 0 8 6 8 - F S 7 .7 A 3 3 3 9 3 5 51
2 6 3 4 5 4 -M S 3 1 A 3 3 3 9 3 5 51
2 7 1 3 2 5 -M S 2 2 A 3 3 3 9 4 3 5 2
2 8 3 4 9 7 - M S 2 0 A 3 3 3 9 4 3 5 2
2 9 0 2 9 1 - M S 3 2 A 3 3 4 3 2 3 5 8
3 0 3 4 3 3 -M S 2 1 A 3 3 4 3 3 3 5 9
31 3 4 8 4 - M S 2 2 A 3 3 4 6 4 3 6 3
3 2 1 1 4 3 -M S 3 4 A 3 3 4 9 4 3 6 8
3 3 3 1 9 3 - M S 2 0 A 3 3 4 9 6 3 6 9
3 4 3 3 4 6 - M S 3 2 A 3 3 4 9 10 3 71
35 0 2 9 1 - M S 4 2 A 3 3 5 1 2 2 7 2
3 6 3 0 4 0 - M S 2 4 A 4 3 1 7 4 3 8 5
3 7 3 2 2 2 - M S  19 A 4 3 4 5 3 3 8 7
3 8 3 7 6 0 - M S 3 3 A 5 3 3 9 3 3 91
3 9 3 5 7 0 - D S 0 4 D 2 3 1 8 3 5 5
4 0 3 1 9 1 - D S 1 2 D 2 3 4 3 6 1 9
41 * * 3 4 7 2 7 D 2 3 4 8 4 8 15
4 2 * * 2 2 0 2 7 D 2 3 4 8 6 3 17
4 3 10 4 9 - D S 0 4 D 2 3 4 9 4 8 19
4 4 0 0 1 7 -D S 0 1 D 2 3 5 8 4 3 21
4 5 * * 2 9 6 2 1 D 3 1 3 8 3 6 3 0
4 6 * * 2 4 7 0 3 0 0 D 3 2 2 5 5 7 3 6
4 7 3 0 4 2 - D S 0 4 D 3 3 1 8 4 3 4 5
4 8 3 6 4 6 - D S 0 9 D 3 3 1 8 4 3 4 5
4 9 4 2 0 4 -D S 0 1 D 3 3 1 8 4 3 4 5
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5 0 1 1 8 6 -D S 2 0 D 3 3 3 1 3 3 4 6
51 0 0 2 1 - D S 0 7 D 3 3 3 6 3 3 4 8
5 2 1 1 8 6 -D S 1 9 D 3 3 3 8 3 3 4 9
53 0 0 2 1 - D S  10 D 3 3 3 8 4 3 5 0
5 4 1 7 6 7 -D S 2 0 D 3 3 3 8 4 3 5 0
55 4 1 9 6 - D S 0 2 D 3 3 3 8 4 3 5 0
56 0 0 1 5 - D S 0 5 D 3 3 3 9 3 5 51
5 7 0 0 2 7 - D S 1 7 D 3 3 3 9 3 5 51
58 3 4 9 7 - D S 0 2 D 3 3 3 9 3 5 51
5 9 5 0 2 7 - D S 0 2 D 3 3 4 1 3 3 5 3
6 0 3 5 7 0 - D S 2 8 D 3 3 4 1 3 4 5 4
61 5 0 3 9 -D S 0 1 D 3 3 4 1 3 4 5 4
6 2 2 9 7 7 - D S 0 2 D 3 3 4 1 4 3 5 6
63 5 0 1 7 - D S 0 2 D 3 3 4 1 4 3 5 6
6 4 1 0 5 7 - D S l  1 D 3 3 4 3 2 3 5 8
65 1 0 3 6 -D S 0 1 D 3 3 4 4 4 3 6 2
6 6 0 8 8 3 - D S 0 4 D 3 3 4 8 3 3 6 4
6 7 4 2 8 3 -D S 0 1 D 3 3 4 8 3 4 6 5
68 0 0 2 7 - D S 1 3 D 3 3 4 8 4 3 6 6
6 9 0 1 3 9 - D S 0 2 D 3 3 4 8 4 3 6 6
7 0 1 0 4 8 -D S 0 1 D 3 3 4 8 4 3 6 6
71 3 6 7 9 - D S 1 5 D 3 3 4 8 4 r  3 6 6
7 2 3 7 4 2 - D S 0 2 D 3 3 4 8 4 3 6 6
73 4 0 4 5 - D S 0 4 D 3 3 4 8 4 3 6 6
7 4 4 1 3 0 -D S 0 1 D 3 3 4 8 4 3 6 6
75 4 2 8 0 -D S 0 1 D 3 3 4 8 4 3 6 6
7 6 4 2 8 1 -D S 0 1 D 3 3 4 8 4 3 6 6
7 7 5 0 1 4 -D S 0 1 D 3 3 4 8 4 3 6 6
7 8 0 0 6 4 - D S 0 6 D 3 3 4 9 3 3 6 7
7 9 1 2 9 2 -D S 0 5 D 3 3 4 9 6 4 7 0
8 0 3 0 4 7 - D S 0 8 D 3 3 4 9 10 3 71
81 5 0 2 8 - D S 0 3 D 3 3 5 8 4 2 7 4
8 2 4 2 4 7 - D S 0 5 D 3 4 3 5 4 5 7 6
83 1 0 3 6 -D S 0 6 D 3 4 3 9 3 5 7 7
8 4 0 8 6 8 - D S 0 4 D 3 4 5 9 3 2 7 9
85 3 6 4 5 - D S 1 4 D 4 2 1 4 5 4 8 0
8 6 3 5 7 0 - D S 1 4 D 4 3 3 8 4 2 8 6
8 7 * * 3 4 6 1 4 D 4 4 1 4 4 5 8 9
8 8 * * 3 2 3 1 1 D 5 3 3 3 11 2 9 0
8 9 L A I D - 0 2 L 2 2 1 5 2 6 1
9 0 L A ID -4 1 L 2 2 4 8 4 8 2
91 L A ID -3 9 L 2 2 6 8 9 4 3
9 2 L A ID -3 3 L 2 3 1 8 3 4 4
93 L A I D - 0 6 L 2 3 1 8 4 4 6
9 4 L A ID -0 3 L 2 3 4 3 6 4 10
9 5 L A N - 6 7 L 2 3 4 4 4 4 11
9 6 L A ID -2 9 L 2 3 4 8 4 6 14
9 7 L A N - 2 7 L 2 3 4 8 4 9 16
9 8 L A I D - 3 7 L 2 3 5 8 3 4 2 0
9 9 L A I D - 1 1 L 2 4 5 4 1 4 2 2
10 0 L A I D - 19 L 2 4 5 8 3 2 2 3
101 L A ID -3 8 L 2 4 5 8 3 2 2 3
102 L A ID -2 5 L 3 1 1 4 5 4 2 7
103 L A N - 5 0 L 3 1 1 5 5 3 2 8
1 0 4 L A P -0 1 L 3 1 1 5 5 4 2 9
105 L A ID -0 8 L 3 2 1 4 6 5 31
10 6 L A ID -3 1 L 3 2 1 4 7 4 3 2
107 L A N -4 7 L 3 2 1 5 5 4 3 3
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108 L A N -4 8 L 3 2 3 8 2 4
oo
109 L A N -6 2 L 3 2 3 8 3 4 3 9
11 0 L A N -6 8 L 3 2 3 8 3 4 3 9
111 L A I D - 12 L 3 2 3 8 4 4 41
112 L A ID -0 5 L 3 2 3 8 4 6 4 2
113 L A N -5 8 L 3 2 4 8 3 1 4 3
114 L A N -2 5 L 3 2 4 8 3 4 4 4
115 L A N -5 1 L 3 3 3 4 4 3 4 7
116 L A I D - 2 4 L 3 3 4 1 4 2 55
11 7 L A I D - 10 L 3 3 4 1 4 4 5 7
118 L A I D - 13 L 3 3 4 3 6 3 6 0
119 L A N -3 9 L 3 3 4 4 3 3 61
120 L A I D - 14 L 3 3 4 8 4 3 6 6
121 L A I D - 3 4 L 3 3 5 1 5 4 7 3
12 2 L A N -4 2 L 3 3 5 8 4 2 7 4
123 L A N - 15 L 3 3 5 8 1 0 4 7 5
1 2 4 ' L A N -3 3 L 3 4 4 2 4 11 7 8
125 L A P - 0 2 L 4 2 3 4 3 4 81
126 L A I D - 4 0 L 4 2 3 5 3 10 8 2
127 L A N -5 7 L 4 3 1 1 4 2 83
128 L A I D - 18 L 4 3 1 5 3 4 8 4
129 L A ID -3 6 L 4 3 4 8 3 10 8 8
130 L A ID -0 1 L 5 3 4 3 2 5 9 2
131 L A ID -3 2 L 5 3 4 6 8 3 9 3
.rv — a&yinpiuiiiaiu;; u  = aiaiTnoeai / aysenieric; ana l , — amucuia uvci aosccss.
*Seven follow-up samples were available from this child. All these showed genotype 7 as o f  MS34 
sample, but MS33 seemed to be transiently infected by another strain which had a unique genotype. The 
transient strain showed PCR patterns: A-L = 3, D-A =3, R-R = 3, N-K2 = 3, S-D = 3, and S-Q = 3, but 
this transient genotype was not considered in the analysis for simplicity. ""These samples were 
collected from the ICDDR.B hospital.
A-L D-A N-K2 R-R S-D S-Q
1=480 1=290 1=500 1=480 1=180 1=320
2=500 2=300 2=530 2=500 2=200 2=330
3=510 3=330 3=540 3=570 3=210 3=340
4=530 4=340 4=560 4=590 4=220 4=350
5=540 5=350 5=580 5=600 5=230 5=360
6=390 6=600 6=680 6=240 6=370
7=620 7=280 7=400
8=630 8=290 8=410
9=650 9=300 9=420
10=690 10=330 10=490
11=700 11=350 11=500
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APPENDIX III
Appendix III. DAR genotypes o f all Bangladeshi E. h is to ly tic a .
S e r ia l ID
C lin ic a l
E . h i s to ly t ic a  s p e c if ic  P C R  a t 
S T R  lo c u s D A R
g e n o ty p es ta tu s D-A A-L R-R
1 1354-MS69 A 2 3 3 5
2 3402-MS34I71 A 2 3 3 5
3 0041-MS34 A 2 3 4 6
4 0199-MS34(2) A 2 3 4 6
5 1004-MS31 A 2 3 4 6
6 1296-MS34 A 2 3 4 6
7 1325-MS33I2I A 2 3 4 6
8 1681-MS34I2) A 2 3 4 6
9 3346-FS7.2 A 2 3 4 6
10 3394-MS31 A 2 3 4 6
11 3600-MS34 A 2 3 4 6
12 3792-MS20 A 2 3 4 6
13 1036-MS59 A 2 4 5 8
14 1631-MS61 A 2 4 5 8
15 4309-MS10 A 2 4 5 8
16 4198-MS10 A 2 5 5 9
17 3599-MS33 A 3 2 1 12
18 3645-MS31 A 3 2 1 12
19 4194-MS10 A 3 2 2 13
20 0024-MS51 A 3 2 3 14
21 3046-MS50 A 3 2 3 14
22 3679-MS24(21 A 3 3 1 16
23 0055-MS23(2) A 3 3 3 17
24 0058-MS27 A 3 3 3 17
25 0868-FS7.7 A 3 3 3 17
26 1325-MS22 A 3 3 3 17
27 3454-MS31 A 3 3 3 17
28 0291-MS32 A 3 3 4 18
29 1143-MS34 A 3 3 4 18
30 3193-MS20 A 3 3 4 18
31 3346-MS32(2) A 3 3 4 18
32 3433-MS21 A 3 3 4 18
33 3484-MS22(2) A 3 3 4 18
34 0291-MS42 A 3 3 5 19
35 3040-MS24 A 4 3 1 25
36 3222-MS19 A 4 3 4 27
37 3760-MS33 A 5 3 3 29
38 3570-DS04 D 2 3 1 4
39 22027 D 2 3 4 6
40 34727 D 2 3 4 6
41 1049-DS04I51 D 2 3 4 6
42 3191-DS12 D 2 3 4 6
43 0017-DS01 D 2 3 5 7
44 29621 D 3 1 3 11
45 2470300 D 3 2 2 13
46 3042-DS04I21 D 3 3 1 16
47 3646-DS09 D 3 3 1 16
48 4204-DS01 D 3 3 1 16
49 0015-DS05(61 D 3 3 3 1750 0021-DS10(2) D 3 3 3 17
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51 0027-DS17 D 3 3 3 17
52 1186-DS20Í2) D 3 3 3 17
53 1767-DS20 D 3 3 3 17
54 3497-DS02Í2) D 3 3 3 17
55 4196-DS02 D 3 3 3 17
56 0027-DS13Í2) D 3 3 4 18
57 0064-DS06Í3) D 3 3 4 18
58 0139-DS02 D 3 3 4 18
59 0883-DS04 D 3 3 4 18
60 1036-DS01 D 3 3 4 18
61 1048-DS01 D 3 3 4 18
62 1057-DS1K2Ï D 3 3 4 18
63 1292-DS05(2) D 3 3 4 18
64 2977-DS02 D 3 3 4 18
65 3047-DS08 D 3 3 4 18
66 3570-DS28 D 3 3 4 18
67 3679-DS15 D 3 3 4 18
68 3742-DS02 D 3 3 4 18
69 4045-DS04 D 3 3 4 18
70 4130-DS01 D 3 3 4 18
71 4280-DS01 D 3 3 4 18
72 4281-DS01 D 3 3 4 18
73 4283-DS01 D 3 3 4 18
74 5014-DS01 D 3 3 4 18
75 5017-DS02 D 3 3 4 18
76 5027-DS02 D 3 3 4 18
77 5039-DS01 D 3 3 4 18
78 5028-DS03 D 3 3 5 19
79 1036-DS06 D 3 4 3 20
80 4247-DS05Í3) D 3 4 3 20
81 0868-DS04 D 3 4 5 22
82 3645-DS14 D 4 2 1 23
83 3570-DS14 D 4 3 3 26
84 34614 D 4 4 1 28
85 32311 D 5 3 3 29
86 LAID-02 L 2 2 1 1
87 LAID-41 L 2 2 4 2
88 LAID-39 L 2 2 6 3
89 LAID-06 L 2 3 1 4
90 LAID-33 L 2 3 1 4
91 LAID-03 L 2 3 4 6
92 LAID-29 L 2 3 4 6
93 LAN-27 L 2 3 4 6
94 LAN-67 L 2 3 4 6
95 LAID-37 L 2 3 5 7
96 LAID-11 L 2 4 5 8
97 LAID-19 L 2 4 5 8
98 LAID-38 L 2 4 5 8
99 LAID-25 L 3 1 1 10
100 LAN-50 L 3 1 1 10
101 LAP-01 L 3 1 1 10
102 LAID-08 L 3 2 1 12
103 LAID-31 L 3 2 1 12
104 LAN-47 L 3 2 1 12
105 LAID-05 L 3 2 3 14
106 LAID-12 L 3 2 3 14
107 LAN-48 L 3 2 3 14
108 LAN-62 L 3 2 3 14
109 LAN-68 L 3 2 3 14
110 LAN-25 L 3 2 4 15
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111 LAN-58 L 3 2 4 15
112 LAN-51 L 3 3 3 17
113 LAID-10 L 3 3 4 18
114 LAID-13 L 3 3 4 18
115 LAID-14 L 3 3 4 18
116 LAID-24 L 3 3 4 18
117 LAN-39 L 3 3 4 18
118 LAID-34 L 3 3 5 19
119 LAN-15 L 3 3 5 19
120 LAN-42 L 3 3 5 19
121 LAN-33 L 3 4 4 21
122 LAID-40 L 4 2 3 24
123 LAP-02 L 4 2 3 24
124 LAID-18 L 4 3 1 25
125 LAN-57 L 4 3 1 25
126 LAID-36 L 4 3 4 27
127 LAID-01 L 5 3 4 30
128 LAID-32 L 5 3 4 30
A = asymptomatic; D = diarrhoeal/dysenteric; and L = liver abscess (amoebic).
The numbers inside the brackets indicate the number of follow-up samples showing same genotypes. 
Three samples (3497-MS20, 0021-DS07, and 1186-DS19) which were present in the Appendix II for 6- 
locus genotypes are not shown in this Appendix because follow-up samples showed identical genotypes 
with these 3 loci, but their 6-locus genotypes were different.
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APPENDIX IV
5 locus m axim um  genotypes
The combined results o f loci A-L, N-K2, R-R, S-D and S-Q (ANRSQ) produced the 5 
locus maximum number o f genotypes (91) across all Bangladeshi samples.
eBURST produced 2 minor groups -  one with 3 genotypes (88, 89 and 91) and the other 
with 6 genotypes (cluster a in the Figure A la), and one major group with 68 genotypes 
(Figure A la). We detected 6 clusters -  one ‘a’ already mentioned, and 5 others (b, c, d, e 
and f  in the Figure A la) which seemed to link genotypes o f clinical importance. Clusters a, 
c, d, and f  contained predominantly liver abscess strains, cluster e contained only 
diarrhoeal/dysenteric strains, and cluster b contained predominantly asymptomatic strains 
(Figure A la).
Appendix IV. eBURST association between genotypes using 5 ,4  and 3 loci.
5 locus m inim um  genotypes
The combined results o f loci A-L, D-A, R-R, S-D and S-Q (ADRSQ) produced the 5 locus 
minimum number o f  genotypes (74) across all Bangladeshi samples.
eBURST produced 2 minor groups -  one with 2 genotypes (55 and 56, cluster a in the 
Figure A lb) and the other with 3 genotypes (20, 22 and 60), and one major group with 60 
genotypes (Figure A lb). We detected 4 clusters -  one ‘a’ already mentioned, and 3 others 
(b, c, and d in the Figure A lb) which seemed to link genotypes o f  clinical importance. 
Cluster a contained 2 liver abscess strains only, c and d contained predominantly liver 
abscess strains, while cluster b contained predominantly asymptomatic strains (Figure 
A lb).
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a)
Clinical
type
Cluster
a b c d c f Total
A 0 16 0 0 0 2 IK
D 1 4 1 1 4 3 14
L 5 3 2 3 0 11 24
Total 6 23 3 4 4 16 56
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,Clinical
type
Cluster
a b c d Total
A 0 6 3 2 11
D 0 1 3 1 5
L 2 0 10 6 18
Total 2 7 16 9 34
Figure A l . eBURST for maximum and minimum numbers o f genotypes using 5 loci. 
Association between genotypes observed in eBURST diagrams using 5-loci a) ‘ANRSQ’ 
(91 genotypes) and b) ‘ADRSQ’ (74 genotypes).
206
The combined results o f loci D-A, N-K2, R-R and S-Q (DNRQ) produced the 4 locus 
maximum number o f genotypes (72) across all Bangladeshi samples.
eBURST produced only a major group with 60 genotypes (Figure A2a) and 12 singletons. 
We detected 4 clusters which seemed to link genotypes o f clinical importance. Clusters a, 
and d contained predominantly liver abscess and diarrhoeal/dysenteric strains, cluster c 
contained predominantly diarrhoeal/dysenteric strains, while cluster b contained 
predominantly asymptomatic strains (Figure A2a).
4 locus maximum genotypes
4 locus minimum genotypes
The combined results o f loci D-A, A-L, R-R and S-D (DARS) produced the 4 locus 
minimum number of genotypes (54) across all Bangladeshi samples.
eBURST produced only a major group with 52 genotypes (Figure A2b) and 2 singletons. 
We detected 3 clusters which seemed to link genotypes o f clinical importance. All 3 
clusters seemed to contain predominantly liver abscess and diarrhoeal/dysenteric strains, 
although asymptomatic strains were present in all o f these (Figure A2b), suggesting the 
association was weaker than we observed above for others.
207
a)
.1
,31 ,71 . 6 9
.32
. 4 5
.67
Clinical
type
Cluster
a b c d Total
A l 5 0 2 8
D 2 1 6 5 14
L 8 1 2 6 17
Total 11 7 8 13 39
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b)
Clinical
type
Cluster
a b c Total
A 1 2 1 4
D 2 3 2 7
L 6 5 3 14
Total 9 10 6 25
Figure A2. eBURST for maximum and minimum numbers of genotypes using 4 loci. 
Distribution and association of genotypes observed in eBURST diagrams using 4-locus a) 
lDNRQ’ (72 genotypes) and b) ‘DARS’ (54 genotypes).
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The combined results o f loci N-K2, S-D and S-Q (NSQ) produced the 3 locus maximum 
number of genotypes (67) across all Bangladeshi samples.
eBURST produced only a major group with 64 genotypes (Figure A3a) and 3 singletons. 
We detected 3 clusters which seemed to link genotypes o f clinical importance. Cluster a 
contained predominantly liver abscess and diarrhoeal/dysenteric strains, while clusters b 
and c contained predominantly asymptomatic strains (Figure A3 a). However, in each 
cluster we noticed presence o f other types of clinical strains and the association seemed to 
be getting weaker as we reduced the number of loci.
3 locus maxim um  genotypes
3 locus minim um  genotypes
The combined results o f loci D-A, A-L, R-R (DAR) produced the 3 locus minimum 
number of genotypes (30) across all Bangladeshi samples.
eBURST produced only one group with all 30 genotypes (Figure A3b) with no singletons. 
However, we did not find any clusters o f clinical significance in this group.
In summary, eBURST showed better association between genotypes when the number o f 
loci used was higher. As we decreased the number o f genotypes, it became easier for the 
eBURST to find more genotypes that differed by one locus and as a result it was linking 
different types o f clinical samples into the same clusters.
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a)
Clinical
type
Cluster
a b C Total
A 2 7 13 22
D 5 1 8 14
L 20 0 0 20
Total 27 8 21 56
2 1 1
b)
Figure A3. eBURST for maximum and minimum numbers of genotypes using 3 loci. 
Association of genotypes observed in eBURST diagrams using 3-loci a) ‘NSQ' (67 
genotypes) and b) ‘DAR’ (30 genotypes). No clusters of clinical significance were detected 
in DAR eBURST.
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APPENDIX V
Appendix V. Genotypes o f E. dispar strains using 6 loci. One representative follow-up 
sample was used for those showing the same genotype.
Serial ID Clinical
status D-A
A-L R-R N-K S-D S-Q Genotype
1 3570-DS04(2) D 1 1 1 9 1 7 1
2 3629-MS32 A 1 1 1 9 1 7 1
3 3498-MS33 A 1 1 1 12 1 7 2
4 3303-MS35 A 2 1 3 1 1 1 3
5 3744-MS33(7) A 2 1 3 1 1 1 3
6 1028-DS11 D 2 1 3 3 1 1 4
7 1324-MS34 A 2 1 3 3 1 1 4
8 3585-MS22 A 2 1 3 3 1 1 4
9 3742-DS05 D 2 1 3 3 1 3 5
10 1805-MS22 A 2 1 1 5 1 6 6
11 3046-MS23(2) A 2 1 3 6 1 1 7
12 3196-MS22 A 2 1 3 6 1 1 7
13 1369-FS7.2 A 2 1 1 11 1 6 8
14 1475-MS34 A 2 1 3 15 1 2 9
15 1066-MS23 A 2 2 3 9 1 1 10
16 1048-MS28 A 3 1 1 1 1 3 11
17 1008-MS25(2) A 3 1 3 1 1 1 12
18 1036-MS29 A 3 1 3 1 1 1 12
19 1071-MS33C3) A 3 1 3 9 1 6 13
20 1631-MS28 A 3 1 4 10 1 7 14
21 1805-MS34 A 3 1 3 13 1 5 15
22 3177-MS29 A 4 1 3 9 1 2 16
23 1194-MS3U4) A 4 3 3 8 1 3 17
24 0165-MS20 A 5 1 4 1 1 1 18
25 3175-MS34 A 5 1 3 7 1 1 19
26 3193-MS3312) A 5 1 3 7 1 1 19
27 3182-MS33(3) A 5 1 3 9 1 1 20
28 0017-MS35 A 5 1 3 14 1 1 21
29 0216-MS26 A 5 2 3 5 1 3 22
30 3146-MS35(31 A 5 2 3 5 1 3 22
31 3247-MS2312') A 5 2 3 5 1 3 22
32 1293-MS36 A 5 2 3 7 1 1 23
33 3319-MS35 A 5 2 3 7 1 3 24
34 3499-MS3313) A 5 2 3 7 1 3 24
35 3585-MS33 A 5 2 3 7 1 3 24
36 3320-MS24 A 5 2 3 9 1 3 25
37 1627-MS31C2’) A 5 2 3 10 1 1 26
38 3240-MS30 A 5 2 3 10 1 1 26
39 1467-MS34 A 6 1 1 9 1 5 27
40 1309-DS08 D 6 1 2 10 1 1 28
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41 3510-MS21 A 7 1 3 1 1 5 29
42 0006-MS23 A 7 1 3 4 1 4 30
43 2899-MS34(2) A 8 1 1 2 1 2 31
44 3432-DS06 D 8 2 3 3 1 3 32
A -  Asymptomatic, D = diarrhoeal/dysenteric. 
Actual band sizes (in base pairs):____________
D -A A - L R -R N - K S -D S - Q
1 = 4 2 0 1 = 4 3 0 1 = 6 0 0 1 = 5 0 0 1 = 2 1 0 1 = 2 7 0
2 =  4 3 0 2  =  4 0 0 2  =  6 1 0 2  =  5 0 0 + 5 6 0 2  =  2 9 0
3 = 4 5 0 3 = 4 3 5 3 =  6 2 0 3 =  5 5 0 3 =  2 6 0
4  =  4 6 0 4  =  5 0 0 4  =  6 3 0 4  =  4 9 0 4  =  3 5 0
5 =  4 7 0 5 =  5 5 0 + 6 2 0 5 =  3 2 0
6 =  4 8 0 6  =  5 1 0 + 5 4 0 6  =  3 1 0
7  =  4 9 0 7  =  5 5 0 + 6 3 0 7  =  3 2 0 + 4 0 0
8 =  5 0 0 8 =  5 1 0 + 5 4 0 + 5 8 0
9  =  5 3 0
10 =  5 3 0 + 6 2 0
11 =  5 3 0 + 5 7 0 + 6 2 0
12  =  4 8 0 + 5 0 0 + 5 5 0 + 6 1 0
13 = 5 0 0 + 5 1 0 + 5 3 5
14  =  4 8 0 + 5 1 0 + 6 1 0
15 =  5 1 0 + 5 4 0
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APPENDIX VI
Appendix VI. DNA samples from 11 countries used for genotyping.
Strain
origin
Sample
ID
Clinical
status
DNA
source
No. o f 
samples Reference
Brazil 462 A AC 2 Silva et al, 
1997RPS
Burma/Myanmar HB-301:NIH D AC 1 Diamond 1968
Georgia
TBC#05
D XC 9 Trapaidze,
unpublished
TBC#06
TBC#07
TBC#08
TBC#09
TBC#10
TBC#23
TBC#24
TBC#27
India Rahman A AC 1 Sargeaunt et al, 1980
Japan
J1 D XC
26 Haghighi et al, 
2002 and 2003
J2 D AC
J3 D AC
J4 NA XC
J5 A AC
*J6 A XC
J7 D+L XC
J8 D+L XC
J9 NA XC
J10 D XC
J ll L XC
ZJ12 A XC
J13 A XC
J14 A XC
J15 D XC
J16 D XC
3ÏÏ7 L XC
J18 NA XC
J19 NA XC
J20 NA XC
J21 NA XC
J22 NA XC
J23 D XC
J24 A XC
J25 A XC
J26 A XC
Korea YS-27 L AC 1 Park et al, 1999
Mexico HM-1:IMSS D AC 1 Diamond et al, 1972
South Africa SA 11 A XC 11 Zaki et al, 
2003aSA27
SA47
SA51
SA52
SA65
SA70
SA115 J
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A = Asymptomatic, AC = Axenic culture, D = Diarrhoea/dysentery, L = Liver abscess, XC = Xenic culture, 
NA = Not available, SS = Stool specimen,1 = this individual had history o f voluntary work in Ghana,2 = this 
individual had history o f  voluntary work in Cambodia,3 = this individual was a Thai national, but a migrant 
worker at Japan.
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APPENDIX VII
Appendix VII. DAR genotypes o f all non-Bangladeshi E. histolytica.
ID Clinical
E. histolytica specific PCR
Genotype
status
Strain origin D-A A-L R-R
J8 D+L Japan 2 2 4 2
SA47 A South Africa 2 3 3 5
J6 A Japan / Ghana 2 3 4 6
Hu 04-08 D Turkey 3 1 3 11
TBC#08 D Georgia 3 1 3 11
SAI 1 A South Africa 3 2 3 14
SA115* A South Africa 3 2 3 14
SAI 19* A South Africa 3 2 3 14
HB-301:NIH D Burma 3 2 3 14
124-1 A Vietnam 3 2 4 15
136-3 A Vietnam 3 2 4 15
22-15 A Vietnam 3 2 4 15
245-3 A Vietnam 3 2 4 15
278-1 A Vietnam 3 2 4 15
31-2 A Vietnam 3 2 4 15
490-1 A Vietnam 3 2 4 15
556-1 A Vietnam 3 2 4 15
557-1 A Vietnam 3 2 4 15
566-2 A Vietnam 3 2 4 15
587-1 A Vietnam 3 2 4 15
649-1 A Vietnam 3 2 4 15
659-4 A Vietnam 3 2 4 15
697-3 A Vietnam 3 2 4 15
78-1 A Vietnam 3 2 4 15
J24 A Japan 3 2 4 15
J25 A Japan 3 2 4 15
J26 A Japan 3 2 4 15
Rahman A India 3 2 4 15
SA154 A South Africa 3 2 4 15
J17 L Japan / Thailand 3 2 4 15
J18 NA Japan 3 2 4 15
J21 NA Japan 3 2 4 15
Hu 04-96 A Turkey 3 3 3 17
Hu 04-64 D Turkey 3 3 3 17
Hu 04-81 D Turkey 3 3 3 17
Hu 04-87* D Turkey 3 3 3 17
TBC#05 D Georgia 3 3 3 17
TBC#09 D Georgia 3 3 3 17
TBC#10 D Georgia 3 3 3 17
547-5 A Vietnam 3 3 4 18
576-3 A Vietnam 3 3 4 18
585-1 A Vietnam 3 3 4 18
608-3 A Vietnam 3 3 4 18
HM-1:IMSS D Mexico 3 3 4 18
TBC#23 D Georgia 3 3 5 19
Hu 04-39 D Turkey 3 4 3 20
183-2 A Vietnam 3 4 4 21
212-1 A Vietnam 3 4 4 21
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523-1 A Vietnam 3 4 4 21
529-1 A Vietnam 3 4 4 21
631-1 A Vietnam 3 4 4 21
652-3 A Vietnam 3 4 4 21
J16 D Japan 4 2 3 24
YS-27 L Korea 4 2 3 24
SA65 A South Africa 4 3 4 27
J10 D Japan 5 3 3 29
J7 D+L Japan 5 3 3 29
J9 NA Japan 5 3 3 29
SA27 A South Africa 5 3 4 30
SA52* A South Africa 5 3 4 30
TBC#06 D Georgia 1 3 3 31
TBC#07 D Georgia 1 3 3 31
TBC#27* D Georgia 1 3 5 32
SA70 A South Africa 2 1 4 33
J ll L Japan 2 2 3 34
IULA: 1092:1 D Venezuela 4 2 4 35
J19 NA Japan 4 2 4 35
#462 A Brazil 4 4 4 36
J12 A Japan / Cambodia 4 5 3 37
IULA:0593:2 D Venezuela 4 5 4 38
SA153 A South Africa 5 2 3 39
SA51* A South Africa 5 2 3 39
J2* D Japan 5 2 3 39
J22* NA Japan 5 2 3 39
155-4 A Vietnam 5 2 4 40
J13 A Japan 5 2 4 40
J14 A Japan 5 2 4 40
J1 D Japan 5 2 4 40
J15* D Japan 5 2 4 40
J20 NA Japan 5 2 4 40
RPS A Brazil 5 2 5 41
J5* A Japan 5 3 1 42
J3 D Japan 5 3 1 42
J4 NA Japan 5 3 5 43
614-3 A Vietnam 5 4 4 44
J23* D Japan 5 5 5 45
TBC#24* D Georgia 6 3 5 46
A = Asymptomatic, D = Diarrhoeal/dysenteric, L = Liver abscess, '"these showed multiple bands in one o f  the 
3 loci but only the higher intensity band was considered for genotyping for simplicity.
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